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Abstract 
The ubiquitin proteolysis pathway utilizes three enzymes, an E1 activating 
enzyme, an E2 conjugating enzyme and an E3 ligating enzyme, to respectively activate, 
transfer and ligate ubiquitin (Ub) onto a substrate protein.  The creation of a K48-linked 
poly-Ub chain on a substrate will target this protein to be degraded by the 26S 
proteosome.  E2 conjugating enzymes are central proteins in this pathway and interact 
with the E1 and E3 enzymes to perform Ub transfer.  The mechanism by which Ub 
molecules are interconnected remains poorly understood.  The E2 enzymes HIP2 and 
Ubc1 have been shown to create poly-Ub chains in the absence of E3 enzymes and 
substrates.  In this thesis, HIP2 and Ubc1 were investigated through physical and 
structural methods to clarify their mechanism of poly-Ub chain assembly. 
The study of HIP2 and Ubc1 was aided by the formation and purification of stable 
HIP2-Ub and Ubc1-Ub disulphide linked complexes that closely resemble the HIP2~Ub 
and Ubc1~Ub thiolester intermediates.  The physical techniques of sedimentation 
equilibrium and SAXS determined that HIP2 and Ubc1 as well as their disulphide 
complexes are predominantly monomeric.  Activity assays were also performed on these 
enzymes indicating that the E2~Ub thiolester is the sole species required to create poly-
Ub chains.  Additionally, these assays determined that both free Ub and E2-Ub 
complexes could act as Ub acceptors for poly-ubiquitin chain extension.  NMR 
experiments were also performed through the use of isotopically labelled HIP2, HIP2-Ub 
and HIP2-Ub2 complexes.  NMR chemical shift perturbation experiments identified 
significant intramolecular interactions between HIP2 and Ub in both HIP2-Ub and HIP2-
 iv 
Ub2 complexes.  The intramolecular interaction within HIP2-Ub2 utilizes a C-terminal 
Ub-associated (UBA) domain and this domain is not present in other human E2 enzymes.  
These intramolecular interactions indicate the HIP2-Ub and HIP2-Ub2 complexes behave 
predominantly as Ub donors within poly-Ub chain formation. These results have allowed 
the formulation of mechanisms to describe HIP2 and Ubc1 function.  The determination 
of these mechanisms is especially important for HIP2, as its function has been associated 
with the progression of both Huntington’s and Alzheimer’s disease. 
 
 
Keywords: ubiquitin, HIP2, Ubc1, E2 conjugating enzyme, poly-ubiquitination, UBA 
domain, nuclear magnetic resonance, chemical shift perturbation, sedimentation 
equilibrium, small angle X-ray scattering, Huntington’s disease, Alzheimer’s disease 
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Chapter 1 
Introduction 
1.1 The Ubiquitination Pathway 
The genetic code of all organisms is held within DNA used to synthesize proteins 
that are responsible for carrying out virtually all cellular processes.  These proteins exist 
in a dynamic state where both protein synthesis and protein degradation are regulated to 
maintain a state of homeostasis within the cell (1, 2).  A major mechanism of protein 
degradation has been attributed to the ubiquitin proteolysis pathway, which has been 
found to be responsible for the degradation of short-lived, damaged, misfolded or 
denatured proteins within the cell (3).  The ubiquitin proteolysis pathway was primarily 
discovered through the results of a single scientific study in 1978 that eventually lead to 
the awarding of the 2004 Nobel prize in chemistry to Hershko, Ciechanover and Rose (4).  
Further studies identified and characterized the primary enzymatic components and 
function of this pathway (5-11). 
The ubiquitination pathway focuses on the small, heat stable, 76-residue protein 
named ubiquitin (Ub).  Ubiquitin is highly conserved in eukaryotes as only four amino 
acids differ among yeast, plant and animal sequences (12, 13).  The ubiquitination 
pathway consists of three key enzymes that activate and transfer Ub onto a lysine residue 
in a target protein (Fig 1.1).  Ubiquitin first associates non-covalently with a ubiquitin-
activating enzyme (E1) and the C-terminal glycine (G76) of Ub is adenylated through an 
ATP-dependant reaction.  This adenylated Ub molecule then reacts with the E1 enzyme’s 
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Figure 1.1 A schematic representation of the ubiquitination pathway.  The ubiquitination 
pathway consists of three key enzymes, the E1 activating enzyme (green), the E2 conjugating 
enzyme (blue) and the E3 ligating enzyme (yellow) that activate and transfer Ub (pink) onto a 
lysine residue in a substrate (orange) protein.  Chemical bonds are shown for the atoms 
representing the C-terminus of Ub (COOH), enzyme cysteine side chains (SH), and substrate or 
ubiquitin lysine side chains (NH2).  Thiolester bonds are formed on E1, E2 and E3 enzymes.  
Isopeptide bonds are created on Ub and substrate side chain lysines.  Substrates undergo poly-
ubiquitination through the interconnection of Ub lysine side chains with additional Ub molecules. 
 
  
3 
active site cysteine to covalently link Ub to the E1 enzyme through a reactive thiolester 
bond (Fig 1.1).  The Ub is then transferred from the E1 active site cysteine to a ubiquitin-
conjugating enzyme (E2) active site cysteine through a transthiolesterification reaction 
(Fig 1.1).  A ubiquitin-ligating enzyme (E3) then binds simultaneously to a substrate 
protein and the E2 to transfer Ub to the ε-amino group of a lysine residue in a substrate.  
There are two major types of E3 enzymes, a RING (really interesting new gene) E3 aids 
in the transfer of Ub directly from the E2 enzyme onto the substrate, and a HECT 
(homologous to E6AP carboxyl terminus) E3 first forms a thiolester with Ub and then 
transfers Ub onto the substrate (Fig 1.1).  The covalent linkage of Ub is converted from a 
reactive thiolester to a more stable isopeptide bond on the target substrate. 
 
1.1.1 Poly-Ub chains 
The ubiquitination pathway can result in the attachment of either a single Ub or 
multiple Ub molecules to a target protein (Fig 1.1).  Multiple Ub molecules may be 
attached to substrates on several different lysine residues or by the creation of a poly-
ubiquitin (poly-Ub) chain attached to a single lysine.  Poly-Ub chains are formed by the 
connection of the C-terminus of one Ub to a lysine residue on another Ub creating an 
isopeptide bond resulting in a stable chain of interconnected Ub molecules.  Ub contains 
seven lysine residues (K6, K11, K27, K29, K33, K48 and K63) and each lysine has been 
shown to participate in poly-Ub chain linkages, although K48, K63 and K11-linked poly-
Ub chains are the most prominent (14).  The type of poly-Ub chain linkage determines 
the biological function of the target substrate (15, 16).  Proteins labelled with a single Ub 
have been identified to play roles in several cellular functions including protein sorting, 
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trafficking and processing, gene expression and silencing, and endocytosis (15-17).  
Proteins labelled with K63-linked poly-Ub chains have been linked to other non-
proteolytic functions including DNA repair, kinase activation, protein trafficking, protein 
translation and endocytosis (15, 16).  Proteins labeled with K11-linked poly-Ub chains 
have been linked to degradative and non-degradative roles within the cell (18, 19).  
Proteins labelled with K48-linked poly-Ub chains are the most prevalent form of 
ubiquitination.  K48 poly-Ub chains composed of four or more Ub molecules are 
recognized by the 26S proteosome whereby the attached proteins are degraded and 
recycled by the cell (20).  The poly-Ub chains are themselves are then dismantled back 
into single Ub molecules by deubiquitinases for the purpose of recycling Ub for further 
ubiquitination events (21, 22).  The K48-linked poly-Ub degradation signal is the most 
common fate of ubiquitinated proteins within the cell.  This ubiquitin proteolysis pathway 
will be the primary system studied in this work. 
 
1.1.2 Substrate specificity 
In humans, there are two known E1 enzymes, at least 35 E2 enzymes and over 
1000 E3 ligases in the ubiquitination pathway (23, 24).  Each E1 enzyme can interact 
with multiple E2 enzymes, and each E2 enzyme interacts with many different E3 
enzymes.  Substrate specificity within this pathway is partially determined by specific 
E2/E3 combinations but mostly by unique E3/substrate interactions (25).  Substrate 
specificity is therefore driven by substrate-specific protein binding domains located in 
each E3 ligase.  These various E2/E3 combinations allows for the specific regulation of 
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certain substrates during different cellular cycles and stresses to maintain cellular protein 
homeostasis. 
 
1.1.3 Ubiquitin-like proteins 
Following the discovery of the ubiquitin proteolysis pathway, many ubiquitin-like 
(Ubl) proteins have been identified.  The Ubl proteins all contain a similar structure to 
that of Ub and function by an analogous enzyme cascade of E1, E2, and E3 enzymes that 
covalently attach Ubl proteins to lysine residues of specific substrate proteins (26, 27). 
Ubl conjugations do not primarily result in degradation of substrates, but rather act by 
regulating a wide variety of cellular functions (27).  The Ub and Ubl pathways 
encompass a massive amount of regulatory control within the cell resulting in a large 
amount of research in this area in the recent decade.  The two most well studied Ubl 
proteins are SUMO (small ubiquitin-like modifier) and NEDD8 (neural precursor cell-
expressed developmentally downregulated-8).  NEDD8 is the most similar Ubl to Ub 
sharing 60% sequence identity (28).  NEDD8 is activated by the heterodimeric E1 Uba3-
Ula1 and is conjugated by the E2 enzyme Ubc12 (29).  SUMO is activated by the 
heterodimeric E1 Uba2-Aos1 and is conjugated by the E2 enzyme Ubc9 (28).  Many 
other identified Ubl proteins include FAT10, ISG15, LC3, ATG12, UFM1, and URM1.  
These Ubl proteins are just beginning to be understood and have been linked to many 
highly divergent functions (27).  Cross-talk between the Ub and Ubl pathways can be 
performed in many ways including multiple modifications of a single substrate such as 
tumor suppressor p53 that can be modified with Ub, NEDD8, SUMO and FAT10 (28).  
Cross-talk is also observed for the SUMO modification of the E2 enzyme HIP2 that 
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inhibits its function in the ubiquitination pathway (30).  Due to the highly analogous 
enzyme cascades in the Ub and Ubl pathways, structural studies of NEDD8 and SUMO 
related enzymes have provided valuable insight into the function of Ub related enzymes.  
The structural knowledge acquired from Ubl pathways has greatly advanced the 
proposals for functional mechanisms utilized in the ubiquitin proteolysis pathway. 
 
1.2 Diseases Related to Ubiquitination 
Malfunction of the ubiquitination proteolysis pathway can result in many different 
diseases.  The unwanted accumulation and aggregation of ubiquitinated proteins into 
inclusion bodies (large protein aggregates) is the hallmark of many neurodegenerative 
diseases.  Ubiquitination has also been linked to several forms of cancer as well as 
muscle wasting disorders, and inflammatory diseases.  Due to the wide variety of enzyme 
functions related to the ubiquitination pathway, the list of diseases known to be affected 
by ubiquitination is expected to rise significantly as more studies in this field are 
performed. 
 
1.2.1 Neurodegenerative Diseases 
The most prominent diseases linked to ubiquitination are neurodegenerative 
diseases including Alzheimer’s disease, Parkinson’s disease and polyglutamine disorders 
such as Huntington’s disease and spinocerebellar ataxias (31).  Alzheimer’s disease is 
involved in progressive memory loss and is characterized by extracellular plaques that are 
composed of misfolded and aggregated amyloid β peptides (Aβ).  Alzheimer’s disease 
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has been linked to ubiquitination through the incorporation of the ubiquitin variant 
UBB+1 (32), reduced proteosomal activity (33), mutated ubiquitin hydrolyases (34), and 
the effect of specific E3 ubiquitin ligases (35).  The UBB+1 Ub variant contains a C-
terminal extension that does not allow thiolester formation and is therefore a non-
functional Ub molecule.  However, the UBB+1 is recognized as a substrate and is poly-
ubiquitinated itself.  This UBB+1 capped poly-Ub chain is resistant to disassembly by 
deubiquitinating enzymes and correspondingly inhibits the 26S proteosome (36).  
Autosomal recessive juvenile parkinsonism (ARJP) is an early-onset form of Parkinson’s 
disease and has been shown to be caused by mutations in the protein parkin (37).  The 
parkin protein was later identified to be a RING E3 ligase, and disease causing mutations 
result in the accumulation of parkin’s substrate proteins (38, 39).  Polyglutamine 
disorders including Huntington’s disease and spinocerebellar ataxias are 
neurodegenerative diseases that are biochemically identified by intracellular inclusion 
bodies that contain ubiquitinated proteins (31).  The polyglutamine region of the protein 
huntingtin is expanded in Huntington’s disease and aggregates into these inclusion 
bodies.  The biological function of wild type huntingtin remains poorly defined, however, 
huntingtin is associated with the ubiquitination pathway as mutant huntingtin is found to 
be ubiquitinated in vivo and has been shown to interact with the E2 enzyme HIP2 
presumably responsible for this ubiquitination (40).  Mutant huntingtin overexpression 
was also observed to inhibit proteosomal activity (41).  All of these neurodegenerative 
diseases result in lower 26S proteosome levels and activity indicating that aberration in 
the proteolysis pathway is critical in all neurodegenerative diseases (42-44).  Large 
protein aggregate formation in these diseases appears to be for the purpose of avoiding 
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the toxic effect of the accumulation of soluble ubiquitinated proteins and the aggregation 
is a way to handle these non-degradable proteins (45).  The true nature of toxicity in these 
diseases is still poorly understood. 
 
1.2.2 Cancers 
Human Papillomaviruses (HPV’s) exist in many different subtypes, some of 
which produce oncoproteins E6 and E7 that interact with tumor suppressor protein p53 
and the retinoblastoma susceptibility protein Rb respectively (31).  Interaction of the 
HPV oncoprotein E7 with Rb promotes the ubiquitination and degradation of Rb (46).  
Rb normally interacts inhibits growth promoting E2F transcription factors, and thus 
degradation of Rb promotes cell growth leading to cancer (47).  The E6 protein binds to 
the E3 ligase E6AP and this complex then interacts with p53 promoting its ubiquitination 
and degradation (48).  The p53 protein acts as a tumor suppressor by arresting cellular 
proliferation, inducing repair mechanisms and in extreme stress induces apoptosis.  
Regulation of p53 is normally achieved through ubiquitination by the E3 ligase Mdm2.  
The design of a chemical inhibitor (nutlin) for Mdm2 can result in extended p53 function 
by minimizing its degradation resulting in longer cell cycle arrest and increased apoptosis 
of tumor cells in various cancers (49). 
During oxygen shortage (hypoxia) a transcription factor called hypoxia inducible 
factor (HIF-1α) promotes the synthesis of proteins important in red blood cell creation 
and angiogenesis.  HIF-1α is normally an unstable protein with a half life in cells of less 
than 10 minutes and is ubiquitinated and degraded by the E3 ligase VCB-Cul2 complex 
(31).  A component of the VCB-cul2 complex, pVHL, is a tumor suppressor that is 
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mutated in almost all renal cancers allowing HIF-1α to be constantly active promoting 
tumor formation (50). 
 
1.3 The E1, E2 and E3 Enzyme Cascade 
1.3.1 E1 activating enzyme 
The initial enzyme utilized in ubiquitination is the E1 activating enzyme.  The E1 
activating enzymes are large proteins (~110-120 kDa) that initially bind Ub non-
covalently and adenylate the C-terminus of Ub through ATP hydrolysis.  The E1 
activating enzyme uses a second domain that contains an active site cysteine to perform a 
nucleophilic reaction with the adenylated Ub moiety to create a reactive thiolester bond 
(51).  After formation of an E1~Ub thiolester, the E1 activating enzyme binds to an E2 
conjugating enzyme and through a transthiolesterification reaction transfers the Ub to a 
cysteine residue at the active site on the E2.  There are two human E1 activation 
enzymes, Uba1 and Uba6, that activate Ub molecules and both of these enzymes interact 
with a different set of E2 conjugating enzymes allowing for increased specificity in the 
ubiquitination pathway (23, 52).  The crystal structure of the yeast Uba1 E1 activating 
enzyme allows for further insights into how this enzyme functions (Fig 1.2A) (51).  The 
yeast Uba1 shares 50% sequence identity to the human Uba1, indicating these enzymes 
are likely to function similarly (51).  The E1 activating enzyme can be divided into 
several functional domains (Fig 1.2A).  The core of E1 houses the adenylation domain 
(AD) that binds ATP and Ub and assists in the adenylation of the C-terminus of Ub.  The 
N-terminal region of E1 contains the first and second catalytic cysteine half 
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Figure 1.2 Structures of E1 activating enzymes.  (A) The crystal structure for the S. cerevisiae 
Uba1 E1 activating enzyme (PDB: 3CMM).  Different domains have been coloured differently to 
show the division of functional units within the enzyme where the adenylation domain (AD - 
purple) binds Ub (teal) non-covalently for adenylation, the first and second catalytic half domains 
(FCCH - green, SCCH - blue) contain the active cysteine used for creation of the E1~Ub 
thiolester, and the ubiquitin fold domain (UFD – red) is responsible for E2 binding.  (B) The 
crystal structure of the human NEDD8 E1 heterodimer APPBP1-Uba3 (PDB: 2NVU) 
demonstrates how NEDD8 can be transferred onto the E2 enzyme.  The E1 heterodimer 
APPBP1-Uba3 (2 shades of green) interacts with two NEDD8 (orange) molecules, one on the 
adenylation site and one through a thiolester linkage.  The UFD (red) is rotated compared to (A) 
showing that UFD movement occurs upon Ubc12 (blue) E2 enzyme binding.  The active site 
cysteine side chains (yellow) are the site of thiolester formation with Ub or Ubl proteins. 
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domains (FCCH and SCCH) responsible for housing the E1 active site cysteine for Ub 
thiolester bond formation.  The C-terminal region of E1 contains the Ub fold domain 
(UFD) that binds to E2 conjugating enzymes to assist a transthiolesterification reaction to 
transfer Ub from an E1~Ub thiolester to an E2~Ub thiolester (51).  The E1 enzyme can 
bind 2 Ub molecules at the same time, one on the active site cysteine and another on the 
adenylation domain.  The method by which adenylated Ub is transferred onto the E1 
active site cysteine is not obvious as there is a 36 Å separation between the cysteine side 
chain and the adenylated Ub C-terminus in this structure (Fig 1.2A).  Experimental 
studies on the SUMO E1 activating enzyme have shown that adenylated SUMO is 
transferred to the catalytic cysteine domain (equivalent to FCCH/SCCH in Uba1) through 
allosteric changes and a rotation of this domain bringing the catalytic cysteine into close 
contact with the SUMO C-terminus (53).  These allosteric changes are also expected to 
occur in the FCCH/SCCH domain of Uba1 to move adenylated Ub onto the catalytic site 
(53).  Insights into the position of the E2 conjugating enzyme in relation to the E1 
enzyme were elucidated through experimentation on the NEDD8 heterodimeric E1 
activating enzyme APPBP1-Uba3 in complex with the NEDD8 E2 Ubc12 (Fig 1.2B) 
(54).  In this E1/E2/NEDD8/NEDD8 quaternary structure, both thiolester linked and 
adenylated NEDD8 protein are represented and a rotation of the UFD domain is required 
to position the E2 enzyme’s catalytic cysteine into close proximity (23 Å) with the E1 
enzyme’s catalytic cysteine.  It is expected that a further rotation of the UFD domain will 
position the active sites of the E1 and E2 enzymes to within 5 Å allowing for a 
transthiolesterification transfer reaction to occur to form the E2~Ub thiolester (Fig 1.2B).  
The importance of a rotation in the UFD domain of Uba1 was shown through proline 
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mutations in the flexible linker that impaired thiolester transfer from E1 to E2 enzymes 
indicating the Ub E1 functions similarly to the NEDD8 E1 (51).  The Uba1 enzyme also 
shows nanomolar affinity for E2 enzymes when it is dually loaded with Ub and has much 
weaker affinity for the E2 in the absence of ATP and Ub (51).  These affinity changes on 
the E1 enzyme indicate that E2 enzymes bind to the E1 to accept Ub and then dissociate 
from the E1 once the E2~Ub thiolester has formed.  This bind and release action likely 
allows the Ub E1 enzyme to efficiently charge a wide variety of Ub E2 conjugating 
enzymes. 
 
1.3.2 E2 conjugating enzymes 
The E2 conjugating enzyme is the central enzyme in the ubiquitination pathway.  
The E2 enzyme first interacts with the E1~Ub thiolester and Ub is transferred to the E2 
enzyme to form the E2~Ub thiolester intermediate.  The E2~Ub thiolester then interacts 
with an E3 ligase and transfers Ub to the E3 enzyme and then onto the substrate or 
directly onto a substrate.  There are at least 35 E2 enzymes in the human proteome, 30 of 
which are known to directly activate Ub in the ubiquitination pathway (24).  These E2 
conjugating enzymes all contain an ~150 residue structurally conserved catalytic core 
domain (55).  This catalytic core domain is found in all E2 enzymes and consists of 4 β-
strands that make up an anti-parallel β-sheet, 4 α-helices, and a very short 310 helix 
immediately following the active site cysteine (Fig 1.3A) (55).  Many E2 enzymes also 
contain a highly conserved HPN motif about 7-8 residues upstream of the conserved 
catalytic cysteine at the active site (56).  The conserved catalytic cysteine is utilized to 
form a thiolester with the C-terminus of Ub.  The asparagine within the HPN motif has  
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Figure 1.3 General structure of E2 conjugating enzymes and E2~Ub thiolesters.  (A) The crystal 
structure for human UbcH5a (PDB: 2C4P) illustrates the general structure of all E2 enzymes. The 
structurally conserved catalytic core domain of E2 enzymes consists of 4 β-strands that make up 
an anti-parallel β-sheet, 4 α-helices, a very short 310 helix, and the active site is centered around 
the conserved active site cysteine (yellow) and oxyanion hole stabilizing asparagine (green).  (B) 
The structural alignment and overlay of five E2~Ub thiolesters demonstrates the variation of 
reported Ub positions in relation to the catalytic core domain.  For clarity only the UbcH5b 
(green) catalytic core is shown while the Ub is positioned and coloured differently for each 
E2~Ub thiolester: Ubc1~Ub (PDB: 1FXT - red), UbcH5b~Ub (PDB: 3A33 - cyan), Ubc13~Ub 
(PDB: 2GMI - blue), UbcH5b~Ub (PDB: 3JVZ - orange), and UbcH8~Ub (PDB: 2KJH - 
magenta) are labelled Ub1, Ub2, Ub3, Ub4 and Ub5 respectively. 
  
14 
been proposed to stabilize an oxyanion intermediate of the E2~Ub thiolester to aid in the 
preceding nucleophilic attack of a lysine side chain on a substrate (56-58).  The function 
of the histidine in the HPN motif remains unknown, although it could be used to aid the 
catalytic activity of the asparagine or be involved in protein stability (56, 59). 
Although the structures of these E2 enzymes are highly conserved, there are very 
few highly conserved residues within these proteins providing a large diversity between 
E2 enzyme surface residues (59).  The electrostatic properties of E2 enzymes have also 
been shown to vary widely based on significantly different surface charges (60, 61).  
These variations in residues and electrostatics may facilitate specific interactions for each 
individual E2 enzyme.  An added variation of E2 enzymes includes additional N-terminal 
and C-terminal protein extensions to the catalytic core domain, and these can be sub-
categorized into 4 classes.  Class I E2 enzymes contain only the catalytic core (Fig 1.3A) 
(62).  Class II, III and IV E2 enzymes contain a C-terminal extension, a N-terminal 
extension, and both C-terminal and N-terminal extensions respectively (62).  These 
extensions form unstructured and structured protein domains of various sizes and provide 
additional protein interaction surfaces to modulate the specific functions of individual E2 
enzymes. 
The E2 enzyme must interact with both the E1 and E3 enzymes to carry out Ub 
transfer.  The E2 enzyme utilizes its N-terminal α1 helix and loop between β1 and β2 to 
contact the E1 enzymes UFD domain (63).  The E2 enzyme also utilizes its N-terminal 
α1 helix, loop between β3 and β4, and loop between the 310 helix and α2 to contact E3 
enzymes (64).  These interaction regions on the E2 enzyme for E1 and E3 involve 
overlapping surfaces.  E2 enzymes have been shown to bind either the E1 or E3, but not 
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both simultaneously, indicating that the E1-E2-E3 ubiquitination pathway is a stepwise 
cascade reaction as opposed to a large protein complex (65).  This fact also indicates that 
the E2 enzyme is in a constant state of association and dissociation with its E1 and E3 
interacting partners (65). 
 
1.3.3 The E2~Ub thiolester and stable intermediate 
The E2~Ub reactive intermediate represents an active ‘charged’ conjugating 
enzyme.  Most structural knowledge of E2 enzymes has been accumulated on free E2 
enzymes as the E2~Ub thiolester is highly reactive and unstable, making its purification 
and characterization difficult.  Experimental study of the E2~Ub reactive intermediate is 
vital towards advancing knowledge in this pathway as it is predicted that most E2 
enzymes are usually found in the active E2~Ub state in vivo and therefore the E2~Ub 
thiolesters are more likely to be recognized by interacting proteins than E2 enzymes 
alone (66).  Two different types of stable E2-Ub thiolester mimic complexes have been 
produced to study the E2~Ub thiolester intermediate.  The first E2-Ub complex can be 
formed by an E2 active site cysteine to serine mutation that results in a longer lived ester 
bond (67).  The second E2-Ub complex can be formed by a Ub C-terminal glycine to 
cysteine mutation that can be used to form a stable disulphide bond with the active site 
cysteine of the E2 enzyme (68).  There are currently 5 structures of E2-Ub intermediate 
complexes including Ubc1~Ub (69), UbcH8-Ub (70), Ubc13-Ub (67), and two UbcH5b-
Ub structures (71, 72).  The alignment and overlay of these 5 structures illustrates the 
varying reported positions of Ub in these different E2~Ub structures (Fig 1.3B).  The 
covalent attachment of Ub to the E2 enzyme does not result in any significant 
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conformational changes in either protein, which indicates that the mere placement of Ub 
onto the E2 enzyme is responsible for alterations in protein interactions (55).  The 
structure of the Ubc1~Ub thiolester (truncated Ubc1) was produced through NMR studies 
where the unstable short lived Ubc1~Ub thiolester was produced in situ and the observed 
interactions between Ubc1 and Ub allowed the structure of this thiolester to be modelled 
(Fig 1.3B – Ub1/red) (69).  The UbcH8-Ub disulphide complex was also solved using 
NMR and the Ub position on the E2 enzyme was found to be much different to that of 
Ubc1~Ub (Fig 1.3B – Ub5/magenta) (70).  Additionally, crystal structures of Ubc13-Ub 
and two UbcH5b-Ub ester complexes also place Ub in several different positions.  These 
crystal structures make some contact with neighbouring molecules within the crystal 
lattice allowing for the possibility that the Ub position may be affected by these contacts 
(Fig 1.3B – Ub2/cyan, Ub3/blue, Ub4/orange) (67, 71, 72).  Taken together these 
structures all adopt significantly different positions for Ub in their E2~Ub thiolesters (Fig 
1.3B).  The various positions for Ub on different E2 enzymes can affect access to the 
reactive thiolester and expose or block different surfaces of the E2~Ub, which may affect 
reactivity in regards to interactions with E3 enzymes and substrates, although this has not 
yet been well investigated (70, 73).  The variation in Ub positioning between these 
structures also supports recent experimental evidence that the E2-Ub intermediate may be 
highly dynamic and mobile (74).  This would indicate that the observed Ub positions in 
these E2-Ub structures may be ‘snap shots’ or predominant species of a mobile Ub 
molecule (Fig 1.3B).  Further studies on E2-Ub intermediate complexes are required to 
fully understand the dynamics and effects of Ub placement within E2~Ub thiolesters. 
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The E2~Ub thiolester also affects protein affinities to drive the E1-E2-E3 enzyme 
cascade.  This is observed as unconjugated E2 enzymes strongly bind E1 enzymes and 
upon formation of the E2~Ub thiolester, these enzymes preferably dissociate (51).  
Recent studies have shown that certain E2~Ub species have increased affinity for E3 
enzymes over the free E2 enzyme (72, 75) (Dr Spratt personal communication).  The 
E2~Ub would then enhance interaction with E3 enzymes and after transfer the E2 
enzyme may preferably dissociate to recharge on the E1 enzyme.  A fixed or mobile 
position of Ub in the E2~Ub thiolester may or may not affect these interactions.  More 
experimentation on affinity of E2~Ub versus free E2 enzymes is required to clarify 
association and dissociation within the E1-E2-E3 enzyme cascade. 
 
1.3.4 E3 ligating enzymes 
The E3 ligases are the final enzyme in the ubiquitination pathway responsible for 
the selective binding of substrates and E2 enzymes to assist transfer of the thiolester 
linked Ub onto a substrate.  The thiolester linked Ub is converted to a stable isopeptide 
bond when the C-terminus of Ub is linked to the ε-amino group of a lysine residue in a 
substrate.  There are more than 1000 E3 ligases and substrate specificity is accomplished 
by each E3 ligase having a different set of substrates allowing for differential regulation 
of various proteins within the cell (24).  E3 ligases can be distinguished by their 
enzymatic function and fall into two major categories, the HECT (homologous to E6AP 
carboxyl terminus) E3 ligases and RING (really interesting new gene) E3 ligases.  More 
than 95% of all known human E3 enzymes are RING E3 ligases (76).  HECT E3 ligases 
contain a conserved active site cysteine used for the transfer of Ub from the E2~Ub 
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thiolester to make an E3~Ub thiolester prior to reaction with an E3 bound substrate lysine 
residue.  The RING E3 ligase does not contain an active site cysteine, but rather works as 
a scaffold in substrate ubiquitination by placing the E2~Ub thiolester in close proximity 
to a substrate to aid Ub transfer. 
Structural knowledge of E2 enzyme interactions with E3 ligases is aided by the 
crystal structure of the E2 enzyme UbcH7 interacting with the E6AP (human 
papillomavirus E6 associated protein) E3 ligase HECT domain (Fig 1.4A) (77).  The 
E6AP HECT domain contains an N-terminal region (N-lobe) that binds the E2 enzyme, 
and a C-terminal region (C-lobe) that contains the conserved cysteine residue responsible 
for thiolester formation (Fig 1.4A).  This UbcH7/E6AP structure indicates that a 41 Å 
distance exists between the E2 and HECT E3 active site cysteine residues (Fig 1.4A). 
Additional structures of other HECT E3 ligases have shown that the C-lobe can adopt 
alternative positions due to a flexible linker that can result in the reduction in this spatial 
gap between cysteine residues (78).  This was confirmed with the structure of 
UbcH5b~Ub with the Nedd4L HECT E3, which illustrates a significantly moved C-lobe 
placing the E3 catalytic cysteine within 8 Å of the thiolester bound Ub C-terminus (Fig 
1.4B) (72).  This structure shows that movement of the C-lobe of the HECT domain is 
required for Ub transfer from the E2 to the E3.  Contacts between the E2 attached Ub 
moiety and the C-lobe stabilize the movement of the C-lobe to aid in Ub transfer (72). 
Structural knowledge of E2 enzyme interactions with RING E3 ligases is revealed 
by the crystal structure of c-Cbl (casitas B-lineage lymphoma) RING E3 ligase in 
complex with the E2 enzyme UbcH7 and a substrate peptide (Fig 1.4C) (64).  The c-Cbl 
RING E3 associates with the E2 enzyme UbcH7 through its zinc-stabilized RING domain  
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Figure 1.4 Structures of a several E2/E3 enzyme complexes.  (A) The crystal structure of 
UbcH7-E6AP (PDB: 1C4Z) and (B) UbcH5b~Ub-Nedd4L (PDB: 3JVZ) illustrate the binding of 
an E2 (UbcH7 - blue) and E2~Ub (UbcH5b~Ub – blue ~ teal) thiolester to the HECT E3 ligases 
E6AP and Nedd4L respectively.  The HECT domain is divided into 2 lobes, the N-lobe (orange) 
and C-lobe (purple).  Movement of the C-lobe details the allosteric changes required to position 
the E2 and E3 active site cysteine residues (yellow) into close proximity.  (C) The crystal 
structure of ZAP-70/c-Cbl/UbcH7 (PDB: 1FBV) illustrates the interaction between the RING 
domain (purple) of the E3 c-Cbl (orange) interacting with the E2 UbcH7 (blue).  There is a large 
distance between the E2 active site (yellow) and the substrate peptide ZAP-70.  (D) The crystal 
structure of UbcH5b (blue) and Cnot4 RING domain (purple) illustrates the common interface 
between RING domains and the N-terminal region of the E2 enzyme (PDB: 1UR6).  The RING 
domains are structurally stabilized by two Zn2+ ions (teal spheres). 
 
 
  
20 
(Fig 1.4C).  RING domains contain a highly conserved C3HC4 motif that coordinates two 
zinc ions to stabilize its structure (79).  RING E3 ligases utilize the RING domain to bind 
the E2 enzyme’s N-terminal α1 helix as well as several loops near the N-terminus (Fig 
1.4C).  The UbcH7/c-Cbl complex is one of very few solved E2/RING E3 structures.  
Other solved E2/E3 RING structures include UbcH5b/Cnot4 RING E3 (Fig 1.4D), 
Ubc13/TRAF6 RING E3, and UBE2D1/IDOL RING E3, which show very similar 
protein interaction surfaces are utilized in all reported E2/RING E3 structures (80-82).  
E3 ligases incorporate many other protein binding domains for the purpose of binding 
substrates and recruiting other proteins required for larger functional E3 complexes (79).  
The UbcH7/c-Cbl complex also includes a peptide from the ZAP-70 protein kinase, a 
known ubiquitinated substrate of this E2/E3 complex (Fig 1.4C) (64).  The distance from 
the E2 enzyme active site’s bound Ub thiolester to the ZAP-70 substrate is 60 Å.  A 
similar large spatial gap has been observed between an E2~Ub thiolester and substrate in 
the large E3 RING ligase containing SCF complexes (83).  The mechanism utilized by 
these enzymes for bridging this spatial gap is still under investigation, although it is likely 
that some allosteric change in the E3 enzyme or protein interactors is required to allow 
substrate ubiquitination.  There are currently no structural details that show how Ub is 
transferred from the E2~Ub thiolester directly to a substrate. 
 
1.4 Formation of Poly-Ub Chains 
Structural knowledge acquired from E1, E2 and E3 enzymes in various complexes 
has illustrated the general mechanisms utilized to activate and transfer Ub onto the E2 
and E3 enzymes.  Additional structures of E2~Ub/RING-E3/substrate or HECT-
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E3~Ub/substrate are required to clarify how the thiolester linked Ub is directly 
transferred to an ε-amino group on a substrate lysine residue.  It is expected that 
conformational changes in E3 enzymes are required to transfer Ub onto substrates.  The 
general mechanism of Ub activation and transfer onto substrates has been developed from 
these various E1, E2 and E3 structures, however, the mechanism by which these enzymes 
interconnect Ub molecules into poly-Ub chains remains very poorly understood. 
 
1.4.1 Proposed Poly-Ub chain formation mechanisms 
Several mechanisms have been proposed to explain how the ubiquitination 
pathway enzymes position Ub molecules for the creation of various Ub-Ub linkages 
found in poly-Ub chains (84, 85).  The simplest proposed mechanism for poly-Ub chain 
formation is the sequential addition model.  In this model, the substrate lysine reacts with 
the first Ub and subsequent Ub additions are attached to the lysine residues on Ub itself, 
thus creating a chain sequentially (Fig 1.5A).  The logical complication with this 
mechanism is that the site of attachment of each new ubiquitin molecule becomes more 
remote as the chain extends, presumably making the required nucleophilic attack from 
each Ub lysine’s ε-amino group less probable.  Alternative methods for poly-Ub chain 
formation are supported by experimentation on many E2 and E3 enzymes that show poly-
Ub chains can be produced prior to interaction with substrates.  These results suggest 
poly-Ub chains may not be constructed on the substrate but rather preassembled 
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Figure 1.5 Schematic representation of several proposed mechanisms for the formation of poly-
Ub chains.  Ub molecules (yellow, orange, red and green) are depicted by small coloured circles.  
(A) The sequential addition model involves Ub added one at a time to first the substrate and then 
lysine side chains of Ub itself.  (B) Preassembly of chains on the HECT E3 enzyme is performed 
like the sequential addition model only the chain is built on the E3 enzyme and then transferred 
onto the substrate.  (C) A thiolester attached juggling model suggests an E2/E2 dimer allows for 
chains to be built on the E2 enzyme.  In this model, both Ub molecules are thiolester bound and 
proper Ub positioning would allow one Ub to act as an acceptor and the other to act as a donor.  
In this manner chains extend on the proximal side of the growing chain.  A similar juggling 
model can be performed using an E2/E3 HECT pairing.  (D) Preassembly of chains may also 
require non-covalent binding of an acceptor Ub to be positioned so its lysine side chain can react 
with a thiolester bound Ub donor.  In this model, a HECT E3 is depicted to have both the active 
site thiolester and non-covalent binding site for Ub.  This model could also be replaced with any 
combination of E2 monomer, E2/E2, or E2/E3 complex where a non-covalently connected Ub 
acceptor can be positioned for reaction with an E2 or E3 thiolester bound Ub donor. 
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prior to attachment to substrate.  One mechanism to preassemble poly-Ub chains would 
be similar to the sequential addition model except that poly-Ub chains would be built on 
a HECT E3 ligase and then transferred in a single step onto the substrate (Fig 1.5B).  This 
mechanism would require an E2~Ub/E3~Ub interaction that would position the two 
thiolester bound Ub molecules in an orientation such that a lysine side chain of the 
E3~Ub could react with the E2~Ub reactive thiolester to yield E3~Ub2.  In this process 
the chain extends via multiple charging of the E2 enzyme.  Another mechanism to 
preassemble poly-Ub chains would require an E2-E2 dimer to positions two Ub 
molecules such that one E2~Ub lysine can react with the thiolester of a second E2~Ub 
(Fig 1.5C).  In this process the chain extends via multiple charging of the E2 enzymes, 
and a back and forth juggling of the thiolester attached proximally extending poly-Ub 
chain.  Alternative mechanisms of poly-Ub chain preassembly may also utilize non-
covalent Ub interacting surfaces on either the E2 or E3 enzyme (Fig 1.5D).  These 
mechanisms would be driven by the positioning of a non-covalently bound Ub within 
reactive distance to a thiolester bound Ub on either the E2 or E3 enzymes.  The model 
depicted in Figure 1.5D could also be replaced with any combination of E2 monomer, 
E2/E2 complex, or E2/E3 complex where a non-covalently connected Ub acceptor can be 
positioned for reaction with an E2 or E3 thiolester bound Ub donor.  These preassembled 
poly-Ub chain mechanisms all require the placement of two Ub molecules in close 
proximity to allow one Ub’s lysine ε-amino side chain to react with the C-terminus of a 
thiolester bound Ub to create a stable isopeptide bond.  More detailed experimentation is 
required to clarify how poly-Ub chains can be created in the ubiquitination pathway. 
 
  
24 
1.4.2 K63 poly-Ub chain formation 
The only well defined structural model showing poly-Ub chain formation 
involves the Ubc13/Mms2 complex responsible for the production of K63-linked poly-
Ub chains (73).  Ubc13 is an ‘active’ E2 conjugating enzyme that contains an active site 
cysteine utilized to form a Ubc13~Ub thiolester.  Mms2 is a ubiquitin conjugating 
enzyme variant that is an ‘inactive’ E2 paralogue that shares significant sequence 
similarity with E2 enzymes but does not contain an active site cysteine.  The Mms2 
protein does not form a thiolester bond with Ub, but rather forms a non-covalent bond 
with free Ub in solution (86).  Ubc13 interacts with Mms2 and the crystal structure of the 
Ubc13/Mms2 can be combined with the NMR modelled non-covalent Mms2/Ub 
structure and the Ubc1~Ub thiolester structure to place both Ub molecules on this E2 
heterodimer such that the K63 side chain of the Mms2 bound Ub comes into close 
proximity of the C-terminus of the Ubc13~Ub thiolester (Fig 1.6) (67, 69, 73, 87, 88).  
This model constructed from three PDB files contains a 12 Å reaction distance between 
one Ub’s K63 lysine and the thiolester Ub C-terminus, but another NMR modeled 
version of this same structure indicates the reactive distance to be ~3 Å (73).  This model 
directly shows how one Ub can be reacted with a second Ub to create a K63-linked 
diubiquitin (Ub2) molecule in the absence of an E3 enzyme or substrate.  Cycles of this 
reaction presumably explain how longer K63-linked poly-Ub chains are created by the 
Ubc13/Mms2 E2 heterodimer (67).  The method utilized to build these chains is a 
mixture of the mechanisms depicted in Figure 1.5C and 1.5D, where an E2 dimer is used 
to position the non-covalently bound Ub to react with the thiolester bound Ub for poly- 
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Figure 1.6 The human E2 heterodimer Ubc13/Mms2 structurally illustrates the mechanism for 
K63-linked poly-Ub chain formation.  This four protein complex is composed of the Ubc13 
(purple) and Mms2 (orange) which were crystallized in complex (PDB: 1J7D), aligned with the 
thiolester connected Ub (blue) positioned from Ubc1~Ub (PDB: 1FXT) and the non-covalent 
interaction of Ub (red) on Mms2 (PDB: 1ZGU).  The side chain Lys63 (green) of Ub (red) acts as 
an acceptor for reaction with a thiolester bound Ub (blue) donor connected at the Ubc13 active 
site (yellow).  This model contains a roughly 12 Å reaction distance. 
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Ub chain attachment.  In this way the growing chain would be free in solution as opposed 
to attached at the active site thiolester.  A highly detailed Ub-Ub positioning for 
attachment has not yet been presented for any other poly-ubiquitination pathways. 
 
1.4.3 Cdc34 experiments indicate Cdc34~Ub may directly dimerize for activity 
Initial studies using chemical cross-linking reagents indicated possible 
dimerization of the E2 enzymes Ubc1, Ubc4 and Cdc34 (Ubc3) (89-91).  Further 
investigation of Cdc34 determined that this E2 produces both free K48-linked poly-Ub 
chains and Cdc34 attached K48-linked chains in the presence of Ub, ATP, E1, Cdc34, 
and its E3 RING protein complex (92).  Fusion proteins that force Cdc34 to dimerize 
were found to increase poly-Ub chain formation activity in the absence of the normally 
required E3, suggesting that dimerization activates Cdc34 activity (92).  Further studies 
on Cdc34 showed that two differentially tagged E2 enzymes can coimmunoprecipitate in 
vivo (yeast cells) (93).  Coimmunoprecipitations could still be performed on Cdc34 
proteins absent E3 enzyme binding, and the active site cysteine was required for 
coimmunoprecipitation, indicating that dimerization of Cdc34 appears to be dependant on 
the presence of an activated thiolester (93).  Previous sedimentation equilibrium studies 
on free Cdc34 indicate the enzyme is monomeric, although the Cdc34~Ub thiolester was 
not investigated (92).  Combining these results indicates either the E3 enzyme or 
Cdc34~Ub thiolester may assist dimerization to drive the mechanism depicted in Figure 
1.5C.  Regardless of the exact mechanism used, the fact that poly-Ub chains can be 
formed without substrate further supports the possibility that poly-Ub chains may be 
preassembled prior to substrate attachment. 
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1.4.4 K48-linked Poly-Ub chains can be built on Ube2g2 enzymes 
Another example of poly-Ub chain formation activity prior to substrate addition 
comes from the E2 enzyme Ube2g2 (Ubc7).  Activity assays performed on Ube2g2 with 
its RING E3 ligase gp78 resulted in K48-linked poly-Ub chain formation (94).  In this 
study, reactions of ATP, E1 and Ube2g2 with either wild type Ub or Flag tagged Ub with 
a K48R substitution (UbK48R-Flag) were used to create two different Ube2g2 thiolesters, 
Ube2g2~Ub and Ube2g2~UbK48R-Flag.  The Ube2g2~Ub thiolester contains the reactive 
K48 residue on Ub that can act as a Ub acceptor, while the Ube2g2~UbK48R-Flag 
thiolester contains the unreactive K48R substitution and therefore can only act as a Ub 
donor.  The addition of the RING E3 ligase gp78 causes the reaction of these two 
intermediates to yield a diubiquitin attached thiolester Ube2g2~Ub-UbK48R-Flag.  These 
results indicate a direct reaction between two Ube2g2 (E2) enzymes can occur causing 
the attachment of one Ub to a second Ub while both are covalently linked to the E2.  This 
reaction required the gp78 RING E3 enzyme that has been shown to oligomerize (95).  
Therefore, the requirement for E3 may be to allow oligomerization of Ube2g2 enzymes 
in order to position Ub molecules in proximity for poly-ubiquitination activity.  Further 
supporting the biological significance of this in vitro activity is the fact that poly-Ub 
chains linked to Ube2g2 can also be transferred onto a substrate, HERPc, indicating that 
preassembled chains can be transferred from the E2 enzyme onto a substrate (94).  This 
evidence suggests a dimeric mechanism for Ube2g2 in which chains are preassembled 
prior to their attachment to substrates by thiol juggling as depicted in Figure 1.5C. 
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1.4.5 HECT E3 enzymes in poly-Ub chain extension 
A study of two HECT E3 ligases has shown poly-Ub chain activity in the absence 
of substrates (85).  In these studies the HECT E6AP E3 ligase was found to synthesize 
poly-Ub chains using an E2/E3 heterodimer by reacting two covalently bound Ub 
molecules, one connected to the UbcH5a (E2~Ub) and one connected to the E6AP 
(E3~Ub), to yield E6AP~Ub2 (85).  These results indicate that poly-Ub chains could form 
on the E3 enzyme and the growing chain’s distal Ub would continually act as the Ub 
acceptor during chain extension (Fig 1.5B).  This model of Ub chain extension is 
presumably assisted by movement in the C-lobe of E6AP to allow positioning of a 
growing chain attached to the E3 ligase (Fig 1.4A/B) (85). 
An alternative mechanism for poly-Ub chain activity was observed for the HECT 
E3 ligase KIAA10 and UbcH5a.  In this mechanism KIAA10 was observed to bind Ub 
non-covalently and this Ub acts as the acceptor by reacting with the KIAA10 thiolester 
bound Ub donor to build unanchored poly-Ub chains (85).  The non-covalent Ub binding 
on KIAA10 must position the acceptor Ub lysine into reactive distance with the 
KIAA10~Ub donor as is depicted in Figure 1.5D.  Chain extension would occur on the 
distal end of the growing chain where a K48 lysine is still available to be positioned by 
the non-covalent binding site (Fig 1.5D). 
 
1.4.6 Alternative poly-Ub chain mechanisms 
Non-covalent Ub binding has been observed on the UbcH5c E2 enzyme on the 
backside of the enzyme far removed from the active site cysteine (96, 97).  The 
positioning of the non-covalently bound Ub is too far to interact with the active site 
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linked UbcH5c~Ub thiolester.  This result indicates UbcH5c can bind 2 Ub molecules 
simultaneously, but does not position them for direct interaction in poly-Ub chain 
activity.  The non-covalent binding of Ub on UbcH5c is however required for its 
observed poly-Ub chain formation activity in the presence of several different E3 
enzymes (97).  This non-covalent binding also causes oligomerization of UbcH5c~Ub 
thiolesters as the E2 bound Ub can associate with the non-covalent binding surface of a 
neighbouring UbcH5c (97).  The mechanism of poly-Ub chain formation in this enzyme 
remains poorly understood but oligomerization may be a key requirement for function.  
The Ubl proteins SUMO2 and SUMO3 have also been shown to interact non-covalently 
with an equivalent region of the E2 enzyme Ubc9.  The non-covalent binding in Ubc9 is 
also required for SUMO chain formation, likely through a similar mechanism to UbcH5c 
(98). 
The process of dimerization is not solely limited to E2 enzymes, as many E3 
ligases have been shown to dimerize including Brca1/Bard1 involved in breast cancer and 
Ring1b/Bmi involved in histone mono-ubiquitination (99, 100).  This E3 dimerization 
was shown to be very important as mutations in the dimerization domain of Brca1 
promotes cancer formation (99). 
 
1.5 HIP2 and Ubc1 E2 conjugating enzymes 
The mechanisms of poly-Ub chain formation become complicated as interactions 
involve E2/E3, E3/E3, or more complex dimeric combinations of these enzymes to 
position Ub molecules for reactivity.  The simpler function of the E2 heterodimer 
Ubc13/Mms2 that does not require an E3 enzyme or substrate has provided very sound 
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structural information towards the assembly of K63-linked poly-Ub chains.  Similar 
structural information is lacking for K48-linked poly-Ub chains.  Two well studied 
enzymes that also have K48-linked poly-Ub chain formation activity in the absence of 
both E3 ligases and substrates are the yeast E2 enzyme Ubc1, and its human homolog 
HIP2.  Since these E2 enzymes do not require E3 ligases, they should utilize a simpler 
mechanism for poly-Ub chain assembly in comparison to other K48 poly-ubiquitination 
pathways.  How these two E2 enzymes function still remains poorly understood. 
 
1.5.1 Ubc1 
The E2 conjugating enzyme Ubc1 from yeast Saccharomyces cerevisiae was first 
identified in 1990 (101).  The primary function for Ubc1 in yeast was found to be the 
selective degradation of short lived and abnormal proteins during early stages of growth 
after spore germination (101).  Ubc1 also appears to functionally overlap with the other 
E2 enzymes Ubc4 and Ubc5 as single mutants of Ubc1 or Ubc4 have a slow growth 
phenotype, while double mutants fail to sporulate (101).  This result shows that Ubc4, 
Ubc5, and Ubc1 have overlapping function.  Ubc4 and Ubc5 are class I E2 enzymes 
containing only the traditional ~150 residue catalytic core domain while Ubc1 is a longer 
215 residue class II E2 conjugating enzyme that possesses an additional C-terminal 
extension.  The first experimental work on purified Ubc1 showed that K48-linked poly-
Ub chains were formed on the Ubc1 enzyme itself in the presence of only E1, MgATP, 
Ubc1 and Ub (102).  These poly-Ub chains were linked to the Ubc1 K93 residue 
indicating that Ubc1 performs an auto-ubiquitination of itself reminiscent of substrate 
ubiquitination.  Auto-ubiquitination assays were also performed on a Ubc1 truncation 
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(Ubc1Δ) that had the C-terminal domain removed.  Comparison of activity in Ubc1 and 
Ubc1Δ demonstrated that wild type Ubc1 could form poly-Ub chains up to four Ub 
molecules in length, while Ubc1Δ resulted in much longer poly-Ub chains up to 12 Ub 
molecules in length (102).  This result indicates that the 65 residue C-terminal domain 
may control the length of poly-Ub chains produced.  Further investigation indicated Ubc1 
may dimerize as it was shown to chemically crosslink and elute earlier than expected by 
size exclusion column chromatography (89).  The poly-Ub chain formation activity of 
Ubc1 may therefore require a dimeric mechanism to function. 
The structure of full length Ubc1 was solved using NMR spectroscopy and is 
composed of the traditional catalytic core domain of 4 α-helices, 4 β-strands, and the 
very short 310 helix immediately following the active site cysteine C88 residue (Fig 
1.7A).  The Ubc1 enzyme also contains a C-terminal Ub-associated (UBA) domain that is 
composed of a small 3 helix bundle (α5-α7) (Fig 1.7A) (103).  UBA domains are found 
in several other proteins and have been shown to bind Ub non-covalently (104), in some 
cases bind poly-Ub chains preferentially (105), and also been implicated as a 
dimerization domain (106).  The Ubc1 UBA domain was shown to interact non-
covalently with free Ub (103).  The full length Ubc1 NMR structure shows that the 
catalytic core domain and the UBA domain are connected by a flexible linker (103).  This 
flexible linker allows a wide range of movement of the UBA domain in relation to the 
catalytic core.  Therefore, the structure of full length Ubc1 is elongated, which may 
explain prior results in gel filtration experiments where Ubc1 eluted earlier than expected 
(89).  The Ubc1 structure also shows that the proximity of K93 in the 310 helix is very 
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Figure 1.7 Structure of the E2 conjugating enzyme Ubc1 and Ubc1Δ~Ub thiolester.  (A) The full 
length Ubc1 was solved using NMR spectroscopy (PDB: 1TTE) showing the classic catalytic 
core domain of 4 α-helices, a short 310 helix, and 4 β-strands that form an anti-parallel β-sheet 
that wraps around the central α2 helix.  Ubc1 also contains a C-terminal ubiquitin associated 
(UBA) domain composed of a 3-helix bundle of α5-α7.  The catalytic core domain is connected 
to the UBA domain through an unstructured flexible linker.  (B) Ubc1Δ (no UBA domain) was 
modelled with a thiolester bound Ub (teal) to position this Ub on the surface of Ubc1Δ (PDB: 
1FXT).  In this structure the hydrophobic side of Ub (located on the β-sheet) faces and interacts 
with the α2 helix in Ubc1.  In this way the Ubc1~Ub thiolester bound Ub is held closely to the 
Ubc1 enzyme.  Ubc1 secondary structural elements include α-helices (blue), β-strands (red), 
unstructured loops (grey) and the active site cysteine (yellow). 
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close to the C88 active site indicating that auto-ubiquitination may occur as a result of an 
intramolecular transfer of Ub directly from the active site to the K93 residue. 
The structure of the Ubc1Δ~Ub thiolester was modelled using NMR spectroscopy 
by creating the thiolester in situ (Fig 1.7B) (69).  In this structure the hydrophobic surface 
of Ub (located on the β-sheet) faces and interacts with the α2 helix in Ubc1Δ.  This 
results in Ub being tightly bound to the Ubc1 catalytic core domain.  Further 
experimentation on Ubc1 was greatly aided by the creation of a stable thiolester mimic 
formed with a disulphide bond between a substituted Ub (UbG76C) and the C88 of the 
active site (68).  This Ubc1-Ub disulphide complex was shown to accurately mimic the 
Ubc1~Ub thiolester complex through NMR experiments (68).  Experimentation on this 
Ubc1-Ub complex indicates that the UBA domain does not interact non-covalently with 
the thiolester bound Ub, but can interact with free Ub (68).  The ability of the UBA 
domain to bind Ub in the Ubc1-Ub complex shows that Ubc1 has the ability to bind two 
Ub molecules simultaneously.  The binding of two Ub molecules may support a 
monomeric mechanism of Ubc1 as the UBA domain could theoretically position the non-
covalently bound Ub in proximity to a thiolester bound Ub.  The Ubc1 protein was also 
shown to be monomeric by sedimentation equilibrium (107), although the formation of 
Ubc1~Ub thiolester may facilitate dimerization as was observed in Cdc34 (93). 
Very recent work on Ubc1Δ has suggested a novel function of the E1 enzyme that 
would be required for poly-Ub chain formation on the auto-ubiquitinated Ubc1Δ (108).  
This implies that an E1/E2 complex is required to position 2 Ub molecules together for 
poly-Ub attachment rather than an E2/E2 complex.  This could imply the E1 enzyme 
directly extends chains on E2 enzymes, or may assist E2 dimerization.  Additional recent 
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Ubc1 experimentation has shown that Ubc1 and Ubc4 E2 conjugating enzymes can poly-
ubiquitinate Cyclin B involved in cell cycle progression with a large RING E3 complex 
called APC (anaphase-promoting complex) (109).  In this study Ubc4 and Ubc1 appear to 
have different functions as Ubc4 is more active in initial Ub attachment to substrates and 
Ubc1 is more active at extending chains on substrates that already have a single attached 
Ub (109).  This study also tested Ubc1Δ (UBA removal) and observed products with 
shorter chain length (109).  This result contrasts with the Ubc1Δ auto-ubiquitination 
experiments where longer poly-Ub chains were produced (102).  These results may 
support a sequential addition model using combinations of E2 enzymes.  Even with these 
few activity results, the mechanism for poly-Ub chain formation of Ubc1 remains very 
poorly understood. 
 
1.5.2 E2 conjugating enzyme HIP2 (E2-25K) 
The E2 conjugating enzyme E2-25K was shown to interact with the protein 
huntingtin and is suspected to poly-ubiquitinate huntingtin for degradation resulting in 
E2-25K being renamed HIP2 (huntingtin interacting protein 2) (40, 110).  HIP2 is a 200 
residue E2 conjugating enzyme that is highly conserved as human HIP2 has 100% 
sequence identity with bovine HIP2, and 66% sequence similarity with its yeast homolog 
Ubc1 (40, 111).  The active site of HIP2 contains even greater conservation having 90% 
identity with Ubc1 within 20 residues around the active site (111).  HIP2 has been shown 
to be widely expressed in many tissues but is highly expressed in brain tissue (40).  The 
HIP2 structure was solved as a dimer by X-ray crystallography and is classified as a class 
II E2 indicating it possesses the traditional catalytic core domain and a C-terminal UBA 
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domain (Fig 1.8A) (PDB: 1YLA - unpublished).  HIP2 was not observed to crosslink 
(112), and its dimerization capacity is not well investigated.  Therefore the relevance of 
this dimeric crystal structure remains unknown.  The monomer of this structure is 
depicted in Figure 1.8B.  The HIP2 structure is again composed of the classic 4 α-helices, 
4 β-strands, a 310 helix, and a C-terminal UBA domain (Fig 1.8B).  Compared to the 
similar Ubc1, HIP2 has a shorter linker connecting the catalytic core to the UBA domain, 
and it is unknown if this linker is also flexible (Fig 1.7A versus Fig 1.8B).  The C92 
catalytic active site is used to create a thiolester with Ub, and the UBA domain has 
recently been shown to bind free Ub non-covalently, giving HIP2 the ability to bind 2 Ub 
molecules simultaneously, just like Ubc1 (113, 114).  These structural similarities to 
Ubc1 indicate that HIP2 should function by a similar mechanism to Ubc1. 
Very recently the crystal structure of HIP2 with non-covalently bound Ub was 
solved showing the nature of Ub binding to the HIP2 UBA domain (Fig 1.8C) (113).  
UBA domains are characterized by a conserved hydrophobic MGF patch between α1 and 
α2 in the 3 helix bundle used for protein interactions (115).  It is this MGF region of the 
HIP2 UBA domain that was seen to bind free Ub (113).  Ubc1 also utilizes its similar 
QGF residues in UBA/Ub binding (103).  This general UBA/Ub binding surface has been 
observed for several other UBA domains and is shown in more detail on an example 
UBA domain (Ede1) in Figure 1.8D (104).  The major binding interface between these 
two proteins is composed of the MGF and α3 of the UBA domain and the C-terminal end 
and hydrophobic residues in the β-sheet portion of Ub.  The HIP2 UBA domain has also 
been shown to bind poly-Ub chains (Ub4) with higher strength than single Ub 
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Figure 1.8 Structure insight into the human HIP2 E2 conjugating enzyme.  (A) The full length 
HIP2 enzyme was solved using X-ray crystallography (PDB: 1YLA) as a dimer where the β-sheet 
side of HIP2 opposite the active sites contact each other.  (B) Half of the structure shown in (A) 
leaves a monomeric HIP2 showing the classic catalytic core domain and a C-terminal UBA 
domain.  The unstructured linker between the catalytic core and UBA domain is shorter than that 
observed for Ubc1.  (C) A recent structure of HIP2 has shown the non-covalent binding of Ub 
with the UBA domain (PDB: 3K9P).  In this structure the hydrophobic face of Ub interacts with a 
highly conserved MGF sequence in the UBA domain of HIP2.  (D) Many other UBA domains 
show a similar interaction with Ub.  An example from the protein Ede1 depicts a similar UBA/Ub 
non-covalent interaction (PDB: 2G3Q).  Most UBA domains contain this MGF motif and use a 
large portion of the third α-helix in this 3-helix bundle to contact the hydrophobic face of Ub.  
HIP2 secondary structural elements include α-helices (blue), β-strands (red), unstructured loops 
(grey) and the active site cysteine (yellow) and oxyanion stabilizing asparagine (green) while Ub 
(teal) is coloured uniformly. 
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molecules (105).  NMR experiments on a similar UBA domain (UBA2 from hHR23A) 
have shown a K48-linked Ub2 used both Ub hydrophobic surfaces to contact the UBA 
domain (116).  These results are consistent with stronger binding to poly-Ub chains 
indicating that HIP2 may bind poly-Ub chains in a similar manner. 
HIP2 activity was initially found to create unanchored K48-linked poly-Ub chains 
with only E1, MgATP, and Ub (117).  The function of HIP2 is similar to Ubc1 only the 
K48-linked poly-Ub chains are free in solution as opposed to connected to the K93 
residue in Ubc1.  HIP2 was also found to be able to use non-thiolester linked Ub 
molecules as Ub acceptors indicating Ub acceptors may be thiolester linked or bound 
non-covalently (117).  Diubiquitin (Ub2) was also found to be a better Ub acceptor than 
Ub alone indicating the kinetics of poly-Ub chain formation become more favourable as 
the chain grows (117).  Since the HIP2 UBA domain has also been shown to bind poly-
Ub chains (Ub4) with higher strength than single Ub molecules, the UBA domain may 
account for the use of longer poly-Ub chains as more efficient Ub acceptors (105).  These 
results imply that the UBA domain is required for chain extension.  Further experimental 
studies on HIP2 were performed with a truncated HIP2Δ155 (UBA removed at residue 
155) or HIP2Δ159 and these truncations still retained poly-Ub chain activity although 
they were not as efficient (30, 114).  These results indicate that UBA aids in activity but 
may not be essential.  Very recent experiments have shown the UBA domain is required 
for full activity of HIP2 (114), and its yeast homolog Ubc1 (109).  The presence of even 
partial activity with UBA removal indicates HIP2 dimerization may be required to place 
two Ub molecules in close proximity.  The purpose of the UBA domain therefore remains 
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poorly understood but its known affinity for Ub and poly-Ub chains allows for many 
possible interactions with E2, E3 or substrate linked Ub or poly-Ub molecules.   
The purpose of HIP2 building unanchored poly-Ub chains remains unknown, 
although the E1 enzyme can form thiolesters with both Ub and Ub2 and transfer these 
thiolesters onto HIP2 with similar kinetics (117).  This indicates that preassembled Ub2 
can be utilized to form HIP2~Ub2 that could act as a Ub donor in further chain extension 
or substrate labelling (117).  This is supported by the discovery that unanchored poly-Ub 
chains are found in vivo and can be loaded onto substrates using Ubc4 with similar 
kinetics to a single Ub (118).  These results show HIP2 may function by preassembling 
poly-Ub chains prior to substrate attachment. 
Very little is known about HIP2’s cognate E3 enzymes or substrates.  The 
biological activity of HIP2 remains widely unknown.  Only a small number of RING E3 
enzymes were implicated to interact with HIP2 through yeast two-hybrid studies (119).  
HIP2 ubiquitinates the substrate p105 a precursor for p50, involved in NF-kB signaling, 
through an unknown E3 ligase (120).  Very recent work has identified HIP2 to bind the 
RING E3 NARF (Nemo-like Kinase (NLK)-associated Ring finger) to ubiquitinate 
transcription factors TCF/LEF, and their corresponding degradation suppresses Wnt-β-
catenin signaling involved in embryonic development and tumorigenesis (121).  HIP2 has 
also been linked to Cyclin B1 degradation and DIABLO degradation but no E3 ligase has 
been identified (122, 123).  HIP2 may also be involved in the degradation of Rb 
(retinoblastoma tumor suppressor protein) involved with HPV oncoprotein E7 resulting 
in the promotion of cancer (124).  The lack of many identified E3 ligases for HIP2 has 
limited the study of HIP2 activity on specific substrates. 
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The most interesting HIP2 function is in both Alzheimer’s and Huntingtin’s 
disease.  Alzheimer’s disease has been characterized by extracellular plaques that are 
composed of misfolded and aggregated amyloid β peptides (Aβ).  HIP2 was shown to be 
upregulated in neurons exposed to Aβ peptides (125).  Alzheimer’s disease has been 
linked to ubiquitination through the incorporation of the ubiquitin variant UBB+1 (32) and 
reduced proteosomal activity (33).  The UBB+1 variant contains a C-terminal extension 
that when added to the end of a K48-linked poly-Ub chain is resistant to deubiquitinating 
enzymes and correspondingly inhibits the 26S proteosome (36).  HIP2 may largely affect 
these functions by incorporating UBB+1 into poly-Ub chains as HIP2 has recently been 
found to bind both Ub and UBB+1 by the UBA with equivalent affinity (113).  HIP2 is 
expressed in many tissue types (126) and is highly expressed in the brain (40), the site of 
polyglutamine and Alzheimer’s diseases.  Huntington’s disease is characterized by the 
expansion of the polyglutamine portion of the protein huntingtin that results in their 
aggregation into inclusion bodies.  HIP2 interacts with the huntingtin protein and 
presumably is responsible for its ubiquitination (40).  HIP2 was also found to exist in 
Huntington’s disease inclusions also containing huntingtin, Ub and UBB+1 (127).  
Additionally, HIP2 is suspected to play a role in aggregate formation and cell death (127, 
128).  HIP2 involvement in both Huntington’s and Alzheimer’s disease may be related by 
a similar mechanism of pathogenesis. 
 
1.6 Scope of Thesis 
The ubiquitination pathway is an important regulatory pathway within the cell and 
its disruption has been linked to many neurodegenerative diseases and cancer.  A 
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significant amount of work over the last two decades has expanded the understanding of 
the E1-E2-E3 enzyme cascade used to poly-ubiquitinate substrates for degradation.  
However, the mechanism by which most these enzymes build poly-Ub chains on their 
substrates remains poorly understood.  An improved understanding of the mechanisms of 
poly-Ub chain assembly will aid in determining how these pathways are disrupted in 
many diseases. 
HIP2 and Ubc1 do not require E3 enzymes and substrates to create poly-Ub chain 
linkages.  HIP2 and Ubc1 employ a simple functional mechanism that only requires the 
addition of Ub, ATP and the E1 enzyme.  Investigating these enzyme structures and 
protein interactions is crucial to fully comprehending their function in the ubiquitination 
pathway. 
 
The work in this thesis is based on the following hypotheses: 
• The E2 conjugating enzymes HIP2 and Ubc1 dimerize upon formation of E2~Ub 
thiolesters. (investigated in Chapter 2) 
• The E1 enzyme does not directly extend a poly-Ub chain on the HIP2~Ub and 
Ubc1~Ub thiolesters. (investigated in Chapter 2) 
• Unique intramolecular interactions exist for HIP2~Ub and HIP2~Ub2 thiolesters 
that will provide a rationale for poly-Ub assembly. (investigated in Chapter 3 and 
4) 
 
These hypotheses were studied through the creation of disulphide complexes to mimic 
Ubc1~Ub, HIP2~Ub and HIP2~Ub2 thiolesters.  Investigation of these complexes was 
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performed using sedimentation equilibrium, small angle X-ray scattering (SAXS), and 
activity assays using unlabelled and fluorescently labelled proteins.  NMR spectroscopy 
chemical shift mapping was utilized to determine protein interactions within HIP2-Ub 
and HIP2-Ub2 through isotopic labelling (15N and 13C) of individual proteins within these 
complexes.  These investigations have led to the clarification of possible mechanisms that 
HIP2 and Ubc1 utilize to assemble poly-Ub chains. 
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Chapter 2 
 Determination of the Dimerization Capacity and Enzymatic 
Component Requirements for Poly-ubiquitin Chain Assembly 
in the E2 Conjugating Enzymes HIP2 and Ubc1 
2.1 Introduction 
The ubiquitin proteolysis pathway utilizes three enzymes, E1, E2 and E3 to 
respectively activate, transfer and ligate ubiquitin (Ub) onto a target protein (Fig 2.1A).  
These enzymes work together to build K48-linked poly-Ub chains that are formed on 
substrate proteins, targeting them to be degraded by the 26S proteosome.  The 
mechanism of Ub-Ub covalent attachment in poly-Ub chain formation remains poorly 
understood. 
There are various competing hypotheses describing the formation of poly-Ub 
chains, and it is possible that different E2 enzymes use different mechanisms to link Ub 
molecules (1).  The sequential addition model, suggests one ubiquitin at a time is added 
to a substrate eventually forming a poly-Ub chain.  Other models involve the preassembly 
of poly-Ub chains that are then transferred as a block onto a substrate.  There is growing 
evidence that preassembly of poly-Ub chains may require the dimerization of E2 
enzymes to position two Ub molecules to be connected together prior to attachment to 
substrate (2-9). 
The E2 conjugating enzymes Ubc1 and HIP2 have poly-ubiquitination chain 
activity in the absence of E3 enzymes and substrates, and thus these E2 enzymes may  
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Figure 2.1 A schematic representation of the ubiquitin proteolysis pathway and a method by 
which poly-Ub chains may be constructed.  (A) Ubiquitin is attached to a ubiquitin activating 
enzyme (E1) through an ATP dependant process that creates a highly reactive thiolester linkage.  
The Ub is then transferred to a ubiquitin conjugating enzyme (E2), and through the use of a 
ubiquitin ligating enzyme (E3) reacts with a lysine residue on a substrate.  Proteins destined for 
degradation are labelled with a poly-Ub chain of four or more Ub molecules targeting the 
substrate to the 26S proteosome.  (B) A model of E2 dimerization driven by interaction between 
the E2 enzymes whereby Kd1 defines the dissociation constant of this interaction.  (C) A model of 
E2~Ub thiolester dimerization driven by interactions between Ub and the E2 enzymes whereby 
Kd2 defines the dissociation constant of this interaction.  (D) A possible mechanism showing how 
poly-Ub chain formation can be performed using an E2 dimer to position Ub molecules 
(numbered 1-3) for attachment.  Each arrow between Ub molecules represents the K48 side chain 
nucleophilic attack to the reactive thiolester of a second Ub.  For simplicity these models do not 
depict the UBA domain of Ubc1 and HIP2, nor attempt to show the exact interaction surfaces 
used in dimerization. 
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function through dimerization (10, 11).  If these E2 enzymes do indeed dimerize, they 
may do so directly (Fig 2.1B) or dimerize through the creation of the E2~Ub thiolester by 
providing the additional interaction surface of Ub to the E2 enzyme (Fig 2.1C).  
Determination of the strength of these possible dimeric interactions will aid in 
determining the mechanism by which Ubc1 and HIP2 function.  One possible mechanism 
for the creation of a poly-Ub chain through an E2 dimer involves the placing of the K48 
side chain of one Ub in close proximity to the reactive thiolester of a second Ub to allow 
a Ub-Ub connection.  In this process the chain extends via multiple charging of the E2 
enzymes with the building chain transferring onto newly charged E2 enzymes (Fig 2.1D).  
The determination of Kd1 and Kd2 in Figure 2.1B and C will indicate the plausibility of 
these models for Ubc1 and Hip2 function. 
 
2.2 Materials and Methods 
2.2.1 Cloning 
Wild-type HIP2 cDNA in a pET28a vector was a generous gift from the 
Structural Genomics Consortium (Toronto).  A C170S substitution in HIP2 was 
introduced using the Quikchange Site-Directed Mutagenesis (Stratagene, La Jolla, CA) 
protocol.  The design of forward and reverse complement primers also included base 
changes for L169 to convert it from a rare to common E. coli. codon. 
Ubiquitin (Ub) and Ubc1 from S. cerevisiae were expressed from a pET3a vector 
as described previously (11).  Incorporation of substitutions into Ub and Ubc1 were 
accomplished by traditional PCR methods or the Quikchange protocol.  Kathryn R. 
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Barber incorporated all substitutions in Ub and Ubc1.  These substitutions include a 
G76C substitution (UbG76C) and/or a K48R substitution (UbK48R) in yeast Ub, and a K93R 
substitution in Ubc1 (Ubc1K93R) to inhibit auto-ubiquitination.  Human Ub with an N-
terminal cysteine tag (GPCLGS) in the pGEX-6P1 GST fusion vector was a kind gift 
from Dr. Leo Spyrocopoulos (University of Alberta) and was modified to generate a 
K48R version by the Quikchange protocol.  All substitutions were confirmed to be 
correct by DNA sequencing performed at the London Regional Genomics Centre. 
 
2.2.2 Protein expression and purification of HIP2, Ubc1 and substituted ubiquitins 
Various substituted ubiquitins and Ubc1K93R (hence forward just Ubc1) from S. 
cerevisiae were over expressed in BL21(DE3)pLysS E. coli strain and purified using a Q 
anion exchange column, followed by a Sephadex G75 (GE Healthcare) size exclusion 
column as previously described (11).  Electrospray ionization mass spectrometry 
confirmed the integrity of Ubc1 (MWobs 24162.4 ± 0.8Da, MWcalc 24162.2).  Kathryn R. 
Barber purified Ubc1.  Protein concentrations of Ubc1 were determined through Bradford 
(BioRad) reactions performed in triplicate.  Protein concentrations of Ub were 
determined by weight of lyophilized proteins. 
Hexahistidine (His6) tagged HIP2C170S (hence forward just HIP2) was 
overexpressed in the BL21(DE3)star E. coli strain.  The bacteria were grown at 37 °C 
overnight in LB media (10 mL) containing the antibiotic kanamycin (30 µg / mL).  The 
culture was then diluted 1:100 into 1 L of LB containing the same antibiotics and grown 
at 37 °C to an A600 between 0.60-0.75.  Protein expression was induced for 16-20 hours 
with 0.7 mM IPTG at 15 °C.  Harvested cells were re-suspended in 20 mM Tris-HCl, 200 
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mM NaCl, 1 mM TCEP, 5 mM imidazole at pH 8.0 with the addition of a COMPLETE 
mini EDTA-free protease inhibitor cocktail tablet (Roche Diagnostics).  Cells were lysed 
with a French pressure cell and cellular debris was removed by centrifugation at 95500 
xg.  All following purification procedures were performed at 4 °C to minimize protein 
degradation.  The clarified extract containing His6-HIP2 was applied to Ni-NTA Agarose 
(Qiagen) and washed with 20 mM Tris-HCl, 200 mM NaCl, 1 mM TCEP, 10 mM 
imidazole at pH 8.0 to elute non specifically bound material.  His6-HIP2 was eluted with 
20 mM Tris-HCl, 200 mM NaCl, 1mM TCEP, 200 mM imidazole pH 8.0.  The protein 
was concentrated and loaded on to a Superdex 75 10/300 GL column (GE Healthcare) in 
20 mM Tris-HCl, 200 mM NaCl, 1mM TCEP, 10 mM imidazole pH 8.0.  Thrombin (2 
µg / mL) was utilized to cleave the His6 tag at room temperature for two hours and a 
subsequent Ni-NTA Agarose column was utilized to remove the tag and any uncut 
protein from HIP2.  A final Superdex 75 10/300 GL column run in 20 mM Tris-HCl, 200 
mM NaCl, 1 mM TCEP pH 8.0 was used to remove residual thrombin from the purified 
HIP2 protein.  Purification steps were monitored using SDS-PAGE.  SDS-PAGE was 
performed using 16.5% tris-tricine gels in a mini-gel system (BioRad) and was stained 
with Coomassie dye.  HIP2 concentrations were determined through Bradford (BioRad) 
reactions performed in triplicate.  Purified HIP2 was confirmed using electrospray 
ionization mass spectrometry (MWobs 22534.8 ± 0.3Da, MWcalc 22534.7). 
 
2.2.3 Protein expression and purification of NCys-Ub and NCys-UbK48R 
Human Ub proteins were modified to contain a cysteine residue in a peptide 
extension (GPCLGS) at the N-terminus of both wild type Ub (NCys-Ub) and UbK48R 
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(NCys-UbK48R).  GST fusion proteins of NCys-Ub and NCys-UbK48R were over expressed in 
the BL21(DE3)pLysS E. coli strain.  Cell cultures were grown overnight in LB media (10 
mL) containing the antibiotic carbenicillin (50 µg / mL).  The culture was then diluted 
1:100 in LB media containing the same antibiotic and grown at 37 °C to an A600 of 0.60.  
Protein expression was induced with 0.5 mM IPTG for 4 hours at 37 °C.  Harvested cells 
were re-suspended in binding buffer consisting of 25 mM Tris-HCl, 100 mM NaCl, 3 
mM DTT at pH 7.5 with the addition of a COMPLETE mini EDTA-free protease 
inhibitor cocktail tablet (Roche Diagnostics).  Cells were lysed with a French pressure 
cell and cellular debris was removed by centrifugation at 95500 xg.  The lysate was 
purified using a GST affinity column (GE Biosciences), washed with the same binding 
buffer and eluted with 25 mM Tris-HCl, 100 mM NaCl, 3 mM DTT, and 20 mM 
glutathione.  The GST affinity tag was cut using TEV (Shaw lab; 50 µg / mL) and 
removal of the GST tag, any uncut protein and the TEV protease was achieved by size 
exclusion chromatography on a Sephadex G-75 column (GE Healthcare) with 25 mM 
Tris-HCl, 100 mM NaCl, 0.5 mM EDTA pH 7.4.  Purification steps were monitored 
using SDS-PAGE.  SDS-PAGE was performed using 16.5% tris-tricine gels in a mini-gel 
system (BioRad) and was stained with Coomassie dye.  NCys-Ub and NCys-UbK48R 
concentrations were determined through SDS-PAGE comparison to Ub substitutions.  
Purified NCys-Ub and NCys-UbK48R were confirmed using electrospray ionization mass 
spectrometry (NCys-UbK48R: MWobs 9107.61 ± 0.42 MWcalc 9107.4; NCys-Ub: MWobs 
9079.08 ± 0.94 MWcalc 9079.44). 
NCys-Ub and NCys-UbK48R were then reacted with Alexa-Fluor 680 C2-Maleimide 
(Invitrogen) to fluorescently label the Ub and UbK48R.  The cysteine in NCys-Ub and NCys-
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UbK48R reacts with the C2-maleimide to yield Alexa-Ub and Alexa-UbK48R.  These 
reactions were performed by a 10:1 (v/v) mixing of 100 µM NCys-Ub in 100 mM NaCl, 
0.5 mM EDTA, 25 mM Tris-HCl pH 7.4 and 5 mM Alexa-Flour in 100% isopropanol 
respectively.  This reaction was stopped with the addition of 5 mM DTT, and then 
purified using a PD-10 desalting column (GE Healthcare) and extensive dialysis with 25 
mM Tris-HCl, 100 mM NaCl pH 7.3 was used to remove unreacted Alexa dye.  Ub 
molecules were confirmed to be labelled with Alexa via electrospray ionization mass 
spectrometry (Alexa-UbK48R MWobs 10089.21 ± 0.31 agrees with expected values for 
NCys-UbK48R (9107.46 Da) and Alexa dye (~982 Da)); Alexa-Ub MWobs 10061.89 ± 0.40 
agrees with expected values for NCys-Ub (9079.44 Da) and Alexa dye (~982 Da)). 
 
2.2.4 E2-Ub disulphide complex formation 
Two different versions of disulphide complexes were created for both HIP2 and 
Ubc1.  UbK48R-G76C (shortened to UbCys) was used for all protein interaction studies while 
UbG76C (UbK48Cys) was used for activity assays on disulphide chain extension.  Since the 
choice of UbCys or UbK48Cys is immaterial to purification, only UbCys shall be described for 
simplicity.  Solutions of UbCys, Ubc1 or HIP2 (0.1 mM) were fully reduced with 2 mM 
TCEP.  Ubc1 or HIP2 was combined with an excess of UbCys and dialyzed at 4 °C against 
several changes of 100 mM Na2HPO4/NaH2PO4, 100 mM NaCl, 10 µM CuCl2 at pH 7.5. 
The progress of the disulphide complex formation was monitored by non-reducing SDS-
PAGE and was considered complete when Ubc1 or HIP2 was exhausted, usually 
requiring 72-96 hours.  The completed E2-UbCys reaction also contains the disulphide by-
products UbCys-UbCys and E2-E2 dimers.  The protein solution was concentrated and the 
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by-products removed by size exclusion chromatography on a Sephadex G-75 column 
with 25 mM Tris-HCl, 1 mM EDTA, and 150 mM NaCl (Ubc1-UbCys) or 400 mM NaCl 
(HIP2-UbCys), at pH 7.5.  Purification steps were monitored using SDS-PAGE.  SDS-
PAGE was performed using 16.5% tris-tricine gels in a mini-gel system (BioRad) and 
was stained with Coomassie dye. Ubc1-UbCys and HIP2-UbCys concentrations were 
determined through Bradford (BioRad) reactions performed in triplicate. HIP2-UbCys 
concentrations for SAXS studies were determined with amino acid analysis (Advanced 
Protein Technology Center).  Fractions containing pure Ubc1-UbCys or HIP2-UbCys were 
pooled and their purity and identity confirmed by mass spectrometry (Ubc1-UbCys MWcalc 
32791.1, MWobs 32,794.59 ± 4.0Da; HIP2-UbCys MWobs 31163.2 ± 1.0Da, MWcalc 
31163.5). 
 
2.2.5 Analytical ultracentrifugation 
Sedimentation equilibrium experiments were performed on a Beckman Optima 
XL-A analytical ultracentrifuge capable of UV/VIS wavelength scanning.  An An-60 Ti 
analytical rotor was used with six-channel equilibrium double sector Epon-charcoal 
center pieces, which contain three protein/buffer pairs.  Quartz windows were used on the 
ends of the 12 mm thick center pieces to allow absorbance values to be collected at either 
250 or 280 nm in 0.002 cm radial steps and averaged over 10 readings.  Experiments 
were performed at 5 °C and at rotor speeds of 15000, 18000, 22000 and 26000 rpm.  A 
delay of 20 hours (Ubc1, HIP2) or 16 hours (Ubc1-UbCys, HIP2-UbCys) was used to reach 
the initial state of equilibrium, and further increases in speed were allowed 8 hours to 
reach equilibrium before readings were measured.  At each speed two scans were 
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performed two hours apart.  These scans were superimposed to confirm that a state of 
equilibrium had been properly achieved.  Protein sample cells were loaded with 100 µL 
protein and reference sample cells were loaded with 110 µL buffer.  All protein samples 
were dialyzed into their respective buffers (Ubc1 and Ubc1-UbCys: 25 mM Tris-HCl, 1 
mM EDTA, 150 mM NaCl at pH 7.5 (plus 2 mM TCEP for Ubc1); and HIP2: 20 mM 
Tris-HCl, 200 mM NaCl, 1 mM TCEP at pH 8.0; and HIP2-UbCys: 25 mM Tris-HCl, 400 
mM NaCl, 1 mM EDTA at pH 7.5) and diluted with this dialysis buffer to the desired 
concentrations.  The experiments were performed on Ubc1 and HIP2 with concentrations 
of 14.7 µM and 9.6 µM respectively.  Three different concentrations were analyzed for 
both HIP2-UbCys (7.2, 14.4 and 24 µM) and Ubc1-UbCys (10.8, 21.5 and 43 µM).  The 
solvent densities were calculated from published tables of buffer components (12) (13).  
Partial specific volumes of all proteins were calculated using their amino acid 
compositions (14).  Data was analyzed using Prism 4 (Graphpad) with two different 
models using a global analysis for multiple data sets on an Apple iMac G4 computer.  
One analysis involved the single ideal species model defined by equation 1, 
   Cr = Co exp[(ω2/2RT)Mobs(1-υρ)(r2-ro2)]+Io   (1) 
where Cr is the protein concentration at radius r, Co  is the concentration at the reference 
radius ro, ω is the angular velocity of the rotor, R is the ideal gas constant, T is the 
temperature in Kelvin, Mobs is the protein molecular weight, υ is the partial specific 
volume of the protein, ρ is the density of the solvent, and Io is the baseline offset.  A self-
associating model defined by equation 2 was also used to fit data for a monomer-dimer 
equilibrium, 
Cr={Coexp[(ω2/2RT)Mp(1-υρ)(r2-ro2)]}+{Co2Kaexp[(ω2/2RT)2Mp(1-υρ)(r2-ro2)]}+Io  (2) 
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   Kd = 1/Ka = [monomer]2 / [dimer]    (3) 
where Mp is the mass of the monomer, Ka and Kd are the equilibrium association and 
dissociation constants (in absorbance units, AU) defined by equation 3, and all other 
terms are identical to equation 1.  Kd values were converted from absorbance units to 
molarity using the extinction coefficients calculated for each protein from low speed 
scans. 
 
2.2.6 Small angle X-ray scattering 
Small angle X-ray scattering (SAXS) data was collected on three separate 
occasions at BioCAT Beamline ID-18 of the Advanced Photon Source (Argonne, Illinois) 
using X-rays with a wavelength of 1.03 Å. The beam centre was determined from silver 
behenate powder diffraction, and the sample to detector distance varied from 1892 mm to 
2810 mm. Data were recorded on a Brandeis II or Mar165 CCD detector. 
The sample chamber consisted of a 1.5 mm diameter quartz capillary mounted in 
a brass holder maintained at 10 °C and connected to a syringe pump. Three to ten 
exposures (approximately 2 s each) were recorded for each sample and its matched 
buffer. During the recording the sample (80 µL volume) was kept moving through the 
capillary to limit radiation-induced aggregation. The two dimensional images were 
radially integrated using either Fit2D (15) or Igor Pro (Wavemetrics, Lake Oswego, 
Oregon), and the individual frames were averaged after removal of outliers. Scattering 
from buffer alone was subtracted from the protein-containing samples to yield scattering 
from the hydrated protein. Additional data processing was carried out in Microsoft Excel 
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and/or the Igor Pro macros developed at BioCAT.  The momentum transfer (Q) is defined 
as 4πsinθ/λ, where 2θ is the scattering angle. 
The buffer conditions used for SAXS data collection are identical to 
sedimentation equilibrium studies, except HIP2-UbCys that had a pH change to 8.0.  A 
second data set for HIP2-UbCys SAXS data was collected in 100 mM phosphate, 400 mM 
NaCl, 3 mM EDTA at pH 7.4.  The change in buffer conditions had little affect on HIP2-
UbCys protein scattering. 
CRYSOL (16) was used to calculate theoretical scattering from atomic 
coordinates and adjust hydration parameters to compare to experimental data.  The 
quality of the match of theoretical scattering to experimental scattering is measured with 
a goodness of fit value (χ2) that is defined as: 
   χ2 = 1/N (NΣi=1) [ (Ie(si) – cIc(si))/σ(si) ]2   (4) 
where N is the number of data points, s is the magnitude of the scattering vector, c is a 
scale factor, Ie is the experimental intensity, Ic is the calculated intensity, and σ is the 
experimental error (16). 
All figures for SAXS CRYSOL curves were produced using the default input 
parameters for CRYSOL curve fitting (16).  The PDB files used in CRYSOL analysis 
figures were 1TTE (for Ubc1), 1UBQ (for ubiquitin), 1YLA (for HIP2), 1FXT (for the 
Ub position in the ‘compact’ thiolester), and 2GMI (for the Ub position in the ‘elongated’ 
thiolester). 
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2.2.7 E2 poly-ubiquitination activity assays 
Ubiquitination reactions were performed with purified E2 enzymes, disulphide 
complexes and unlabelled Ub proteins.  Several reactions were performed which 
contained different combinations of E2 enzymes and Ub proteins.  All reactions contain a 
subset of the following final protein concentrations: 150 nM E1 enzyme, 4.1 µM HIP2 
conjugating enzyme, 2.0 µM HIP2-UbK48Cys thiolester mimic, 4.1 µM Ubc1 conjugating 
enzyme, 2.0 µM Ubc1-UbK48Cys thiolester mimic, 11.0 µM Ub, and 10.8 µM UbK48R.  All 
reactions also had final concentrations of 10 mM Mg-ATP and 50 mM Hepes pH 8.0.  
Reaction protein species were visualized using 16.5% tris-tricine gels in a mini-gel 
system (BioRad) stained with Coomassie dye.  Reactions were carried out for 5 min, 30 
min and 1 hour with the HIP2 conjugating enzyme, and 5 min, 2 hours, and 5 hours with 
the Ubc1 conjugating enzyme since Ubc1 seems to have a lower poly-ubiquitination 
activity.  Each reaction was stopped with excess EDTA buffer and then combined with 
non-reducing SDS running buffer and heated for 5 min at 95 °C. 
 
2.2.8 HIP2 and Ubc1 activity assays with Alexa labeled Ub 
Alexa dye labelled ubiquitination reactions were performed with purified E2 
enzymes, disulphide complexes and Alexa fluorescent dye labelled NCys-Ub or NCys-
UbK48R.  Several reactions were performed with different combinations of E2 enzymes 
and Ub proteins.  All HIP2 enzyme reactions had a subset of the following final protein 
concentrations: 225 nM E1 enzyme, 12 µM HIP2 conjugating enzyme, 15.2 µM HIP2-
UbK48Cys thiolester mimic, 3.9 µM Alexa-UbK48R, and 3.9 µM Alexa-Ub.  All Ubc1 
reactions had a subset of the following final protein concentrations: 214 nM E1 enzyme, 
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12.3 µM Ubc1 conjugating enzyme, 10.5 µM Ubc1-UbK48Cys thiolester mimic, 5.5 µM 
Alexa-UbK48R, and 5.5 µM Alexa-Ub.  Both of the above reactions use final 
concentrations of 10 mM Mg-ATP and 50 mM Hepes pH 8.0.  Reactions were carried out 
in a manner similar to previous activity assays except the Ubc1 reaction was performed 
for 4 hours, and the HIP2 reaction was performed for 1 hour.  Reactions were visualized 
using 16.5% tris-tricine gels in a mini-gel system (BioRad) stained with Coomassie dye 
or visualized by fluorescence using an Odyssey imaging system (LI-COR). 
Additional activity assays were performed utilizing purified E2 thiolesters to 
remove E1 from poly-ubiquitination reactions.  The Alexa-UbK48R thiolester was formed 
with either Ubc1 or HIP2 in a 30 min reaction with final concentrations of 18.3 µM 
Alexa-UbK48R, 12.3 µM Ubc1, 214 nM E1 for the Ubc1 thiolester and 16.4 µM Alexa-
UbK48R, 32.8 µM HIP2, 214 nM E1 for the HIP2 thiolester.  This thiolester reaction 
mixture was then immediately loaded onto a Sephadex G75 10/300 size exclusion 
column to purify the thiolester from unconjugated Alexa-UbK48R and E1 enzyme.  
Thiolesters were then concentrated with a 3K Nanosep concentrator (Pall).  Purified 
thiolesters were then reacted with different mixtures of purified proteins.  All Ubc1 
thiolester reactions contained a subset of the following final protein concentrations: 500 
nM reactive Alexa dye, 90 µM Ub, 90 µM UbK48R, 9.2 µM Ubc1-UbK48Cys.  All HIP2 
thiolester reactions contained a subset of the following final protein concentrations: 500 
nM reactive Alexa dye, 54 µM Ub, 54 µM UbK48R, 6 µM HIP2-UbK48Cys.  HIP2 thiolester 
reactions proceed for 1 hour at 37 °C, while Ubc1 thiolester reactions proceeded for 5 
hours at 37 °C.  All of the above reactions used final concentrations of 10 mM Mg-ATP 
solution, and 50 mM Hepes at pH 8.0. 
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2.3 Results 
2.3.1 Expression and purification of HIP2 
A C170S substitution was introduced into the E2 enzyme HIP2 to ensure that the active 
site C92 was the only cysteine residue available for the future creation of a disulphide 
thiolester mimic.  Previous studies have shown this C170S substitution does not affect 
enzyme activity (17).  HIP2C170S (hence forward just HIP2) was overexpressed with an N-
terminal hexahistidine (His6) tag and was soluble in BL21(DE3)star E. coli cells when 
induced with IPTG (Fig 2.2A).  Purification of His6-HIP2 from E. coli cells was 
performed by cell lysis with a French Press, followed by centrifugation to remove cellular 
debris.  The remaining lysate was then subjected to Ni2+-affinity chromatography that 
selectively binds to the N-terminal His6 fusion tag (Fig 2.2B – lane 5).  The fusion tag 
was removed by the cleavage enzyme thrombin leaving an N-terminal GS extension on 
the normally 200 amino acid long HIP2 protein.  A second Ni2+-affinity chromatography 
purification step was performed on thrombin treated protein leaving only the purified 
HIP2 in the flow through fraction (Fig 2.2B - lane 7).  Size exclusion purification was 
then performed on the pure protein to remove any minor trace proteases and residual 
thrombin.  Using electrospray ionization mass spectrometry, a single major peak was 
observed (MWobs 22534.8 ± 0.3Da) at the expected molecular weight (MWcalc 22534.7) 
confirming that the purified HIP2 protein was intact (Fig 2.2C). 
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Figure 2.2 Expression and purification of the E2 conjugating enzyme HIP2.  The E2 conjugating 
enzyme HIP2 was first expressed with a His6 tag.  (A) Protein expression testing of His6-HIP2 
was performed using 2 mL LB cultures, and analyzed using SDS-PAGE samples on cell cultures.  
The Coomassie stained gel shows first uninduced sample (lane 1) followed by IPTG induced cells 
showing the expression of His6-HIP2 (lane 2), and finally the soluble fraction of protein was 
isolated by lysozyme cell lysis and centrifugation to remove insoluble protein (lane 3).  (B) 
Purification of His6-HIP2 depicted by Coomassie stained SDS-PAGE gels following procedures 
listed in Section 2.2.2.  The HIP2 purification gel is loaded from left to right with induced cells 
(lane 1), lysate following centrifugation (lane 2), Ni2+-affinity column flow through (lane 3), 
wash (lane 4) and elution (lane 5), HIP2 following thrombin cleavage (lane 6) and flow through 
from the second Ni2+ affinity column (lane 7).  Molecular weight standards are listed in kDa to 
the left of each gel.  (C) Electrospray ionization mass spectrometry analysis of purified HIP2 
indicates the correct mass. 
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2.3.2 Expression and purification of substituted ubiquitins 
Specific Ub substitutions are essential for the creation of E2-Ub thiolester mimics 
and for use in wild type and blocked poly-Ub chain activity assays with HIP2 and Ubc1.  
The Ub molecule carrying a G76C substitution was required for C-terminal disulphide 
formation used to make E2 enzyme thiolester mimics while a K48R substitution on Ub 
was utilized to block K48-linked poly-Ub chain extension.  Wild type Ub and UbK48R 
(UbK48R) were purified for use in poly-Ub chain activity assays as functional and blocked 
Ub species respectively.  UbK48R-G76C (shortened to UbCys) and UbG76C (UbK48Cys) were 
used to create blocked and extendable thiolester mimics respectively.  All of these Ub 
substitutions were purified as previously described (11, 18). 
 
2.3.3 Formation and purification of HIP2-Ub disulphide thiolester mimics 
Ubc1 and HIP2 conjugating enzymes function by allowing a highly reactive 
thiolester to be formed between their active site cysteine side chain and the C-terminal 
carboxylic acid of G76 in ubiquitin.  This thiolester intermediate is susceptible to 
hydrolysis at basic pH and thus only lasts a few hours in solution (19).  The instability of 
the thiolester limits in depth structural studies on these species.  Through the use of a Ub 
G76C substitution a much more stable thiolester mimic can be created by the formation 
of a disulphide bond between the newly added C-terminal cysteine side chain on Ub and 
the active site cysteine on the E2 enzyme.  This disulphide bond will persist for months 
allowing direct study of the E2 intermediate.  Previous NMR studies on this disulphide 
show that the E2-Ub interactions are nearly identical compared to the activated thiolester, 
and thus the E2-Ub disulphide model accurately mimics the E2~Ub thiolester 
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intermediate (18).  NMR chemical shift index analysis of this disulphide bond has also 
shown that the secondary structures of the E2 enzyme and Ub undergo no major changes 
upon bond formation (18, 20). 
HIP2 disulphide complexes were created for both UbCys that is blocked from K48 
poly-Ub chain formation and UbK48Cys that has an available K48 residue for poly-Ub 
chain formation.  UbCys was used for all protein interaction studies while UbK48Cys was 
used for activity assays on disulphide chain extension.  UbCys and UbK48Cys are purified 
identically so only purification of UbCys shall be described for simplicity.  In order to 
create the disulphide intermediate, both HIP2 and UbCys are chemically reduced and then 
dialyzed into an oxidization buffer over the course of 72-96 hrs promoting the formation 
of disulphide bonds (Fig 2.3A).  The resulting HIP2-UbCys disulphide was contaminated 
with the disulphide by-products of HIP2-HIP2 and UbCys-UbCys dimers as well as 
unreacted HIP2.  These unwanted by-products were removed by size exclusion 
chromatography yielding pure HIP2-UbCys disulphide (Fig 2.3B).  Using electrospray 
ionization mass spectrometry, a single major peak was observed (MWobs 31163.2 ± 
1.0Da) at the expected molecular weight (MWcalc 31163.5) confirming that the purified 
HIP2-UbCys thiolester mimic was the correct mass (Fig 2.3C). 
 
2.3.4 Expression and Purification of Ubc1 and the Ubc1-Ub disulphide 
The E2 enzyme Ubc1 is the yeast homolog of HIP2 and was purified as previously 
described (11, 18).  The Ubc1-UbCys and Ubc1-UbK48Cys disulphides were created and 
purified in an identical manner to the HIP2-UbCys and HIP2-UbK48Cys disulphides.  An 
example SDS-PAGE gel shows a single band demonstrating the extent of purification 
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Figure 2.3 Creation and purification of the HIP2-UbCys disulphide.  (A) Purified and TCEP 
reduced UbCys (lane 1) is mixed with purified and TCEP reduced HIP2 (lane 2) and dialyzed into 
an oxidation buffer containing 10 µM CuCl2 driving disulphide bond creation to produce HIP2-
HIP2, HIP2-UbCys and UbCys-UbCys (lane 3).  (B) Protein purification of HIP2-UbCys from other 
disulphide byproducts using size exclusion chromatography (Sephadex G-75) depicted by 
Coomassie stained SDS-PAGE.  A sample set of size exclusion elution fractions are shown 
whereby the larger HIP2-HIP2 byproduct elutes first (lane 1-5), followed by overlap of the HIP2-
UbCys disulphide (lane 1-13), and finally unreacted HIP2 elutes last (lane 10-13).  Pure HIP2-
UbCys fractions (lane 7-8) are combined with other runs to give the final purified HIP2-UbCys 
disulphide preparation (lane 14).  Molecular weight standards are listed in kDa to the left of each 
gel.  (C) Electrospray ionization mass spectrometry analysis of purified HIP2-UbCys indicating the 
protein is the correct mass. 
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of Ubc1 and Ubc1-UbCys (Fig 2.4A).  Using electrospray ionization mass spectrometry, a 
single major peak was observed for both Ubc1 and Ubc1-UbCys confirming the correct 
mass of the proteins (Ubc1: MWobs 24162.4 ± 0.8Da, MWcalc 24162.2; Ubc1-UbCys 
MWcalc 32791.1, MWobs 32794.59 ± 4.0Da). 
 
2.3.5 Expression and purification of N-terminal cysteine tagged ubiquitin  
The sensitivity of activity assays was improved through the use of Alexa-Fluor 680 C2-
maleimide fluorescent dye to label Ub proteins.  The fluorescent Alexa dye was 
covalently bound to Ub molecules containing a cysteine residue in an N-terminal peptide 
extension (GPCLGS) on Ub (NCys-Ub) and UbK48R (NCys-UbK48R).  The GST fusion 
proteins GST-NCys-Ub and GST-NCys-UbK48R were overexpressed and soluble in E. coli 
BL21(DE3)pLysS cells when induced with IPTG.  Purification of these GST fusion 
proteins from E. coli cells was performed by cell lysis with a French Press, followed by 
centrifugation to remove cellular debris.  The remaining lysate was subjected to GST-
affinity chromatography that selectively binds to the N-terminal GST-fusion tag leaving 
mostly purified protein (Fig 2.4B - lane 4).  The GST fusion tag was cut off by the 
cleavage enzyme TEV (50 µg / mL) and removal of the GST-fusion tag, any uncut 
protein, and the TEV enzyme was accomplished with size exclusion chromatography 
leaving purified NCys-Ub or NCys-UbK48R (Fig 2.4B - lane 6).  Using electrospray 
ionization mass spectrometry, a single major peak was observed at the expected 
molecular weights confirming that the purified NCys-Ub and NCys-UbK48R proteins were 
the correct mass (NCys-UbK48R: MWobs 9107.61 ± 0.42, MWcalc 9107.4; NCys-Ub: MWobs 
9079.08 ± 0.94, MWcalc 9079.44).  These N-terminally cysteine tagged ubiquitins are then 
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Figure 2.4 Purity check of Ubc1 and Ubc1-UbCys, and purification of NCys-Ub.  (A) SDS-PAGE 
gels run on purified samples of Ubc1 (lane 1 and with DTT lane 2) and Ubc1-UbCys (lane 3) show 
proteins to be relatively pure for further studies.  (B) Protein purification GST-NCys-Ub depicted 
by Coomassie stained SDS-PAGE shows centrifuged cell lysate of overexpressed GST-NCys-Ub 
(lane 1) followed by GST affinity chromatography flow through (lane 2), wash (lane 3), and 
elution with 20mM Glutathione (lane 4).  The GST is then removed by addition of the cleavage 
enzyme TEV (lane 5) and finally a size exclusion column (Sephadex G-75) is used to purify NCys-
Ub (lane 6) from uncut protein and freed GST fusion tag.  Molecular weight standards are listed 
in kDa to the left of each gel, and protein species are listed to the right of each gel. 
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reacted with Alexa-Fluor 680 C2-maleimide to yield Alexa-NCys-Ub (Alexa-Ub) and 
Alexa-NCys-UbK48R (Alexa-UbK48R).  Purification of Alexa-Ub and Alexa-UbK48R was 
performed using desalting columns and extensive dialysis to remove unreacted Alexa 
dye.  The identity of Alexa-Ub and Alexa-UbK48R were confirmed by electrospray 
ionization mass spectrometry (Alexa-UbK48R MWobs 10089.21 ± 0.31 agrees with 
expected values for NCys-UbK48R (9107.46 Da) and Alexa dye (~982 Da)); Alexa-Ub 
MWobs 10061.89 ± 0.40 agrees with expected values for NCys-Ub (9079.44 Da) and Alexa 
dye (~982 Da)). 
 
2.3.6 HIP2 and Ubc1 can build poly-Ub chains on their E2-UbK48Cys disulphides 
The best example of an E2~Ub thiolester interacting with another E2~Ub 
thiolester involves the Ube2g2 (Ubc7) E2 enzyme.  In this example, poly-Ub chains form 
on the E2 active site presumably assisted by dimerization (2, 3).  A similar approach was 
used to test the dimerization capacity of Ubc1 and HIP2 by testing the possible reaction 
of an E2~Ub thiolester with an E2-Ub disulphide.  This reaction was accomplished using 
two specific Ub substitutions, UbK48Cys and UbK48R (Fig 2.5A/2.6A).  UbK48Cys containing 
a reactive K48 residue was used as the ubiquitin acceptor, while UbK48R, which is blocked 
from K48 chain extension, was used as the ubiquitin donor.  A reaction containing ATP, 
UbK48R, E1, and either E2 enzyme was used to create the E2~UbK48R thiolester that is 
unable to build poly-Ub chains on its own.  The E2~UbK48R thiolester can however, act as 
a ubiquitin donor.  The E2-UbK48Cys disulphide was formed to incorporate an available 
K48 residue on the attached Ub, and therefore act as the acceptor in poly-Ub chain  
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extension.  Therefore, a mixture of E2~UbK48R and E2-UbK48Cys will only be able to form 
one possible poly-Ub chain resulting from the transfer of UbK48R to E2-UbK48Cys to form 
E2-UbK48Cys-UbK48R.  This reaction is predicated on the proposal that the E2~UbK48R 
thiolester and E2-UbK48Cys thiolester mimic can indeed interact to allow a Ub-Ub 
connection to occur representing the basis for poly-Ub chain formation (Fig 2.5A/2.6A). 
Several reactions were carried out with identical controls using purified HIP2 and 
HIP2-UbK48Cys (Fig 2.5B) as well as Ubc1 and Ubc1-UbK48Cys (Fig 2.6B).  HIP2 and 
Ubc1 contain minute traces of the oxidized disulphide E2-E2 dimer, but these trace high 
MW bands will have no bearing on any observed products as their active sites are joined 
together and are therefore unreactive (Fig 2.5B/2.6B – lane 1).  A standard ubiquitination 
reaction with the presence of E1, ATP, Ub, and either E2 yields a clearly visible 
HIP2~Ub or Ubc1~Ub thiolester as well as formation of free Ub2 species thus showing 
the enzymes Ubc1 and HIP2 are active (Fig 2.5B/2.6B – lane 5).  In the case of HIP2, 
higher molecular weight poly-Ub unanchored chains are visible since HIP2 has a high 
activity for unanchored chain formation (10).  UbK48R was used with E1, E2 and ATP to 
form the E2~UbK48R thiolester, and the lack of Ub2 formation proves HIP2 and Ubc1 
poly-Ub activity is K48 specific (Fig 2.5B/2.6B – lane 6).  When either E2-UbK48Cys 
disulphide was mixed with E1, Ub and ATP, no reaction was seen to occur for both HIP2 
and Ubc1 (Fig 2.5B/2.6B – lane 7).  This indicates that a reactive active site on these E2 
enzymes is essential for their poly-Ub activity, and that the E1~Ub thiolester cannot 
directly react with either the HIP2-UbK48Cys or Ubc1-UbK48Cys disulphide.  In the next 
reaction the E2-UbK48Cys disulphide is combined with all of the components used to form 
the E2~UbK48R thiolester, and a larger molecular weight band forms that corresponds to a 
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E2-Ub2 for both HIP2 and Ubc1 (Fig 2.5B/2.6B – lane 8).  The apparent E2-Ub2 was 
produced only with addition of the E2-UbK48Cys disulphide as the same components used 
previously did not produce this species with either HIP2 or Ubc1 (Fig 2.5B/2.6B – lane 6 
vs lane 8).  This reaction therefore represents the nucleophilic attack of the K48 residue 
in the E2-UbK48Cys disulphide to the E2~UbK48R thiolester to allow formation of E2-
UbK48Cys-UbK48R (E2-Ub2).  This reaction product accumulates for both HIP2 and Ubc1 as 
the distal Ub is now blocked from further reactions by the K48R substitution (solid black 
dot on Fig 2.5B/2.6B – lane 8).  Addition of reducing agent leads to reduction of the 
disulphide separating the HIP2 or Ubc1 E2 enzyme and Ub2 proving the product is E2-
Ub2 (solid black dot in Fig 2.5B/2.6B – lane 9). 
These activity assays were repeated using Alexa fluorophore (680 nm) tagged 
forms of Ub (Alexa-Ub) and UbK48R (Alexa-UbK48R) and the use of the untagged E2-
UbK48Cys complex for both HIP2 and Ubc1.  In this way, the donor Ub protein is provided 
by E2~Alexa-Ub and E2~Alexa-UbK48R thiolesters that can be independently tracked by 
fluorescence imaging.  Reactions using Alexa labelled proteins can be visualized through 
standard Coomassie dye staining (Fig 2.5C/2.6C – top gel) or the Alexa label can be 
directly observed through fluorescence (Fig 2.5C/2.6C – bottom gel).  These reactions 
distinctly show the formation of E2-UbK48Cys-Alexa-UbK48R (E2-Ub2-Alexa) and 
reduction of this disulphide separates E2 and UbK48Cys-Alexa-UbK48R (Ub2-Alexa). The 
reaction of the E2~Alexa-UbK48R thiolester with the E2-UbK48Cys disulphide shows that 
these two molecules can indeed interact to place the K48 sidechain of the disulphide in 
reactive distance to the thiolester bond to create a Ub-Ub connection (Fig 2.5C/2.6C – 
lane 8, 9). 
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These activity assays show that the thiolester mimic and active thiolester can 
associate and react to form an E2 attached Ub2 molecule.  These results may be consistent 
with a dimerization mechanism for the observed poly-Ub chain formation activity of 
HIP2 and Ubc1.  Further studies to investigate direct dimerization of the Ubc1 and HIP2 
enzymes and their HIP2-Ub and Ubc1-Ub thiolester mimics were performed. 
 
2.3.7 HIP2, Ubc1, HIP2-UbCys and Ubc1-UbCys show minimal tendency to dimerize 
at low concentrations 
Sedimentation equilibrium was utilized to assess the propensity of the E2 
enzymes Ubc1 and HIP2 to dimerize.  This technique is ideal for acquiring accurate 
molecular weights in solution since it is not dependant on protein standards.  Molecular 
weights determined by sedimentation equilibrium are also not affected by protein shape, 
which is important as Ubc1 and HIP2 are expected to be elongated proteins (21).  
Sedimentation equilibrium experiments were performed at four different rotor speeds on 
14.7 µM Ubc1 and 9.6 µM HIP2.  Global fits using all rotor speeds were first performed 
for an ideal monomeric species model.  The global fit for the HIP2 enzyme to an ideal 
monomeric species yielded a mass of 23441 ± 136 Da that was within 4% of the expected 
monomeric mass of 22534.7 Da (Table 2.1).  A representative solution curve of the 
global fit to an ideal monomeric species is shown for HIP2 at 22000 rpm (Fig 2.7A).  
Similar results were acquired upon analysis of the Ubc1 enzyme whereby the 
experimental weight yielded a mass of 24464 ± 107 Da that agrees within 1.3% of the 
expected monomeric mass of 24162.2 Da (Table 2.1).  A representative solution curve of 
the global fit to an ideal monomeric species is shown for Ubc1 at 26000 rpm (Fig 2.7C).  
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Table 2.1 Observed molecular weight of E2 enzymes and their thiolester mimics by 
sedimentation equilibrium 
Proteina Concentration (µM) MWCalc (Da) MWObsb (Da) Kdc (µM) 
Ubc1 14.7 24162.2 24464 ± 107 1920 ± 658 
Ubc1-UbCys 43.0 32791.1 31347 ± 222 N/A 
Ubc1-UbCys 21.5 32791.1 32536 ± 212 N/A 
Ubc1-UbCys 14.3 32791.1 35238 ± 265 376 ± 55 
HIP2 9.6 22534.7 23441 ± 136 455 ± 74 
HIP2-UbCys 24.0 31163.5 34619 ± 175 266 ± 16 
HIP2-UbCys 14.4 31163.5 34220 ± 169 214 ± 14 
HIP2-UbCys 7.2 31163.5 34461 ± 219 105 ± 9 
a Hip2 and Ubc1 were analyzed at 280 nm, while Ubc1-UbCys and HIP2-UbCys were 
analyzed at 250nm to allow for higher protein concentrations. 
b Molecular weight determined using global fits of 15k, 18k, 22k and 26k rpm to a 
single species model 
c Kd values for self-association determined using global fits of 15k, 18k, 22k and 
26k rpm to a self association model with molecular weights fixed to the expected 
monomeric weight 
 
 
 
Figure 2.5 HIP2 activity gels showing Ub transfer from the HIP2~UbK48R thiolester onto the HIP2-UbK48Cys disulphide. 
Figure 2.6 Ubc1 activity gels showing Ub transfer from the Ubc1~UbK48R thiolester onto the Ubc1-UbK48Cys disulphide. 
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Figure 2.7 Sedimentation equilibrium analysis indicates both HIP2 and Ubc1, and their HIP2-
UbCys and Ubc1-UbCys disulphides do not significantly dimerize.  Sedimentation equilibrium was 
performed on each sample at four different rotor speeds (15k, 18k, 22k, and 26k rpm) at 5 °C to 
determine their solution based molecular weight.  Experimental data was globally fit from 
triplicate measurements at each rotor speed to a single species model.  A representative data set 
(open circles) is graphed with the globally fit line (solid line) for (A) 9.6 µM Hip2 at 22k rpm, 
(B) 24 µM HIP2-UbCys at 22k rpm, (C) 14.7 µM Ubc1 at 26k rpm, and (D) 21.5 µM Ubc1-UbCys 
at 26k rpm.  Residuals of the data points to the fit line (filled diamonds) are shown above each 
curve fit.  The expected curve for the monomer (dotted line) and dimer (dashed line) species for 
HIP2-UbCys and Ubc1-UbCys are also plotted using fixed molecular weights and the same baseline 
offset as was used in that window for the global fits. 
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Experimental data points compared to the globally fit curves for both proteins showed a 
random spread of the residual errors, indicating that the single species model was 
appropriate (Fig 2.7A,C).  The observed molecular weights for Ubc1 and HIP2 are within 
the accuracy of this technique, which is around 5% (Biomolecular Interactions and 
Conformations Facility – UWO – personal communication). 
Assuming that the 1.3% and 4% increase in molecular weights observed for Ubc1 
and HIP2 respectively, were the result of dimerization, this data was fit to a self-
association model.  The global fit for HIP2 to a self-associating model yielded a 
dimerization Kd of 455 ± 74 µM (Table 2.1).  The global fit for Ubc1 to a self-associating 
model yielded a dimerization Kd of 1920 ± 658 µM (Table 2.1).  The quality of the fits 
and spread of residuals in the self-associating model fits are of equal quality to those 
observed with a single species model, and therefore the simplified equation for the single 
species solution is preferred to the self-associating solution.  Since the experimental 
protein concentrations of Ubc1 and HIP2 are significantly lower than the determined Kd 
values, and since calculated molecular weights are within the accuracy range for a 
monomeric species, these Kd values are for illustrative purposes and any minute self-
association cannot be accurately determined without the use of higher protein 
concentrations.  Overall these Kd values are extremely weak and molecular weights are 
very close to the expected monomeric species showing these enzymes have minimal 
tendency to dimerize at low concentrations. 
Sedimentation equilibrium experiments on HIP2-UbCys and Ubc1-UbCys 
disulphides were performed in a similar manner to the isolated E2 enzymes.  Three 
different concentrations of the protein complexes were used to determine any possible 
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concentration dependence that might arise due to oligomerization.  Global fits were 
performed for an ideal monomeric species model using all rotor speeds for each protein 
concentration.  Experiments on HIP2-UbCys at concentrations of 7.2, 14.4 and 24 µM 
yielded masses of 34461 ± 219, 34220 ± 169 and 34619 ± 175 Da respectively (Table 
2.1).  These masses are 10.6% (7.2 µM), 9.8% (14.4 µM) and 11.1% (24 µM) larger than 
the expected monomeric mass of 31163.5 Da.  These results are beyond the expected 
error rate of 5%.  This overestimation of molecular weight could be consistent with weak 
dimerization of HIP2-UbCys, however, molecular weight would then be expected to 
increase as concentration was elevated from 7.2 µM to 24 µM, and no such increase was 
observed (Table 2.1).  A representative solution curve of the global fit to an ideal 
monomeric species is shown for 24µM HIP2-UbCys at 22000 rpm (Fig 2.7B).  A random 
spread of residual errors from the data showed that the single species equation used to 
analyze the data was acceptable even though molecular weight was larger than expected 
(Fig 2.7B). 
By fitting the data to a self-association model, the dimerization capacity of HIP2-
UbCys can be measured, although use of this model did not improve the quality of fits or 
residuals.  The global fit for all speeds of HIP2-UbCys to a self-associating model yielded 
Kd values of 105 ± 9, 214 ± 14, and 266 ± 16 µM for concentrations of 7.2, 14.4, and 
24.0 µM HIP2-UbCys respectively (Table 2.1).  These dimerization Kd values for HIP2-
UbCys vary widely from 7.2 to 24.0 µM and since the concentrations are much less than 
the observed dissociation constants, these Kd values are not reliable.  These results 
illustrate that the dimerization Kd of HIP2 is at best in the order of 100’s of µM.  
Although the observed molecular weights for HIP2-UbCys are slightly higher than 
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expected, they are relatively consistent while protein concentration is increased indicating 
it is highly likely that the true Kd for HIP2-UbCys dimerization is significantly higher than 
the range of 105-266 µM. 
Similar experiments were performed on the Ubc1-UbCys disulphide with four rotor 
speeds and three different concentrations of 14.3, 21.5 and 43 µM.  Global fits were 
performed for all speeds at each protein concentration and the data was fit to a single 
species model.  Experiments on Ubc1-UbCys at concentrations of 14.3, 21.5 and 43.0 µM 
yielded masses of 35238 ± 265, 32536 ± 212 and 31347 ± 222 Da respectively (Table 
2.1).  These masses are 4.4% (43.0 µM), and 1.8% (21.5 µM) lower than the expected 
monomeric mass, and 7.5% (14.3 µM) larger than the expected monomeric mass of 
31163.5 Da respectively.  Only one of these measurements is beyond the expected error 
rate of 5%.  If molecular weights were affected by dimerization of Ubc1-UbCys, then 
these values would be expected to increase as concentration was elevated from 14.3 µM 
to 43.0 µM, but the opposite was observed (Table 2.1).  A representative solution curve 
of the global fit to an ideal monomeric species is shown for 21.5 µM Ubc1-UbCys at 
26000 rpm (Fig 2.7D).  A random spread of residual errors from the data showed that the 
single species equation used to analyze the data was appropriate (Fig 2.7D). 
By fitting the data to a self-association model, the dimerization capacity of Ubc1-
UbCys was measured, although use of this model did not improve the quality of fits or 
residuals.  The global fit for all speeds of Ubc1-UbCys to a self associating model yielded 
Kd values that are negative (non-existent) for 21.5 and 43.0 µM experiments, and 376 ± 
55 µM for 14.3 µM Ubc1-UbCys (Table 2.1).  Since the molecular weights apparently 
reduced upon concentration increase, the Kd value for Ubc1-UbCys is not accurate.  These 
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results indicate Ubc1-UbCys does not appear to dimerize to any degree at the 
concentrations tested, and thus higher concentrations need to be analyzed to determine if 
there is any significant dimerization of this protein. 
The sedimentation equilibrium results provide strong evidence that the propensity 
for HIP2, Ubc1, and their disulphide thiolester mimics to dimerize at the concentrations 
tested is extremely low, as this technique has shown the observed molecular weights 
closely agree with the expected molecular weights. 
 
2.3.8 HIP2, Ubc1, HIP2-UbCys and Ubc1-UbCys show minimal tendency to dimerize 
at high concentrations 
In order to provide greater detail about the degree of association, size, and shape 
of the E2 enzymes and their disulphide complexes, small angle X-ray scattering (SAXS) 
experiments were performed.  SAXS is a method that is used to investigate low-
resolution structural details of proteins at high concentrations in solution.  The increased 
concentration range for the study of HIP2 and Ubc1 should be complementary to the 
sedimentation equilibrium analysis.  SAXS experiments can be used to determine the 
radius of gyration (Rg) for a protein, which is the root mean square of the distances of all 
electrons from their common center of mass, and the forward scattering (Io), which is 
proportional to the molecular weight (MW) of the protein.  The Rg and MW values are 
acquired using the low angle region of the scattering curves that when plotted using 
Guinier plots are linear near the axis.  Guinier plots were produced for HIP2, HIP2-UbCys, 
Ubc1 and Ubc1-UbCys for five protein concentrations ranging from 36-284 µM, 44-218 
µM, 29-235 µM, and 24-197 µM respectively.  These Guinier plots display excellent 
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linear relationships indicating these proteins behave in a monodisperse fashion in solution 
(Fig 2.8).  Large protein aggregates would cause a significant upwards inflection in the 
Guinier plots near the y-axis and since these effects are not observed, the proteins tested 
were considered well behaved. 
The Rg and apparent MW values were calculated for each protein in a dilution 
series to determine the variation of these values in regards to protein concentration.  If 
self-association of any of these proteins occurs as protein concentration increases, than 
significant increases in Rg and apparent MW values will also be observed.  The Rg for 
HIP2 increases from 20.9 to 22.4 Å as protein concentration is increased from 36 to 284 
µM (Fig 2.9A – open triangles).  The Rg for Ubc1 was found to be slowly increasing 
from 23.1 to 24.3 Å over a protein concentration range of 29-235 µM (Fig 2.9B – open 
circles).  The increase in Rg values for HIP2 and Ubc1 are very small, indicating a 
relatively stable protein shape in solution for both HIP2 and Ubc1 over a relatively large 
increase in protein concentrations.  These results provide minimal support for a 
significant self-association of HIP2 and Ubc1.  Comparison of Rg values to high-
resolution structures will be reported later in this chapter (Section 2.3.9 and 2.3.10).  
SAXS data was also used to calculate the apparent MW of HIP2 and Ubc1 using a known 
concentration of a cytochrome C standard.  The apparent MW of HIP2 was observed to 
increase from 24.3 to 27.8 kDa (Fig 2.9C – open triangles), which was 8% to 23.5% 
higher than the expected MW of 22.5 kDa.  The apparent MW of Ubc1 ranges from 27.8 
to 30.5 kDa over the concentration range of 29-235 µM (Fig 2.9D – open circles).  These 
MW values are 14.9% to 26% higher than the expected monomeric weight of 24.2 kDa 
for Ubc1.  SAXS can determine MWs within an accuracy of 10% (22), but small errors in 
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Figure 2.8 SAXS data displayed using Guinier plots for HIP2, HIP2-UbCys, Ubc1 and Ubc1-
UbCys at various concentrations.  Data is presented for five concentrations of each protein 
whereby the top curve (solid line) is the most concentrated sample followed by successive 
dilutions for lower curves (solid lines) whereby all data is normalized to the top concentration.  
Data was collected for (A) HIP2 at 284, 213, 142, 71.0 and 35.5 µM (B) HIP2-UbCys at 218, 175, 
131, 87.3 and 43.6 µM (C) Ubc1 at 235, 176, 118, 58.8, and 29.4 µM (D) Ubc1-UbCys at 197, 
148, 98.7, 49.3 and 24.6 µM.  Similar angular ranges are used to calculate the linear region (open 
circles) for each data set allowing for a good comparison between experiments.  Each data set 
was fit over the linear region (thick straight line) to determine the forward scattering (Io) and 
radius of gyration (Rg) at each concentration. 
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Figure 2.9 Radius of gyration and apparent MW data displayed for HIP2, HIP2-UbCys, Ubc1 and 
Ubc1-UbCys at various concentrations.  (A) and (C) show data points for the proteins HIP2 (open 
triangles) and HIP2-UbCys (filled triangles) at five different concentrations of 284, 213, 142, 71.0 
and 35.5 µM HIP2 and 218, 175, 131, 87.3 and 43.6 µM HIP2-UbCys.  (B) and (D) show data 
points for the proteins Ubc1 (open circles) and Ubc1-UbCys (filled circles) at five different 
concentrations of 235, 176, 118, 58.8, and 29.4 µM Ubc1 and 197, 148, 98.7, 49.3 and 24.6 µM 
Ubc1-UbCys.  The expected molecular weight for HIP2 and Ubc1 (dashed line) as well as HIP2-
UbCys and Ubc1-UbCys (dotted line) are displayed on the apparent MW graphs.  There are various 
expected radius of gyration values depending on positioning of the UBA tail domain and the 
position of attached Ub in relation to the catalytic core for these E2 enzymes and thus no one 
value is displayed for an expected radius of gyration for each protein.  (E) and (F) show the 
theoretical binding curves for dimerization of HIP2-UbCys and Ubc1-UbCys respectively whereby 
the Kd is listed to the right of the line in µM. 
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protein concentrations of either sample or standards will affect the accuracy of the 
apparent MWs reported.  Since this experiment was performed with a series of dilutions, 
the trend of MW change over the change in protein concentration is more accurate than 
the absolute value of any single MW measurement.  The apparent MWs undergo minimal 
change (11.1% for Ubc1 and 15.5% for HIP2) as concentration is increased significantly, 
thus indicating HIP2 and Ubc1 are undergoing minimal dimerization as detailed by this 
technique up to concentrations of 284 and 235 µM respectively.  If these apparent MW 
trends are plotted against a series of theoretical curves defined by a Kd of 10, 100, 1000 
and 10000 µM, the trend in MW change is consistent with a Kd of at least 1000 µM.  The 
trends in apparent molecular weight and Rg appear relatively stable across the large 
concentration range tested, it is therefore very likely that these E2 enzymes do not 
dimerize in solution with a Kd lower than 1000 µM (1 mM). 
The Rg and apparent MW values were also calculated for HIP2-UbCys and Ubc1-
UbCys to determine if these proteins had an increased capacity for dimerization.  The Rg 
for HIP2-UbCys increases from 24.7 to 26.3 Å as protein concentration is increased from 
44 to 218 µM (Fig 2.9A – filled triangles).  The Rg for Ubc1-UbCys slowly increases from 
26.5 to 29.5 Å over a protein concentration range of 25-197 µM (Fig 2.9B – filled 
circles).  The change in Rg values for HIP2-UbCys (1.6 Å) and Ubc1-UbCys (3 Å) is larger 
than was observed for HIP2 (1.5 Å) and Ubc1 (1.2 Å) alone over similar concentration 
increases.  Although the increase in Rg values is more prominent for the disulphide 
complexes, the increase is still small thus providing only weak support for increased self-
association of these proteins.  SAXS data was also used to calculate the apparent MW of 
HIP2-UbCys and Ubc1-UbCys.  The apparent MW of HIP2-UbCys was observed to vary 
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between 29.1 to 35.8 kDa as concentration was varied between 44 and 218 µM (Fig 2.9C 
– filled triangles).  These MWs ranged from 6.6% smaller to 14.9% larger than the 
expected MW of 31.2 kDa, but there was no overall trend in the MW changes as 
concentration was increased.  The apparent MW of Ubc1-UbCys increased from 31.8 to 
40.4 kDa over the concentration range of 25-197 µM (Fig 2.9D – filled circles).  The 
highest MW value for Ubc1-UbCys was 23% higher than the expected monomeric weight 
of 32.8 kDa.   The apparent MW of Ubc1-UbCys also increased as protein concentrations 
were increased, which could indicate minimal dimerization.  There are not enough data 
points from these results to accurately produce a curve to determine the Kd of 
dimerization for either HIP2-UbCys or Ubc1-UbCys.  A series of theoretical curves defined 
by a Kd of 10, 100, 1000 and 10000 µM, however, can be used on a comparative basis to 
find an appropriate range for Kd values that are consistent with the experimental data 
points for HIP2-UbCys and Ubc1-UbCys (Fig 2.9E, F).  The trend in MW change for both 
HIP2-UbCys and Ubc1-UbCys is consistent with a Kd of dimerization of at least 1000 µM. 
The overall trends of increasing values for Rg and apparent MW for both HIP2 
and Ubc1 is consistent with an extremely weak dimerization of these enzymes.  The 
addition of Ub in HIP2-UbCys and Ubc1-UbCys appears to increase the dimerization 
capacity of these enzymes.  The dimerization capacity of HIP2, HIP2-UbCys, Ubc1, and 
Ubc1-UbCys however, is on the whole very weak, as the dimerization Kd values were 
found to be >1000 µM.  Since the concentrations tested in SAXS are far below 1000 µM, 
the reported Kd values are not accurate, but still indicate that HIP2, Ubc1, HIP2-UbCys, 
and Ubc1-UbCys proteins are predominantly monomeric in solution during these 
experiments. 
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2.3.9 HIP2 and Ubc1 SAXS data comparison to high-resolution structures 
SAXS is a method that is used to investigate low-resolution structural details of 
proteins at high concentrations in solution.  The overall shape of proteins can be 
determined through analysis of the radius of gyration (Rg) for a protein acquired from the 
low angle regions of SAXS.  Analysis of the full scattering curves in SAXS were 
performed using the program CRYSOL (16) that allows experimental scattering curves to 
be compared to the theoretical scattering curves calculated from high-resolution structural 
PDB coordinates.  In this way NMR and X-ray crystallographic structures of HIP2, 
HIP2-UbCys, Ubc1, and Ubc1-UbCys can be directly tested against the experimental data.   
If the proteins are predominantly monomeric, the experimental data should allow a 
quality fit to the experimental data. 
Ubc1 is an elongated, two-domain protein possessing a 15-residue flexible linker that 
separates the catalytic core and UBA domains, thus allowing a variety of spatial 
arrangements between the UBA and the catalytic core (21).  In order to sample unique 
UBA domain positions with respect to the core domain, 13 of the 21 lowest energy Ubc1 
NMR structures (PDB: 1TTE) (21) that vary the UBA domain position were analyzed.  
These Ubc1 structures were analyzed by CRYSOL (16) to give theoretical scattering 
curves that could be fit to the experimental data.  The most important region in these 
scattering curve fits are at low scattering angles (low q values), which are most closely 
related to the overall averaged shape of the molecule.  The quality of the fits of these 
various Ubc1 structures to the experimental data was assessed by the goodness of fit 
value (χ2) defined by Equation 4 (Section 2.2.6).  The representative data set (118 µM 
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Ubc1) was best fit to a Ubc1 structure that oriented the UBA domain directly opposite the 
N-terminus and close to helix 4 of the catalytic core (Fig 2.10A).  Structures where the 
UBA domain was moved away from this position yet retained a similar Rg (Fig 2.10B) or 
the UBA domain was extended further away from the catalytic core (Fig 2.10C) result in 
poorer fits.  Similar results were obtained on all other concentrations of Ubc1 fit to these 
various structures.  For all Ubc1 structures analyzed, the best fits were consistently 
acquired from models where the UBA domain is not fully extended away from, nor 
tightly associated with the catalytic core.  This general UBA domain positioning is best 
fit by Figure 2.10A, and thus this structure likely represents the average UBA position for 
Ubc1 in solution.  The CRYSOL calculated Rg for the best fit Ubc1 structure is 24.95 Å.  
SAXS Guinier plot analysis of Ubc1 reveals the experimental Rg to be 23.1 Å to 24.3 Å 
over a protein concentration range of 29-235 µM (Table 2.2).  These experimental Rg 
values are at most 7.4% lower than the expected value of 24.95 Å showing good 
agreement to the best fit Ubc1 structure (Fig 2.10A).  The best fit structure of Ubc1 is 
therefore supported by both high quality fits to the full scattering curves and close 
agreement to experimental Rg values.  The fact that this monomeric model can be well fit 
to the data also supports the notion that Ubc1 is predominantly monomeric at the 
concentrations examined, providing further support for very weak (>1000 µM) Kd values. 
Unlike Ubc1, wild type HIP2 was initially solved as a dimer (PDB: 1YLA) by X-
ray crystallography.  Recently, two more X-ray crystallography structures of wild type 
HIP2 were solved as monomers (PDB: 2BEP, 3K9P) (23, 24).  These structures were 
backbone residue aligned to the catalytic core (1-155) of 1YLA giving RMSD 
measurements of 0.53 Å and 1.09 Å respectively.  These results indicate these structures 
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Table 2.2 Radius of gyration and molecular weight for E2 enzymes and their 
thiolester mimics derived from Small Angle X-ray Scattering Guinier Plots 
Protein Conc. (µM) Rg (Å) MWObsa (kDa) MWExp (kDa) 
Ubc1 29.4 23.1 28.3 24.2 
 58.8 23.4 27.8 24.2 
 118 23.8 30.5 24.2 
 176 24.3 30.5 24.2 
 235 24.3 30.0 24.2 
Ubc1-UbCys 24.6 26.5 31.8 32.8 
 49.3 27.0 36.9 32.8 
 98.7 28.1 38.0 32.8 
 148 28.8 39.3 32.8 
 197 29.5 40.4 32.8 
HIP2 35.5 20.8 ± 0.8 24.3 ± 0.4 22.5 
 71.0 21.2 ± 0.4 25.5 ± 0.2 22.5 
 142 21.4 ± 0.2 26.4 ± 0.1 22.5 
 213 22.2 ± 0.1 27.8 ± 0.1 22.5 
 284 22.4 ± 0.1 27.8 ± 0.1 22.5 
HIP2-UbCys 43.6 24.7 ± 0.2 35.8 ± 0.2 31.2 
 87.3 24.5 ± 0.1 29.1 ± 0.1 31.2 
 131 24.9 ± 0.1 29.5 ± 0.1 31.2 
 175 26.0 ± 0.1 34.1 ± 0.1 31.2 
 218 26.3 ± 0.1 31.8 ± 0.1 31.2 
a Molecular Weight determined by comparison to cytochrome c samples of similar 
concentration  
b Error analysis only available for data analyzed by Igor Pro (HIP2 and HIP2-UbCys). 
Error analysis based on I0 errors. 
 
Figure 2.10 Crysol analysis allows SAXS data to be compared to high resolution structures of Ubc1. 
Figure 2.11 Crysol analysis allows SAXS data to be compared to high resolution structures of HIP2. 
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are redundant and therefore only the 1YLA was utilized as the high-resolution HIP2 
structure to fit to experimental data.  A representative SAXS data set (142 µM HIP2) was 
found to poorly fit the dimeric model (Fig 2.11A), while a much better fit was acquired 
for the monomeric model (Fig 2.11B, half of the dimer coordinates).  Similar results were 
obtained on all other concentrations of HIP2 consistently showing much better fits to the 
monomeric model.  Guinier plot analysis of HIP2 SAXS data reveals the experimental Rg 
to be 20.8 Å to 22.4 Å over a protein concentration range of 29-235 µM (Table 2.2).  
These experimental values are 6.1% to 14.3% larger than the expected Rg of 19.6 Å 
calculated from the monomer crystal structure of HIP2 (Fig 2.11B).  On the assumption 
the UBA domain of HIP2 is connected by a flexible linker, the position of the UBA 
domain was moved to a similar location seen in the well fit Ubc1 structure.  The resulting 
‘relaxed’ UBA position for HIP2, which places the UBA domain further away from the 
catalytic core, had an Rg of 21.8 Å that agreed more closely with the Guinier determined 
Rg values of 20.8-22.4 Å.  This ‘relaxed’ HIP2 structure provided a better fit than the 
crystal monomer at all concentrations, and is illustrated by the representative data set in 
Figure 2.11C.  These results support the idea that the HIP2 crystal structure may have the 
UBA domain positioned too closely to the catalytic core and may be a crystal artifact.  It 
is therefore likely that HIP2, like Ubc1, contains a flexible linker region allowing the 
UBA domain to act as a tethered yet independent element in relation to the catalytic core 
domain, thus explaining a more extended structure in solution than was observed in 
crystal structures.  This ‘relaxed’ HIP2 structure therefore likely represents the average 
position of the UBA domain in solution during SAXS experiments.  The fact 
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that a monomeric model of HIP2 can be well fit to the data supports the notion that these 
proteins are predominantly monomeric at the concentrations examined, providing further 
support for very weak (>1000 µM) Kd values. 
 
2.3.10 HIP2-UbCys and Ubc1-UbCys SAXS data comparison to high-resolution 
structures 
SAXS analysis performed on Ubc1-UbCys and HIP2-UbCys can be used to 
determine the general position of Ub within the thiolester mimic.  To perform this 
analysis high-resolution structures of Ubc1-UbCys and HIP2-UbCys need to be created to 
compose theoretical scattering curves to compare to experimental data.  Previous NMR 
studies show that the UBA domain in Ubc1 does not interact with the thiolester bound Ub 
(18).  As a result the average UBA position found to match SAXS data from Ubc1 alone 
(Fig 2.10A) should be unperturbed and thus was used as a starting point to position the 
Ub molecule onto Ubc1 in Ubc1-UbCys.  An NMR based model for the short lived 
Ubc1~Ub thiolester has been previously determined with a Ubc1 truncation (Ubc1∆) and 
Ub (PDB: 1FXT) (19).  This Ubc1∆~Ub model was aligned with the full length Ubc1 
protein structure modelled from SAXS data (Fig 2.10A) to generate a model for Ubc1-
UbCys.  The theoretical scattering curves for this model fit the experimental scattering 
curves poorly at all concentrations, and is illustrated by the representative data set (99 
µM) in Figure 2.12A.  These results indicate that this model does not accurately depict 
the average shape of the Ubc1-UbCys complex in solution (Fig 2.12A).  To determine if 
poor fits to this model were due to the presence of dimeric Ubc1-UbCys, several 
theoretical models were produced to sample possible dimeric structures.  No quality fits  
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Figure 2.12 CRYSOL analysis allows SAXS data to be compared to high-resolution structures of 
Ubc1-UbCys.  SAXS data is presented for Ubc1-UbCys (99 µM), where the momentum transfer (q) 
is plotted versus the normalized log of scattering intensity (measured in arbitrary units).  
Experimental data points are shown in black (filled triangles) and the theoretical scattering of the 
PDB structure is shown in red (solid line).  The structure used for theoretical scattering is located 
directly above the scattering curve.  (A) SAXS data fit to the ‘compact model’ for Ubc1-UbCys (χ2 
of 13.39, Rg of 25.18 Å).  The ‘compact model’ was produced with the full length Ubc1 structure 
(Fig 2.10A) with the covalently attached Ub modelled by alignment to the truncated Ubc1~Ub 
(1FXT) structure.  (B) SAXS data fit to the ‘elongated model’ for Ubc1-UbCys (χ2 of 3.41, Rg of 
29.78 Å).  The ‘elongated model’ was produced with the full length Ubc1 structure (Fig 2.10A) 
and the covalently attached Ub modelled by alignment to the Ubc13 portion of the 
hMms2/Ubc13~Ub (2GMI) structure.  χ2 defines the quality of the fits whereby a lower score 
indicates a better fit. 
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could be produced for Ubc1-UbCys from any dimeric structure or mixture of the 
monomeric and dimeric species. 
The expected structure of Ubc1-UbCys does not represent the average position of 
the disulphide bound Ub, and thus alternative models were investigated.  There are 
presently four other E2~Ub conjugate structures that place the Ub in various positions: 
Ubc13-Ub (PDB: 2GMI (7)), UbcH8-Ub (PDB: 2KJH (20)), and two structures for 
UbcH5b-Ub (PDB: 3A33 (25), and PDB: 3JW0 (26)).  Alternative models for Ubc1-
UbCys were created from these four structures.  All of these new models position the Ub 
molecule in varying positions further from the catalytic core.  These structures are more 
elongated and thus the model built in Figure 2.12A (PDB: 1FXT/1TTE) is termed the 
‘compact’ model.  The theoretical scattering curves for these new ‘elongated’ models 
were compared to a representative data set (99 µM) with the best fit belonging to the 
most extended Ubc1-UbCys structure based on the Ubc13-Ub complex (PDB: 2GMI) (Fig 
2.12B).  The other new models fit more poorly than the ‘elongated’ model (Fig 2.12B), 
but better than the ‘compact’ model (Fig 2.12A) and these fits are consistent across all 
concentrations examined.  Guinier plot analysis of the Ubc1-UbCys reveals the 
experimental Rg to be 26.5 Å to 29.5 Å over a protein concentration range of 25-197 µM 
(Table 2.2).  The Rg value of the poorly fit ‘compact’ model for Ubc1-UbCys is 25.18 Å 
and the Rg value of the well fit ‘elongated’ model for Ubc1-UbCys is 29.78 Å.  The 
increasing experimental Rg values vary between the expected Rg values for both the 
‘elongated’ and ‘compact’ models of Ubc1-UbCys structure indicating that some 
dimerization or aggregation may be occurring.  In either case, the experimental Rg values 
are closer to the expected Rg for the ‘elongated’ Ubc1-UbCys structure indicating Guinier 
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plots also support this model.  These results indicate that the ‘elongated’ model best 
represents the average shape of Ubc1-UbCys in solution (Fig 2.12B).  Since the Ubc1-
UbCys SAXS data can be fit to a monomeric structure, this further supports a very weak 
(>1000 µM) Kd value describing dimerization of this protein complex. 
In a similar analysis to Ubc1-UbCys, two models of HIP2-UbCys were constructed 
to analyze SAXS data.  These HIP2-UbCys models were built by alignment to the 
‘compact’ and ‘elongated’ models created for Ubc1-UbCys whereby the Ubc1 is replaced 
with the HIP2 ‘relaxed’ UBA structure from Figure 2.11C.  As was seen for the Ubc1-
UbCys, the theoretical scattering curves for the ‘elongated’ model of HIP2-UbCys fit the 
experimental scattering curves very well at all concentrations, and is illustrated by the 
representative data set (96 µM) in Figure 2.13A.  The theoretical scattering curves for the 
‘compact’ model of HIP2-UbCys fit the experimental scattering curves poorly at all 
concentrations tested, and is illustrated by the representative data set (96 µM) in Figure 
2.13B.  Alternative models built from the other E2~Ub structures provided fitting score 
values in between the ‘compact’ and ‘elongated’ models.  Again, no reasonable fits could 
be produced for HIP2-UbCys SAXS data with any dimeric structure or mixture of 
monomeric and dimeric species.  Guinier plot analysis of HIP2-UbCys SAXS data reveals 
the Rg to vary between 24.7 Å to 26.3 Å over a protein concentration range of 44-218 µM 
(Table 2.2).  The expected Rg for the ‘elongated’ model is 26.85 Å, while the ‘compact’ 
model has an Rg of 22.33 Å.  The experimental Rg values are closer to the expected Rg for 
the ‘elongated’ HIP2-UbCys structure indicating Guinier plots also support this model.  
Based on these results, it can be concluded that the ‘elongated’ model (Fig 2.13A) for 
HIP2-UbCys best represents the average shape of HIP2-UbCys in solution.  The fact that 
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Figure 2.13 CRYSOL analysis allows SAXS data to be compared to high-resolution structures of 
HIP2-UbCys.  SAXS data is presented for HIP2-UbCys (96 µM), where the momentum transfer (q) 
is plotted versus the normalized log of scattering intensity (measured in arbitrary units).  
Experimental data points are shown in black (filled triangles) and the theoretical scattering of the 
PDB structure is shown in red (solid line).  The structure used for theoretical scattering is located 
directly above the scattering curve.  (A) SAXS data fit to the ‘elongated model’ for HIP2-UbCys 
(χ2 of 0.97, Rg of 26.85 Å).  The ‘elongated model’ was produced with the ‘relaxed’ HIP2 
structure (Fig 2.11C) with the covalently attached Ub modelled by alignment to the truncated 
Ubc1~Ub (1FXT) structure.  (B) SAXS data fit to the ‘compact model’ for HIP2-UbCys (χ2 of 
6.44, Rg of 22.33 Å).  The ‘compact model’ was produced with the ‘relaxed’ HIP2 structure (Fig 
2.11C) and the covalently attached Ub modelled by alignment to the Ubc13 portion of the 
hMms2/Ubc13~Ub (2GMI) structure.  χ2 defines the quality of the fits whereby a lower score 
indicates a better fit. 
 
 
 
 
 
Figure 2.14 Purified HIP2~Alexa-UbK48R thiolester reacts with both HIP2-UbK48Cys disulphide and free Ub. 
Figure 2.15 Purified Ubc1~Alexa-UbK48R thiolester reacts with both Ubc1-UbK48Cys disulphide and free Ub. 
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HIP2-UbCys SAXS data can provide a good fit to a monomeric structure further supports 
very weak (>1000 µM) Kd values describing dimerization of this protein. 
 
2.3.11 Activity assays on HIP2 and Ubc1 show that E2~UbK48R is the primary 
reactive molecule and directly interacts with E2-UbK48Cys or free Ub 
Initial activity reactions (Section 2.3.6) provided evidence that the E2-Ub 
disulphide and the E2~Ub active thiolester for both HIP2 and Ubc1 might associate to 
form an E2-Ub2 molecule.  These results implied a possible E2 dimerization mechanism 
driving poly-Ub chain formation.  Analytical ultracentrifugation and SAXS results, 
however, indicate Ubc1 and HIP2 alone as well as Ubc1-UbCys and HIP2-UbCys have very 
little tendency (Kd >1000 µM) to self-associate.  In order to clarify the mechanism for 
formation of the E2-Ub2 product, experiments were expanded to include the purification 
of the E2~Ub thiolester to determine the direct contribution of the E2 enzyme to 
reactivity. 
Activity assays were performed with the use of Alexa fluorophore (680 nm) 
tagged Ub such that the reactivity of the E2~Alexa-Ub thiolester can be tracked directly 
through fluorescence imaging.  The use of UbK48R ensures that the E2~UbK48R thiolester 
can only act as a Ub donor in future reactions, as K48 poly-Ub chain elongation is 
blocked.  This blocked thiolester was made by mixing E1, E2, ATP and Alexa tagged 
UbK48R (Alexa-UbK48R) that react to give the E2~Alexa-UbK48R thiolester.  This reaction 
was then subjected to size exclusion chromatography to remove the E1 enzyme, the 
MgATP solution, and the unreacted Alexa-UbK48R.  These purified E2~Alexa-UbK48R 
thiolesters were produced for HIP2 (Fig 2.14) and Ubc1 (Fig 2.15).  Reactions were then 
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performed by mixing these E2~Alexa-UbK48R thiolester Ub donors with varying purified 
proteins that may contain Ub acceptors.  HIP2 and Ubc1 reactions were performed nearly 
identically and for simplicity only the HIP2 experiments will be explained in detail. 
Reactive free Alexa dye was utilized to visualize any unconjugated E1 or E2 
enzymes, and the lack of a fluorescent band confirmed the removal of E1 enzyme from 
the HIP2~Alexa-UbK48R thiolester (Fig 2.14B – lane 1,2).  The purified thiolester was 
shown to be intact (Fig 2.14B – lane 3) and its reactivity is confirmed through reduction 
by DTT that can break the thiolester (Fig 2.14B – lane 4).  The HIP2~Alexa-UbK48R 
thiolester was then tested for reactivity with three different possible Ub acceptors: 
unlabelled UbK48R (Fig 2.14B – lane 5), unlabelled wild type Ub (Fig 2.14B – lane 6 and 
7), and the HIP2-UbK48Cys disulphide complex (Fig 2.14B – lane 8, 9). 
The HIP2~Alexa-UbK48R thiolester reacted with the HIP2-UbK48Cys disulphide as 
was seen in previous assays (Section 2.3.6) only in this instance E1 is absent.  The 
presence of E1 is therefore not required for this reaction to proceed showing that the 
HIP2~Alexa-UbK48R thiolester is directly interacting with HIP2-UbK48Cys to yield HIP2-
UbK48Cys-Alexa-UbK48R (marked with (1) and a solid dot, Fig 2.14B – lane 8).  Addition 
of reducing agent shows the appearance of the Ub2 (UbK48Cys-Alexa-UbK48R) band (Fig 
2.14B – lane 9).  This proves that reaction scheme (1) shown in Figure 2.14A is in fact 
occurring and that E1 was not causing the reaction or indirectly assisting the reaction. 
The purified HIP2~Alexa-UbK48R thiolester was also reacted with two forms of free Ub, 
the substituted UbK48R, and wild type Ub.  The HIP2~Alexa-UbK48R thiolester reacted 
with wild type Ub to yield free Ub2, while the UbK48R mutant does not react to 
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any significant extent (Fig 2.14B – lane 5, 6).  This Ub2 was also stable to reducing agent 
(Fig 2.14B – lane 7).  Due to the absence of ATP and E1, the reactive Ub molecules must 
remain free and cannot form a thiolester with the E2 enzyme.  This indicates that the free 
forms of Ub are conclusively the reactive Ub acceptors for the HIP2 thiolester bound 
Alexa-UbK48R donors.  These results illustrate that the HIP2~Alexa-UbK48R thiolester can 
directly react with any free Ub with an available K48 residue to cause chain extension 
(Fig 2.14A, reaction scheme (2) and (3)).  This assay also shows that reaction scheme (1) 
and reaction scheme (2) can both occur, and therefore both free Ub and HIP2-UbK48Cys 
can act as ubiquitin acceptors when reacted with the HIP2~Alexa-UbK48R thiolester 
ubiquitin donor.  Since the HIP2~Alexa-UbK48R thiolester can interact with either free 
wild type Ub or the HIP2-UbK48Cys disulphide, it is possible that the HIP2-UbK48Cys 
disulphide is simply acting as a reactant because it is being treated as a free Ub molecule 
albeit attached to another protein.  This reaction would then not be driven by dimerization 
of E2 enzymes but simply by HIP2 and Ubc1’s affinity and reactivity towards any Ub 
molecule, either free or attached to another protein.  This would make reaction scheme 
(1) mechanistically the same as reaction scheme (2), whereby both simply rely on an 
available and at least temporarily exposed K48 residue in Ub (Fig 2.14A).  The nearly 
identical reaction procedure produces very similar results for the reaction of the 
Ubc1~Alexa-UbK48R thiolester with both free Ub and Ubc1-UbK48Cys indicating these 
enzymes are functionally very similar (Fig 2.15). 
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2.4 Discussion 
2.4.1 Previous evidence for E2 dimerization 
Recently there have been numerous experiments performed to shed light on the 
mechanism of poly-Ub chain formation and transfer in regards to the E1, E2, and E3 
enzymes in various ubiquitination pathways.  The observation that Ub-Ub linkages can 
be formed in many of these systems prior to interaction with substrates provides evidence 
that poly-Ub chains may be assembled prior to attachment to substrates.  One hypothesis 
for how these Ub-Ub linkages are created involves E2 dimerization.  Solid structural 
evidence for E2 dimerization has been found for Ubc13/Mms2, while reactive 
experimental evidence for E2 dimerization has been found for Ube2g2, Cdc34, and Ubc1 
(2-9, 27).  In this chapter, HIP2 and Ubc1 enzymes were investigated for dimerization.  
These enzymes are highly active in poly-Ub chain formation in the absence of E3 
enzymes and substrates, indicating a simple E2-E2 mechanism could exist for these 
enzymes (10, 11).  Previous studies on Cdc34 also indicated that the presence of the 
Cdc34~Ub thiolester may be required for dimerization.  Therefore, thiolester mimics 
(disulphide complexes) of Ubc1 and HIP2 were also created and studied.  In addition to 
understanding HIP2 and Ubc1 function, insights into the mechanisms utilized by these 
enzymes may shed light on more complicated ubiquitination systems involving E3 
enzymes and substrates. 
Many early experiments on E2 enzymes including Ubc1 and HIP2 used size 
exclusion elution profiles and chemical crosslinking to test for possible dimerization.  
Both Ubc1 and HIP2 had early size exclusion elution profiles that implied significant 
dimerization (17, 27).  The high-resolution structures of these proteins have since been 
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solved, and their elongated shapes were likely the cause for early elution profiles.  
Crosslinking experiments were also performed on both of these proteins where Ubc1 was 
observed to chemically crosslink (27), and HIP2 did not (17).  These results likely do not 
properly predict dimerization since the Ubc1 and HIP2 structures illustrate the presence 
of unstructured flexible linkers that can explain their reactivity to lysine reactive cross-
linking agents.  Ubc1 contains a rather long unstructured tether between its two domains 
(21) with an exposed and highly mobile K157 residue that may be responsible for the 
observed crosslinking activity.  This is supported by another study where the removal of 
this flexible tether, including the UBA domain, greatly reduced crosslinking (27).  HIP2 
contains a shorter tether that lacks an exposed lysine residue, which may explain why this 
protein does not crosslink.  These observations support that these crosslinking studies 
measure specific lysine reactivity as opposed to actual E2 dimerization.  The previous 
studies on the dimerization of HIP2 and Ubc1 are clearly debatable and therefore more 
specific experimentation is required. 
 
2.4.2 In depth studies into dimerization of HIP2 and Ubc1 
The possible dimerization of HIP2 and Ubc1 as well as HIP2-UbCys and Ubc1-
UbCys was thoroughly investigated.  Sedimentation equilibrium was used as a technique 
to investigate dimerization since it reports molecular weights to high accuracy, it is not 
sensitive to protein shape, and it offers the ability to quantify any type of oligomerization.  
The molecular weights (MW) for HIP2 and Ubc1 were found to be within 4% of the 
expected value.  These results are in good agreement with an expected error rate of 5%.  
HIP2-UbCys and Ubc1-UbCys were within 11.1% of the expected values.  These MW 
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measurements were larger than expected and if these small increases are interpreted as 
self-association, we can calculate Kd values around 500 and 2000 of µM for HIP2 and 
Ubc1 respectively, and Kd values around 200-300 of µM for HIP2-UbCys and Ubc1-
UbCys.  These reported Kd values for self-association are much too high to be considered 
reliable since the concentrations used in sedimentation equilibrium are in the range of 10-
20 µM.   To further characterize any possible self-association of these enzymes, SAXS 
was performed at higher protein concentrations in the range of around 25-250 µM.  The 
MW measurements from SAXS were acquired with a dilution series, so any change in 
MW as concentrations are increased are more reliable.  It is important to note the exact 
MW values determined by SAXS can be distorted by inaccurate concentrations of 
proteins or standards in addition to the 10% accuracy of MWs reported by this technique 
(22).  There are not enough data points to accurately fit an entire Kd curve, however, 
approximate Kd limitations can be determined by comparing the experimental data to 
theoretical Kd curves.  The Kd for dimerization of HIP2 and Ubc1 as well as HIP2-UbCys 
and Ubc1-UbCys were determined to be >1000 µM, and these Kd’s may in fact be much 
weaker.  Since HIP2-UbCys and Ubc1-UbCys appear to increase in MW and Rg more so 
than HIP2 or Ubc1 alone, it is likely that these disulphide species increase the very weak 
dimerization capacity of these enzymes.  Although the Kd for dimerization is affected by 
disulphide formation with Ub, these proteins are still predominantly monomeric in 
solution even at concentrations up to ~200 µM.  The cellular concentration of Ub is 
roughly 10 µM (28, 29) and the cellular concentrations of E2 enzymes are likely in the 
low µM (<10 µM) to nM range.  Comparison of these cellular concentrations to the E2 
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and E2-Ub Kd for dimerization of >1000 µM (1 mM) indicates these proteins are almost 
exclusively monomeric at cellular concentrations. 
 
2.4.3 Dimerization scaffold proteins are not used for Ubc1 or HIP2 
Previous experiments on the E2 enzyme Ube2g2 have indicated poly-Ub chain 
formation occurs between two different Ube2g2 enzymes and this activity required the 
E3 enzyme gp78 (2).  Subsequent studies on this enzyme deduced that these E2 
interactions were aided by the dimerization of the E3 enzyme, indicating the E3 enzyme 
may be a scaffold for E2 dimerization in the Ube2g2 pathway (3).  The Ubc1 and HIP2 
enzymes have poly-Ub chain activity without an E3 enzyme indicating that they do not 
require an E3 scaffold like Ube2g2.  The only protein left in our reactions that could act 
as a dimerization scaffold is the E1 enzyme.  There is currently no evidence that an E1 
enzyme can bind two E2 enzymes, however, HIP2 and Ubc1 retain the ability to form 
Ub-Ub linkages upon removal of the E1 enzyme, which suggests that the E1 enzyme 
does not act as a scaffold for E2 dimerization.  These results indicate that there are no 
additional proteins present in the activity assays performed in this work that increase the 
Kd of dimerization of Ubc1 or HIP2. 
 
2.4.4 The E1 enzyme is not directly used to create Ub-Ub linkages 
It has been previously reported that the E1 enzyme may be directly responsible 
for the formation of a poly-Ub chain on the E2 enzyme Ubc1 (30).  This proposed 
function of E1 is novel and was performed with K93 auto-ubiquitination on a truncated 
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version of Ubc1, which lacks the UBA domain (30).  The Ubc1 enzyme utilized in this 
chapter has a K93R substitution to avoid auto-ubiquitination, and retains the UBA 
domain to ensure proper enzymatic function.  Activity assays on the full length HIP2 and 
Ubc1 do not support an E1 catalyzed poly-Ub chain formation mechanism since the 
addition of E1 enzyme, ATP, and wild type Ub could not react with the HIP2-UbK48Cys or 
Ubc1-UbK48Cys disulphides.  These results demonstrate that the K48 residue on disulphide 
bound Ub does not act as a Ub acceptor with the E1~Ub thiolester. 
The requirement for the E1 enzyme was further investigated by forming E2~Ub 
thiolesters followed by a purification procedure to remove the E1 enzyme.  This process 
created ‘purified’ E2~Ub thiolesters to determine if they can react alone with Ub 
acceptors.  The ‘purified’ E2~Ub thiolesters reacted with both E2-UbK48Cys disulphides 
and free wild type Ub to create Ub2 in the absence of the E1 enzyme.  Therefore, the E1 
is only required for E2 thiolester charging, and not required for the extension of poly-Ub 
chains. 
 
2.4.5 A proposed monomeric mechanism for Ubc1 and HIP2 activity 
Poly-ubiquitination activity assays with HIP2 and Ubc1 were performed without 
E3 enzymes or substrates, indicating only E1 and E2 enzymes are involved in poly-Ub 
chain formation.  Activity assays demonstrated that the E1 was only required for E2 
charging, proving that poly-Ub activity is driven solely by HIP2 and Ubc1.  Initial work 
on E2 enzymes in several pathways suggested that these enzymes function using a 
dimeric mechanism.  The HIP2 and Ubc1 enzymes were determined to have a weak Kd of 
dimerization of >1000 µM (Fig 2.16A).  Weak dimerization could occur through 
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Figure 2.16 A schematic representation of the strength of protein interactions and possible 
mechanisms involved in poly-Ub chain formation activity observed for the E2 enzymes Ubc1 and 
HIP2.  The strength of protein interactions are reported as dissociation constants (Kd values).  (A) 
The self-association of E2 enzymes presumably through core-core interactions.  (B) The self-
association of E2~Ub enzymes presumably driven by UBA domain interactions with attached 
ubiquitin.  (C) The association of Ub with the UBA domain resulting in reaction with the E2~Ub 
thiolester causing the formation of Ub2.  (D) The association of Ub2 with the E2 UBA domain.  
(E) The association of the disulphide attached Ub with the UBA domain of another E2~Ub 
thiolester reacting to yield E2-Ub2.  All reactions shown with arrows account for the nucleophilic 
attack of a K48 side chain to a thiolester attached Ub, resulting in a Ub-Ub K48-linked poly-Ub. 
Each arrow between Ub molecules represents the K48 side chain nucleophilic attack to the 
reactive thiolester of a second Ub. 
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catalytic core interactions between E2 enzymes (7) or through UBA-UBA domain 
interactions (31).  Another method for E2 dimerization would be through the formation of 
an E2~Ub thiolester.  The HIP2 and Ubc1 C-terminal UBA domains have been observed 
to bind Ub non-covalently (21, 23, 32, 33).  These UBA/Ub binding interactions could 
drive dimerization whereby the UBA domain of each E2 could interact with the Ub 
attached to the neighbouring E2 enzyme (Fig 2.16B).  By examining HIP2-UbCys and 
Ubc1-UbCys disulphides designed to mimic the active thiolester the dimerization capacity 
was determined to also have a weak Kd of >1000 µM.  The models depicted in Figure 
2.16A and 2.16B have weak Kd values indicating that these E2 enzymes alone and in 
their thiolester mimic form are predominantly monomeric at typical cellular protein 
concentrations in the range of low µM to nM.  Although the Kd of >1000 µM indicates 
<1% of these enzymes are dimeric during the activity assays performed, this weak 
dimeric mechanism may still explain the reaction of purified E2~UbK48R thiolester with 
the E2-UbK48Cys disulphide for both HIP2 and Ubc1.  The low amount of dimerization 
may be the reason these reactions occur slowly, on the order of hours. 
Both purified HIP2~UbK48R and Ubc1~UbK48R thiolesters can react with 
unconjugated wild type Ub.  Previous studies have also implied the use of free Ub in 
HIP2 unanchored poly-Ub chain formation through the use of C-terminal Ub truncations 
that could not form thiolesters (10, 17).  The use of free Ub as an acceptor indicates that 
the activity of the HIP2 and Ubc1 enzymes may be driven by UBA affinity towards free 
Ub.  This activity can be rationalized with a monomeric mechanism.  HIP2 and Ubc1 
have the ability to interact with at least two Ub molecules at once, one through a 
thiolester linkage and a second Ub non-covalently through the UBA domain (21, 33).  
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The UBA/Ub binding may simply increase the local concentration of Ub or the UBA 
could provide the E2 enzyme with an ability to place 2 Ub molecules in close proximity 
to assist in the formation of a Ub-Ub linkage (Fig 2.16C).  The monomeric mechanism 
depicted in Figure 2.16C would be driven by UBA affinity for an acceptor Ub that would 
be positioned so its K48 residue can perform a nucleophilic attack on the thiolester bound 
donor Ub.  The Kd3 value in Figure 2.16C represents the UBA domain’s affinity for Ub 
and has been previously measured to be 400 µM for HIP2 (33) and 228 ± 69 µM for 
Ubc1 (21).  Upon comparison to the dissociation constants for dimerization (Kd1 and Kd2 
>1000 µM), the affinity of E2 to Ub is stronger than the monomer-dimer equilibrium for 
both these enzymes (Fig 2.16A, B, C).  This Kd comparison means the E2 enzymes have 
higher affinity for free Ub than another E2 enzyme.  Therefore, if the monomeric 
mechanism can occur, it would be more probable than the dimeric mechanism. 
A previous study on several isolated UBA domains has shown a higher affinity 
for poly-Ub chains than single Ub molecules (33).  In this study, the HIP2 UBA domain’s 
affinity for Ub4 was measured to have a Kd of 155 µM showing that the UBA domain 
binds poly-Ub chains more strongly than a single Ub with a Kd of 400 µM (33).  It is 
likely the UBA domain in Ubc1 behaves in a similar manner.  Figure 2.16D depicts the 
affinity of E2 for Ub2 that likely has a Kd4 that lies somewhere between the 155 and 400 
µM for HIP2 and less than 228 ± 69 µM for Ubc1 (21, 33).  The fact that the value for 
Kd4 is less than that for Kd3 indicates that the association seen in Figure 2.16D is stronger 
than that for Figure 2.16C.  This affinity difference may explain why HIP2 has previously 
been shown to kinetically favor Ub2 as a Ub acceptor over a single Ub (10).  These 
results indicate that poly-Ub chains should be extended faster than a single Ub. 
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A monomeric mechanism for HIP2 and Ubc1 function does not initially seem to 
explain the reaction of E2~UbK48R thiolesters with E2-UbK48Cys disulphides.  However, if 
the mechanism depicted in Figure 2.16C is redrawn with a disulphide in place of Ub (Fig 
2.16E) the reaction that proceeds would be very similar.  The common feature of both 
reactants is simply a reactive K48 residue available in the Ub acceptor.  In this manner, 
both the E2-UbK48Cys disulphide and free wild type Ub may react with E2~UbK48R by the 
same mechanism.  The Kd5 is likely >1000 µM as the affinity for E2~UbK48R thiolester 
and E2-UbK48Cys disulphide should be identical to the Kd measured for the self-
association of E2-UbCys disulphide.  The Kd5 comparison to Kd3 indicates that the E2-
UbK48Cys disulphide is a less efficient Ub acceptor than free wild type Ub, presumably due 
to a partially or transiently blocked Ub surface.  SAXS results show the E2-UbK48Cys 
disulphides have an exposed disulphide bound Ub that could be recognized by the UBA 
domain.  The idea of a partially exposed thiolester bound Ub is also supported by 
previous experimentation on E2~Ub conjugates suggesting that the Ub is highly mobile 
on the surface of the E2 (34).  Therefore, the reaction of E2~UbK48R thiolesters and E2-
UbK48Cys disulphides may occur only due to lack of a preferred free Ub acceptor in these 
reactions.  Comparison of the Kd’s in the mechanisms in Figure 2.16 indicates free Ub 
and poly-Ub chains are the preferred acceptors for the E2~UbK48R thiolesters. 
 
2.4.6 UBA domain and Ub positioning in HIP2 and Ubc1 structures 
SAXS experiments yield low-resolution structural data for HIP2 and Ubc1 and 
their disulphide complexes that can be used to determine the average shape of these 
proteins in solution.  These low-resolution shapes are sufficient to distinguish between 
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greatly varying positions for the UBA domain and disulphide bound Ub, however the fine 
details describing the exact orientation of the UBA domain or Ub in relation to the 
catalytic core domain cannot be determined.  SAXS analysis in comparison to high-
resolution structures allowed for the determination of the average position of the UBA 
domain in relation to the catalytic core for both HIP2 and Ubc1.  These results indicated 
that both HIP2 and Ubc1 contain few interactions between their catalytic core and UBA 
domains.  This result indicates that the UBA domain is likely mobile in relation to the 
core domain. 
The position of Ub in HIP-UbCys and Ubc1-UbCys adheres more closely to the 
‘elongated’ models (Fig 2.12B, 2.13A) than the ‘compact’ models (Fig 2.12A, 2.13B).  
Although the ‘elongated’ models are based on a rigid high-resolution structure, the high 
quality fits to SAXS data indicates that these structures accurately represent the average 
position of both the mobile UBA domain, and bound Ub in the E2-UbCys disulphides.  
Alternative structures with varied positions for the UBA domain and Ub as well as 
dimeric structures yielded poor fits to the SAXS data. 
SAXS data for both HIP2-UbCys and Ubc1-UbCys disulphides can be fit to models 
where the hydrophobic surface of Ub is highly exposed to solution.  However, previous 
NMR experiments on the Ubc1Δ~Ub thiolester (no UBA) show that there are significant 
contacts between the hydrophobic face of Ub and the Ubc1 enzyme (19).  Similar 
contacts were also observed in NMR studies with HIP2-UbCys (Chapter 4).  These results 
indicate that the hydrophobic face of Ub is at least partially blocked from solution in 
Ubc1-UbCys and HIP2-UbCys.  These results are consistent with previous experiments on 
E2~Ub structures that indicated the thiolester attached Ub on E2 enzymes may be highly 
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mobile (34).  SAXS experiments provide the general position of Ub in the E2-UbCys 
‘elongated’ models, but the orientation of the hydrophobic face of Ub may in fact point 
towards the core domain accounting for the partially blocked Ub surface in this extended 
structure.  Since E2-UbK48Cys disulphides can be reacted with the E2~UbK48R thiolesters, 
the K48 residue of Ub must be occasionally exposed to allow a reaction.  This means that 
regardless of the exact position of the disulphide bound Ub, there is likely a dynamic 
equilibrium between a partially blocked and a more fully exposed disulphide bound Ub. 
 
2.4.7 Purpose of the UBA domain 
The poly-Ub chain formation activity of Ubc1 and HIP2 seems to be driven by 
reactivity towards attached or free Ub (Fig 2.16C, D, E).  This reactivity towards Ub is 
likely due to the UBA domains of Ubc1 and HIP2 that have been shown to bind Ub 
through NMR titration experiments (21, 23, 32).  Complicating the theory that UBA/Ub 
binding drives Ubc1 and HIP2 activity, is the fact that both HIP2 (32, 35) and Ubc1 (11, 
30, 36) retain some poly-Ub chain activity upon UBA domain removal.  The removal of 
the UBA domains from both HIP2 and Ubc1 reduced the full processivity of these 
enzymes causing shorter poly-Ub chains to form (32, 36).  These results indicate that the 
UBA domain aids in reaction efficiency, but is not essential for poly-Ub chain formation.  
In previous studies a chimeric protein created with the catalytic core of the E2 enzyme 
Ubc4 with addition of the HIP2 UBA domain, was not active in poly-Ub chain formation 
(17).  This result suggests the addition of HIP2’s UBA domain on any E2 enzyme is not 
solely responsible for poly-Ub chain formation and that the HIP2 catalytic core domains 
contain unique residues directly responsible for proper Ub placement to allow formation 
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of poly-Ub chains.  This may imply that their catalytic cores have some affinity for Ub 
themselves.  However, Ub has not been observed to bind at the catalytic core of either 
Ubc1 or HIP2 in previous NMR titration experiments (21, 23).  The crystal structure of 
HIP2 with non-covalently bound Ub also did not show any contacts between the catalytic 
core and Ub (23).  The fact that these enzymes still retain some activity upon UBA 
domain removal is perplexing, although it is possible that the UBA domain aids in 
reaction efficiency by increasing the local concentration of reactant (Ub or Ub chains), 
but is not completely required for specific orientation of an acceptor Ub for reaction with 
the reactive thiolester.  The UBA domain may also increase the rate of reaction through 
efficient physical placement of two Ub molecules in close proximity.  There is currently 
no clear mechanism defining how HIP2 and Ubc1 accomplish K48-linkage specificity in 
these poly-Ub chain formation reactions. 
 
2.4.8 Purpose of chain building by Ubc1 and HIP2 
HIP2 and Ubc1 are homologs from human and yeast respectively, and appear to 
function in a similar manner as both have been shown to build K48-linked poly-Ub 
chains.  Activity assays have demonstrated that E2-UbK48R thiolesters can react with 
either E2-UbK48Cys disulphides to form E2-Ub2 or free Ub to form unanchored Ub2.  
Comparison of Kd values favours free poly-Ub chains and free Ub as the acceptor for 
HIP2~Ub and Ubc1~Ub thiolesters.  Removal of the E1 enzyme in activity assays 
indicates that the E2~UbK48R thiolester is the sole reactive enzyme in poly-Ub chain 
extension and is directly responsible for reaction with free Ub.  These free Ub acceptors 
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must then be non-covalently interacting with the E2 enzyme presumably through the 
UBA domain and possibly additional contacts on the E2 catalytic core. 
The resulting reaction from these E2 enzymes is the formation of unanchored 
poly-Ub chains, with HIP2 producing much longer chains (10, 11).  The purpose of 
unanchored poly-Ub chains remains unknown, but free unconjugated poly-Ub chains are 
found in vivo (38).  Previous experimentation has found that Ub2 and Ub4 chains can be 
just as easily activated on E1 and transferred to E2 as mono Ub (10, 38).  Therefore, free 
Ub chains can be utilized to form thiolester intermediates and then act as Ub donors.  The 
creation of these poly-Ub chains without substrate, and the fact that these chains can be 
loaded onto E2 enzymes to act as poly-Ub chain donors, supports the mechanism of 
preassembling chains prior to attachment to substrate. 
It is also possible that HIP2 and Ubc1 are involved in a sequential addition model 
by extending chains on ubiquitinated substrates by a method similar to that seen in 
unanchored chain assembly.  This mechanism is supported by recent work on Ubc4 and 
Ubc1 that found both enzymes can ubiquitinate APC (large RING E3 complex) 
substrates.  These enzymes appear to have different functions as Ubc4 is more active in 
initial Ub attachment to substrates and Ubc1 is more active at extending chains on 
substrates that already have a single attached Ub (36).  The in vitro poly-Ub chain 
activity in the absence of E3 enzymes and substrates may then be a non-physiological by-
product reaction due to lack of a preferred mono or poly ubiquitinated substrate.  
Therefore, the poly-Ub chain activity of these enzymes in vivo may prefer ubiquitinated 
substrate, but in the absence of this substrate, free Ub or auto-ubiquitinated proteins may 
act as substitute reactants. 
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The activity assays performed show direct interaction of E2 thiolesters with both 
free Ub and E2-Ub thiolester mimics.  E2 dimerization is likely not a driving factor for 
these reactions.  These results point towards Ubc1 and HIP2 functioning primarily in a 
monomeric manner in solution with the components tested.  The creation of poly-Ub 
chains may be an artifactual activity due to limited reactants in the sequential addition 
model, or could be the first steps of poly-Ub chain formation in a preassembly model. 
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Chapter 3 
1H, 15N, and 13C Backbone Resonance Assignments of the E2 
Conjugating Enzyme HIP2 
3.1 Introduction 
HIP2 is a Class II E2 conjugating enzyme containing the conserved catalytic core 
and a C-terminal UBA domain.  Importantly, it is the only human E2 enzyme known to 
possess this domain.  HIP2 also appears to be one of the most active E2 enzymes in poly-
Ub chain assembly (1), and yet very few E3 enzymes have been documented to function 
with HIP2.  These results may indicate that HIP2 has a rather novel function in 
comparison to other E2 enzymes.  Most importantly HIP2 has been shown to interact 
with several disease related substrates including the huntingtin protein found to be poly-
ubiquitinated in Huntington’s disease and UBB+1, a frame shift mutant of Ub that HIP2 
can effectively incorporate into poly-Ub chains known to be a factor in Alzheimer’s 
disease. 
The structure of HIP2 has been determined through X-ray crystallography (PDB: 
1YLA and 3E46) (unpublished) (2).  A limited number of physical studies on the HIP2 
enzyme prompted the need for NMR experimentation that can be utilized to determine 
protein interactions with residue specific information.  In order to perform mechanistic 
and structural studies of HIP2, the assignment of 1H, 15N and 13C backbone resonances 
are required.  These to be determined resonance assignments will be used in future 
experiments (Chapter 4) to determine interaction surfaces between HIP2 and attached Ub 
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or Ub2 to develop a more thorough understanding of the purpose and function of the 
HIP2 conjugating enzyme. 
 
3.2 Materials and Methods 
3.2.1 Cloning 
The hexahistidine (His6)-tagged HIP2C170S (HIP2) cDNA was inserted in the 
pET28a vector (Chapter 2).  This vector was then mutated to swap the thrombin cleavage 
site for a TEV (tobacco etch virus) cleavage site.  The 18 DNA bases encoding the TEV 
cleavage sequence was substituted for 12 DNA bases encoding the thrombin cleavage 
sequence in the pET28a vector using the Quikchange Site-Directed Mutagenesis protocol 
(Stratagene, La Jolla, CA).  Forward and reverse complement primers were subjected to 
polymerase chain reaction (PCR) against the pET28a template, followed by digestion of 
the methylated template by DpnI for 1 hour at 37 °C.  The PCR product was then 
transformed into the JM-109 E. coli strain and the correct substitutions were confirmed 
by DNA sequencing.  This plasmid was also transformed into the BL21 
CodonPlus(DE3)RIL E. coli cell line for protein expression. 
 
3.2.2 Protein expression and purification 
For the production of uniformly 15N, 13C-labelled His6-HIP2, BL21 
CodonPlus(DE3)RIL cells were grown at 37 °C in M9 minimal media (10 mL) with 
unlabelled ingredients to ensure growth, then diluted 1:100 into 1L of M9 minimal media 
containing 1.0 g / L 15NH4Cl and 2 g / L 13C-glucose as well as kanamycin (30 µg / mL) 
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and chloramphenicol (34 µg / mL).  The culture was grown to an A600 between 0.60-0.75 
and protein expression was induced with 0.7 mM IPTG.  The temperature was reduced to 
15 °C and cells were allowed to grow for 16-20 hrs.  Harvested cells were re-suspended 
in 25 mM Tris-HCl, 200 mM NaCl, 1 mM TCEP, 5 mM imidazole at pH 7.5 with the 
addition of a COMPLETE mini EDTA-free protease inhibitor cocktail tablet (Roche 
Diagnostics).  All the following purification procedures were performed at 4 °C to 
minimize protein degradation.  Cells were lysed with a French Press and cellular debris 
was removed via centrifugation at 95500 xg.  The clarified extract containing His6-HIP2 
was applied to Ni-NTA Agarose (Qiagen) and washed with 25 mM Tris-HCl, 200 mM 
NaCl, 1mM TCEP, 10 mM imidazole at pH 7.5 to elute non specifically bound material.  
His6-HIP2 was eluted with 25 mM Tris-HCl, 200 mM NaCl, 1mM TCEP, 200 mM 
imidazole pH 7.5.  TEV (Shaw lab) (50 µg / mL) was added to cleave the His6-tag at 
room temperature for 1.5 hours and then overnight at 4 °C while dialyzing into the same 
buffer containing 10 mM imidazole.  A subsequent Ni-NTA Agarose column was utilized 
with the same buffer to remove the His6 fusion tag, any uncut protein and hexahistidine 
tagged TEV.  Immediately following the final Ni-NTA Agarose column, 1 mM EDTA is 
added to the buffer.  EDTA was essential for avoiding subsequent protein degradation by 
trace proteases.  Another tablet of COMPLETE mini EDTA-free protease inhibitor tablet 
(Roche) was also added to avoid protein degradation.  A final Superdex 75 10/300 GL 
column (GE Biosciences) was used to remove trace impurities and perform buffer 
exchange into 25 mM Tris-HCl, 200 mM NaCl, 5 mM DTT, 1 mM EDTA pH 7.5.  
Earlier purifications of HIP2 used for optimization of NMR samples to avoid degradation 
and oxidization, used final buffers with 1 mM TCEP, and no EDTA.  Purification of 15N, 
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13C-labelled HIP2 was monitored using SDS-PAGE using 16.5% tris-tricine gels in a 
mini-gel system (BioRad) and was stained with Coomassie dye.  HIP2 concentrations 
were determined through Bradford (BioRad) reactions performed in triplicate.  HIP2 
molecular weight was confirmed using electrospray ionization mass spectrometry (MWobs 
23779.0 ± 1.4Da, MWcalc 23812.8). 
 
3.2.3 NMR sample preparation 
Purified 15N, 13C-labelled HIP2 used for initial NMR optimization experiments 
was dialyzed into 25 mM Tris-HCl, 200 mM NaCl, 1 mM TCEP pH 7.5.  HIP2 buffer 
conditions were optimized to be 25 mM Tris-HCl, 200 mM NaCl, 5 mM DTT, 1 mM 
EDTA pH 7.5 was used for NMR backbone assignments.  The relatively high DTT 
component was substituted for TCEP used during purification as DTT was found to be a 
more stable reducing agent over the long experimental times required for NMR 
experiments.  15N, 13C-labelled HIP2 was concentrated using a 10000 MWCO Amicon 
spin concentrator (Millipore).  NMR samples (575 µM) were prepared from this 
concentrated HIP2 solution by adding 10% D2O (v/v), 1% 10 mM DSS (v/v), 0.05% 
NaN3 (v/v), and 0.8% Complete MINI EDTA-free protease inhibitor tablet (Roche) 
solubilized with 1 mL H2O (v/v).  The final HIP2 concentration in NMR samples was 
320 µM for degradation observations, 750 µM for initial optimization tests, and 575 µM 
for samples used in triple resonance experiments for backbone assignments. 
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3.2.4 NMR spectroscopy 
All NMR spectra were acquired using a Varian INOVA 600 MHz spectrometer 
(University of Western Ontario) equipped with a pulse field gradient triple resonance 
cold probe.  It was determined that triple resonance experiments were of much higher 
quality at 30 °C then at 25 °C, and thus NMR resonance assignments of 15N, 13C-labelled 
HIP2 were performed at 30 °C. 
For all NMR experiments, the carrier frequencies for 1H, 15N, 13Cα, 13Cβ and 13C’ 
were set to 4.73, 117.01, 57.39, 45.91 and 173.90 ppm respectively.  1H-15N HSQC (3) 
spectra were collected with 1024 complex data points and a spectral width of 8000 Hz in 
the 1H (F2) dimension and 128 increments with a spectral width of 1900 Hz in the 15N 
(F1) dimension.  Sequential assignment of the polypeptide backbone resonances of HIP2 
were completed utilizing the following triple resonance experiments: HNCA (4), 
HN(CO)CA (5), HNCACB (6), HBCBCA(CO)NH (7), HC(CO)NH (8), HNCO (9).  For 
all these experiments, the 1H (F3) dimension was collected with 1024 complex data 
points with a spectral width of 8000 Hz, and the 15N (F2) dimension was collect with 32 
increments and a spectral width of 1900 Hz.  The 13C (F1) dimension for the HNCA and 
HN(CO)CA experiments used 32 increments and a spectral width of 4524 Hz.  The 13C 
(F1) dimension for the HNCACB and HBCBCA(CO)NH experiments used 56 and 52 
increments respectively with spectral widths of 9000 Hz.  The 13C (F1) dimension for the 
HNCO experiment used 24 increments with a spectral width of 3300 Hz, and the 13C (F1) 
dimension for the HC(CO)NH experiment used 40 increments with a spectral width of 
10000 Hz. 
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All data was processed using NMRPipe and NMRDraw (10).  Linear prediction 
was used in the F2 dimension to double the number of points, and zero-filling was 
performed in the F1 and F3 dimensions to 512 and 1024 points respectively.  A π/3 phase 
shifted sine2 bell was applied to the F2 and F3 dimensions, and a π/2 phase shifted sine2 
bell was applied to the F1 dimension prior to Fourier transformation of data.  All spectra 
were analyzed with NMRView (11). 
 
3.2.5 Determination of HIP2 secondary structure 
The secondary structure of HIP2 was predicted using Chemical Shift Indexing 
(CSI) (12, 13) by comparing the assigned 13Cα, 13Cβ and 13C’ chemical shift values of 
HIP2 to chemical shift values expected for these atoms if they adopt a random coil.  The 
CSI program assigns an index value of -1, +1 or 0 indicating that a particular atom has a 
chemical shift similar to an α-helical, β-strand or random coil region respectively. Three 
or more consecutive residues possessing a value of +1 will result in assignment of a β-
strand secondary structure, while four or more densely packed -1 values will result in 
assignment of an α-helical secondary structure.  A consensus secondary structure is 
produced from the analysis of all analyzed atoms.  The secondary structure from the CSI 
calculation was compared to the previously solved X-ray crystal structure of HIP2 (PDB: 
1YLA) (unpublished). 
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3.3 Results 
3.3.1 Mutagenesis 
The pET28a vector contained the His6-HIP2 fusion protein with a thrombin 
cleavage site for fusion tag removal (Chapter 2).  The TEV (tobacco etch virus) cleavage 
sequence was substituted for the thrombin cleavage sequence in the pET28a-LIC vector 
using the Quikchange Site-Directed Mutagenesis protocol (Stratagene, La Jolla, CA).  
Insertion of the new cleavage site was confirmed by DNA sequencing (London Regional 
Genomics Centre - UWO). 
 
3.3.2 Expression and purification of 15N, 13C-labelled HIP2 for NMR studies 
The production of uniformly 15N, 13C-labelled HIP2 was performed by growth in 
M9 minimal media containing 15NH4Cl and 13C-glucose with IPTG used for protein 
induction.  The key changes to the previously described purification protocol (Chapter 2) 
include the buffer pH being lowered from 8.0 to 7.5, and the use of TEV enzyme to 
remove the His6 tag from HIP2 after the first Ni2+-affinity purification step.  Since the 
TEV enzyme was also a hexahistidine tagged fusion protein (His6-TEV), a second Ni2+-
affinity column was used to remove the cleaved His6 tag, any remaining uncut His6-HIP2 
protein and all the His6-TEV enzyme leaving only purified HIP2 in the flow through (Fig 
3.1 B – lane 6).  Once the final Ni2+-affinity column was performed, it was essential to 
add EDTA to the protein solution as well as another Roche tablet of protease inhibitors to 
prevent protein degradation by trace proteases (details in Section 3.3.3).  The 15N, 13C-
labelled HIP2 was then subjected to an additional size exclusion column to remove any  
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trace proteases (Fig 3.1B – lane 7).  Using electrospray ionization mass spectrometry, a 
single major peak was observed at a molecular weight of 23779.0 ± 1.4 Da which 
accounts for 97.3% of the expected molecular weight of full isotopic incorporation of 
23812.8 Da (Fig 3.1 A). 
 
3.3.3 NMR sample preparation and optimization 
In order to obtain high quality NMR spectra, HIP2 must be exposed to high 
temperatures (>25 °C).  Initial NMR experiments on purified 15N, 13C-labelled HIP2 
resulted in severe protein degradation within days due to prolonged exposure to these 
high temperatures.  The original purpose of TEV substitution of the thrombin cleavage 
site was to minimize HIP2 degradation by using a highly pure and removable cleavage 
enzyme.  Even though TEV enzyme was used, NMR samples would degrade in roughly 
72 hours causing obvious changes in the NMR spectra (Fig 3.2).  This degradation was 
confirmed with SDS-PAGE analysis (Fig 3.2 – insets).  The NMR spectral changes are 
caused by a drastic decrease in signal from intact HIP2 as the protein degrades (Fig 3.2 – 
upper boxed region), as well as the appearance of many new signals in the spectrum (Fig 
3.2 – lower boxed region) from the creation of small polypeptides.  Protease inhibitor 
tablets (Roche) and NaN3 were added to all future NMR samples to reduce degradation  
and inhibit possible contaminant growth, respectively.  These measures alone resulted in 
minimal increases in HIP2 sample stability.  The addition of EDTA immediately 
following Ni2+-affinity chromatography was essential to increase protein stability of HIP2 
NMR samples from days to weeks.  This indicates that trace amounts of metalloproteases 
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were the likely cause of HIP2 degradation.  Therefore, the addition of EDTA to all NMR 
buffers was required to obtain high quality NMR spectra. 
NMR samples of the 15N, 13C-labelled HIP2 were then optimized for experimental 
temperatures.  NMR experiments were performed at 25 °C and 30 °C.  Analysis of the 
resulting 1H-15N HSQC spectra showed that data collected at 30 °C showed higher signal 
intensity due to narrower linewidths (Fig 3.3 – boxed signals) and improved signal 
resolution was obtained (Fig 3.3 – circled signals).  At this experimental temperature, 
there was sufficient signal intensity for unambiguous resonance assignments of the triple 
resonance experiments. 
In addition to stability problems, depletion of reducing agent affected spectral 
appearance of certain signals over time, presumably through oxidation.  To alleviate this 
problem, TCEP was replaced with the longer-lived reducing agent DTT to keep the 
sample sufficiently reduced for several weeks.  The final NMR samples used for 1H-15N 
HSQC and triple resonance experiments were prepared with all the optimized conditions 
described. 
 
3.3.4 Sequential backbone assignments of HIP2 
A series of standard multidimensional NMR experiments were used to determine 
the sequential backbone resonance assignment of HIP2.  Sequential assignment of 
residues in any protein is made possible through a series of paired experiments that 
compare the current residue (i) and the previous residue (i-1).  The first pair of NMR 
experiments used for backbone assignments were the HNCA and HN(CO)CA (4, 5). 
  
135 
 Fi
gu
re
 3
.3
 1
H
-1
5 N
 H
SQ
C
 s
pe
ct
ru
m
 o
f 
H
IP
2 
at
 v
ar
yi
ng
 te
m
pe
ra
tu
re
s.
  
B
ac
kb
on
e 
am
id
e 
si
gn
al
s 
ar
e 
sh
ow
n 
fo
r 
1 H
-1
5 N
 H
SQ
C
 s
pe
ct
ra
 o
f 
H
IP
2 
at
 
(A
) 2
5 
°C
 a
nd
 (B
) 3
0 
°C
.  
B
ox
ed
 a
nd
 c
irc
le
d 
si
gn
al
s 
ar
e 
ad
de
d 
to
 a
id
 in
 v
is
ua
l c
om
pa
ris
on
 o
f s
pe
ct
ra
l r
eg
io
ns
, s
ho
w
in
g 
in
cr
ea
se
d 
si
gn
al
 in
te
ns
ity
 
an
d 
re
so
lu
tio
n 
re
sp
ec
tiv
el
y 
at
 3
0 
°C
.  
Th
e 
sp
ec
tra
 w
er
e 
co
lle
ct
ed
 o
n 
a 
15
N
, 1
3 C
-la
be
lle
d 
H
IP
2 
sa
m
pl
e 
(7
50
 µ
M
), 
in
 1
0%
 D
2O
, 2
00
 m
M
 N
aC
l, 
1 
m
M
 T
C
EP
, 1
 m
M
 E
D
TA
, 2
5 
m
M
 T
ris
-H
C
l p
H
 7
.5
. 
  
136 
These two experiments correlate the backbone amide proton and nitrogen chemical shifts 
to the Cα resonances, with HNCA showing the current (i) residue and the preceding (i-1) 
residue, whereas the HN(CO)CA shows only the preceding (i-1) residue.  These 
experiments alone can provide backbone residue linkage, but a moderately high level of 
Cα resonance overlap necessitates the use of a second set of paired experiments, the 
HNCACB and HBCBCA(CO)NH (6, 7).  The HNCACB and HBCBCA(CO)NH 
experiments allow for the determination of both Cα and Cβ resonances.  The HNCACB 
experiment correlates the backbone amide proton and nitrogen chemical shifts to the Cα 
and Cβ resonances, while the Cα(i-1), Cβ(i-1) correlations can often be observed at a 
lower intensity.  The HBCBCA(CO)NH experiment correlates the amide and nitrogen 
chemical shifts to the Cα(i-1), Cβ(i-1) resonances.  When analyzed together, these 
experiments can be used to connect the Cα and Cβ resonances for the i and i-1 residues.  
These results when combined with the HNCA and HN(CO)CA experiments usually leads 
to unambiguous strings of connected backbone residues.  By comparing the chemical 
shifts of these atoms to the BMRB (Biological Magnetic Resonance Data Bank) standard 
chemical shift tables, the amino acid identity can be determined to complete the 
assignment of the HIP2 protein sequence.  Figure 3.4 shows the sequential assignment of 
HIP2 residues A115, L116, L117, A118, and A119 depicted in a strip plot of the 
HNCACB and HBCBCA(CO)NH experiments.  When Cα and Cβ resonances do not 
provide enough variance to unambiguously assign a residue, the HC(CO)NH (8) 
experiment provides resonances for any Cγ, Cδ, and Cε atoms present in the i-1 residue.  
By combining information from all of these triple resonance experiments, and through 
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Figure 3.1 Expression and purification of 15N, 13C-labelled HIP2. 
Figure 3.2 Illustration of degradation effects on the 1H-15N HSQC spectrum of HIP2. 
Figure 3.3 Temperature optimization of the 1H-15N HSQC spectrum of HIP2. 
 
 
 
 
Figure 3.4 Sequential backbone assignment of HIP2.  The strip plot shows alternating panels of 
the HBCBCA(CO)NH spectrum (left) and HNCACB spectrum (right) for each residue of A115 
through A119.  Each strip depicts a 15N plane of the triple resonance experiment, leaving a 2D 
representation of the remaining 1H and 13C correlations.  For each residue the Cα (black) and Cβ 
(red) are shown in the HNCACB spectrum and the corresponding Cα and Cβ for the previous 
residue (i-1) are shown in the HBCBCA(CO)NH (both black).  Connections between i and i-1 
residues are indicated with a dashed line.  The spectra were collected using a 15N, 13C-labelled 
HIP2 sample (575 µM) in 10% D2O, 200 mM NaCl, 5 mM DTT, 1 mM EDTA, 25 mM Tris-HCl 
pH 7.5 at 30 °C. 
 
 
 
 
 
  
138 
the use of distinct chemical shifts for glycine, serine, threonine, and alanine residues, 
almost every residue in HIP2 can be sequentially assigned in an unambiguous manner. 
Finally an HNCO (9) experiment is performed to assign the backbone carbonyl carbons 
for each residue. 
 
3.3.5 Assignment of the 1H-15N HSQC spectrum of HIP2 
In a 1H-15N HSQC spectrum of HIP2, each amino acid residue is depicted by a single 
signal based on the amide correlation of the 1H and 15N atoms, and is the primary type of 
spectra used to illustrate NMR resonance assignments.  The 1H-15N HSQC spectrum for 
HIP2 was assigned by comparison to the assigned triple resonance values for 1H and 15N 
on Cα and Cβ signals.  The 1H-15N HSQC spectra for HIP2 assignment of 175 out of 187 
(94%) non-proline 1H and 15N amide resonances (Fig 3.5).  Many of the remaining 
unassigned 12 residues are located in the N-terminus (M1, N3), the loop between α1 and 
β1 (E20, T22), the loop between β1 and β2 (D33, E34, F36), and within the proposed 
flexible linker between the catalytic core and UBA domain (V157, S159, E161).  These 
residues are likely in highly flexible and solvent exposed regions, resulting in their 1H 
and 15N amide resonances to be unobservable due to fast amide exchange with water.  
Table 3.1 shows all the chemical shift assignments acquired from a combination of the 
HSQC experiment and all triple resonance experiments.  These assignments include the 
amide H and N, Cα and C’ protein backbone atoms, as well as many Cβ, Cγ, Cδ, and Cε 
atoms in each amino acid residue. 
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Figure 3.5 Assigned 1H-15N HSQC spectrum of HIP2.  Backbone amide signals are labelled by 
amino acid single letter code and sequence number.  Signals connected by lines indicate side 
chain amide resonances from Asn and Gln residues.  The signals marked with (*) represent side 
chain amides from Trp residues, while arrows indicate signals that are shifted further downfield 
in 1H than 10ppm.  The spectra was collected using a 15N, 13C-labelled HIP2 sample (575 µM) in 
10% D2O, 200 mM NaCl, 5 mM DTT, 1 mM EDTA, 25 mM Tris-HCl pH 7.5 at 30 °C. 
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Table 3.1 1H, 15N and 13C backbone resonance assignments for HIP2a 
Residue HN N C’ Cα Cβ Others 
M1   176.08 55.83 33.22  
A2 8.344 124.8  52.86 19.28  
N3   176.57 54.60 38.57  
I4 8.288 120.2 177.08 63.47 38.09 Cγ1 28.32, Cγ2 17.33, Cδ1 13.72 
A5 7.887 124.8 179.37 55.88 19.33  
V6 7.798 117.0 177.46 66.28 31.87 Cγ1 20.94 
Q7 8.055 117.6 179.50 58.98 28.58 Cγ 33.95 
R8 8.181 119.4 178.07 58.48 28.80  
I9 8.441 119.6 177.77 62.29 36.19 Cγ1 28.03, Cγ2 18.77 
K10 8.361 120.4 179.54 61.07 32.42 Cδ 29.87 
R11 7.488 119.0 179.40 59.49 30.15 Cγ 27.26, Cδ 40.40 
E12 8.874 121.8 180.11 59.97 30.72 Cγ 33.85 
F13 9.393 122.7 176.79 61.57 39.68  
K14 7.606 118.5 178.45 59.56 32.29 Cγ 25.41, Cδ 29.57, Cε 41.58 
E15 8.139 118.0 179.69 59.11 29.80 Cγ 36.43 
V16 8.007 118.5 178.95 67.01 31.29 Cγ1 22.05 
L17 7.974 121.5 178.48 58.02 41.95  
K18 7.587 115.9 176.76 55.90 32.50 Cγ 24.64, Cδ 28.95, Cε 42.16 
S19 7.857 117.0  59.64 64.86  
E20    178.65 58.68 29.80 Cγ 36.41 
E21 8.992 118.0  61.05 28.69  
T22    175.26 65.17 71.24  
S23 7.944 120.5 175.82 61.23 62.92  
K24 7.812 119.0 176.13 56.55 32.53 Cγ 25.64, Cδ 29.32 
N25 8.281 116.5 175.02 54.34 37.81  
Q26 8.486 116.0 175.49 57.45 29.94  
I27 7.009 110.2 174.47 58.99 42.19 Cγ1 26.77, Cγ2 17.91 
K28 8.478 121.8 174.29 55.90 36.54 Cγ 24.98, Cδ 29.44 
V29 8.024 118.2 172.30 60.48 35.78 Cγ1 22.01 
D30 8.854 122.4 175.04 53.07 45.61  
L31 8.695 121.9 177.15 55.23 42.64 Cδ1 24.72 
V32 8.236 121.8  63.67 32.73  
E34   175.64 57.30 29.31 Cγ 36.23 
N35 7.903 116.6  52.97 39.59  
F36   173.38 60.30   
T37 8.320 104.8 174.85 62.45 69.93  
E38 7.868 123.4 173.39 55.55 32.05 Cγ 36.35 
L39 9.254 123.4 175.72 53.54 46.08 Cγ 26.81 
R40 8.982 122.8 176.15 53.77 32.26 Cγ 27.43, Cδ 42.58 
G41 9.062 111.7 171.76 43.79   
E42 8.828 120.9 174.83 55.65 34.25 Cγ 37.71 
I43 8.650 116.3 174.91 58.78 42.31 Cγ2 17.83 
A44 8.320 125.8 178.99 51.14 20.16  
G45 8.780 107.7  44.35   
P47   176.18 62.67 32.27 Cγ 27.59 
D48 9.025 115.5 175.07 55.83 39.26  
T49 7.391 105.8  59.66 71.28  
P50    173.98 63.68 32.67 Cγ 27.28 
Y51 6.922 113.1 176.85 56.40 38.54  
E52 7.513 123.3 175.75 58.27 30.06 Cγ 35.51 
G53 9.364 115.1 174.25 45.19   
G54 8.335 106.2 173.34 43.50   
R55 8.486 121.8 174.25 55.40 32.69 Cγ 27.48, Cδ 42.63 
Y56 8.736 121.4 174.48 57.79 40.41  
Q57 9.547 121.4 176.14 55.16 30.82 Cγ 34.33 
L58 9.143 121.9 175.03 53.64 45.79 Cγ 27.17 
E59 9.091 124.6 174.63 55.36 33.10 Cγ 37.10 
I60 8.084 126.2 173.85 60.30 40.09 Cγ1 27.50, Cγ2 21.42, Cδ1 17.15  
K61 9.272 127.1 175.35 54.61 34.59 Cγ 26.08, Cδ 29.42 
I62 8.647 125.8  55.07 36.94  
P63     32.55  
E64 9.053 119.6 176.60 59.02 29.61 Cγ 36.16 
T65 7.034 102.4 174.93 60.54 68.74  
Y66 7.670 126.8  58.22 40.61  
P67    174.72 63.35 33.11  
F68 8.799 125.3 175.38 60.48 37.93  
N69 7.128 115.9  50.34 41.00  
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Table 3.1 continued 1H, 15N and 13C backbone resonance assignments for HIP2a 
Residue HN N C’ Cα Cβ Others 
P71   179.71 61.72 31.80 Cγ 26.25 
K72 8.621 120.5 176.05 55.09 32.46 Cγ 24.28, Cδ 28.96, Cε 41.81 
V73 8.847 126.2 173.26 60.19 34.47 Cγ1 22.14 
R74 8.360 123.4 175.75 54.69 34.84 Cγ 27.54 
F75 9.472 124.8 175.97 60.18 38.80  
I76 8.917 124.4 177.47 62.51 39.01 Cγ1 28.22, Cγ2 16.92 
T77 7.306 119.0 173.46 63.44 70.89  
K78 8.193 126.3 176.17 56.92 32.84 Cγ 24.78, Cδ 28.54 
I79 8.524 120.4 170.26 60.95 41.84  
W80 8.040 129.9  54.52 29.12  
H81 10.570 131.1 174.11 56.01   
P82   176.70 65.44 32.51 Cγ 27.57 
N83 11.296 117.4 171.32 55.66 41.05  
I84 7.756 121.4 174.65 59.04 42.93  
S85 9.086 118.5 177.59 58.89 63.14  
S86 9.955 129.7 174.09 61.72 63.52  
V87 8.020 121.4 178.05 64.76 34.18 Cγ1 21.20 
T88 8.189 106.2 176.46 61.67 71.74  
G89 7.881 109.7 173.94 46.55   
A90 7.747 121.8 176.48 52.95 19.39  
I91 8.708 119.3 175.81 60.67 42.72 Cγ1 28.54, Cγ2 18.58 
C92 8.864 127.8 172.11 57.75 26.42  
L93 7.460 125.9 176.35 54.42 45.60 Cγ 26.70 
D94 9.292 130.6 180.28 58.52 38.99  
I95 8.530 117.2 173.36 64.51 38.30 Cγ2 18.73, Cδ1 14.41  
L96 7.331 113.6 176.76 53.64 41.38 Cγ 26.30, Cδ1 21.60 
K97 7.939 122.9 175.92 56.41 32.84 Cγ 24.59, Cδ 29.51, Cε 41.64 
D98 8.621 119.5 176.86 55.80 40.90  
Q99 7.759 115.4 174.66 54.59 28.14 Cγ 33.53 
W100 7.241 121.4 175.30 58.90 30.33  
A101 6.706 129.7 175.33 50.10 22.24  
A102 8.044 120.4 176.72 53.91 18.50  
A103 7.049 116.0 178.53 52.39 19.05  
M104 7.597 120.0 172.70 57.21 32.26  
T105 7.405 103.8 176.54 58.94   
L106 9.134 120.0 178.35 58.23 43.00 Cδ1 25.18 
R107 8.476 117.2 177.06 60.76 30.03 Cγ 27.69 
T108 7.862 114.1 178.43 66.78 68.57  
V109 8.480 123.9 177.30 67.39 31.55 Cγ1 20.68 
L110 8.286 119.4 178.73 58.87 41.35 Cγ 27.10, Cδ1 23.65 
L111 8.479 117.5 181.18 58.06 41.14 Cγ 25.92 
S112 8.409 118.1 176.94 62.73   
L113 8.154 123.9 177.84 57.51 41.90 Cδ1 27.03 
Q114 7.884 118.6 177.72 60.76 29.75 Cγ 35.29 
A115 7.995 120.0 180.28 54.87 17.85  
L116 7.786 120.9 179.48 56.64 42.29 Cγ 28.30, Cδ1 23.86 
L117 7.459 118.0 177.03 58.26 40.58 Cδ1 21.96 
A118 7.286 117.5 176.79 52.56 19.61  
A119 7.935 125.8 174.00 51.54 18.95  
A120 8.184 122.9 176.46 52.11 19.45  
E121 9.005 118.9  52.30 30.02  
P122    175.02 64.32 31.94 Cγ 27.35 
D123 8.475 117.9 175.36 55.07 40.24  
D124 7.202 119.4  51.75 40.93  
P125   177.09 62.96 33.54 Cγ 30.22 
Q126 8.678 117.6 174.59 55.10 30.25 Cγ 33.39 
D127 7.124 118.0  52.80 43.82  
A128 8.937 128.7 179.78 55.38 18.75  
V129 7.920 118.4 178.96 66.01 31.62  
V130 7.162 121.2 178.29 65.61 32.03  
A131 8.293 120.3 178.54 55.62 18.80  
N132 8.212 115.1 176.89 56.43 38.34  
Q133 7.641 121.5 176.97 59.94 31.64 Cγ 36.34 
Y134 8.572 117.5 176.62 61.55 39.15  
K135 7.705 113.6 178.42 59.00 33.76 Cγ 25.78, Cδ 29.56 
Q136 8.488 115.6 177.24 57.62 29.62 Cγ 34.06 
N137 8.793 116.1  50.93 39.35  
  
142 
Table 3.1 continued 1H, 15N and 13C backbone resonance assignments for HIP2a 
Residue HN N C’ Cα Cβ Others 
P138    179.19 65.53 31.83 Cγ 27.59, Cδ 50.29 
E139 8.543 117.6 178.70 59.62 28.96 Cγ 35.83 
M140 7.568 120.9 180.29 58.30 33.82 Cγ 31.22 
F141 9.070 123.7 176.58 62.01 38.60  
K142 8.439 120.6 178.68 60.84 32.62 Cδ 26.65, Cε 38.71 
Q143 7.921 115.6 179.46 58.46 28.11 Cγ 33.03 
T144 8.646 120.4 175.14 68.27 69.24  
A145 9.037 124.8 180.62 55.92 17.85  
R146 8.193 119.2 178.27 58.92 30.77 Cγ 27.59, Cδ 43.42 
L147 7.894 122.9 180.13 57.86 40.46 Cγ 25.51, Cδ1 21.45 
W148 9.253 120.9 181.17 62.78 28.23  
A149 9.035 128.3 174.70 55.70 18.66  
H150 8.626 120.5 176.74 58.23   
V151 8.737 116.8 178.29 65.86 32.78 Cγ1 19.74 
Y152 8.183 113.6 176.33 59.07 39.65  
A153 7.328 120.8 177.85 51.16 22.46  
G154 7.555 106.8 174.61 46.22   
A155 8.067 124.1  51.25 18.15  
V157   174.15 62.07 33.61 Cγ1 20.51 
S158 7.450 117.5  56.65 64.70  
E161   179.01 59.23 29.00 Cγ 36.09 
Y162 7.461 119.1 178.27 58.13 35.80  
T163 7.931 114.6 176.57 67.05 68.10 Cγ2 22.08 
K164 7.893 121.4 178.62 59.52 32.05 Cγ 24.73, Cδ 29.04 
K165 7.315 118.0 178.70 60.47 33.81  
I166 7.884 118.0 179.32 64.34 38.80 Cγ1 29.54, Cδ1 16.82 
E167 8.539 121.4 179.38 59.32 29.36 Cγ 35.97 
N168 8.394 118.0 177.65 56.09 38.30  
L169 7.685 119.0 180.05 57.83 42.76 Cγ 28.86, Cδ1 24.95 
S170 8.766 116.6 177.89 62.21 62.99  
A171 7.959 123.4 178.68 54.19 18.11  
M172 7.385 115.4 175.91 56.39 32.79  
G173 7.837 105.3 173.78 44.80   
F174 6.681 118.0 174.64 56.60 41.81  
D175 8.800 122.4 176.59 54.68 43.28  
R176 8.711 126.4 177.91 60.53 30.81 Cγ 27.81, Cδ 43.33 
N177 8.183 115.1 177.10 56.86 37.84  
A178 8.000 124.0 180.96 55.12 17.88  
V179 8.509 119.9 176.99 66.90 31.48 Cγ1 25.02 
I180 8.160 120.4 179.69 67.10 38.01 Cγ2 16.07, Cδ1 13.94  
V181 8.191 122.9 178.20 68.01 32.03 Cγ1 20.84 
A182 8.440 124.8 178.71 55.72 18.82  
L183 8.310 115.5 178.50 57.84 40.86 Cγ 27.34, Cδ1 23.13 
S184 7.435 113.1 174.88 62.31   
S185 7.789 112.5 174.95 60.79 63.60  
K186 7.217 120.4 176.20 52.85 29.69  
S187 7.927 112.1 172.89 60.10 61.14  
W188 8.714 110.2 172.90 59.47 24.53  
D189 7.288 119.5 175.45 53.39 42.53  
V190 8.736 127.1 178.69 66.92 31.98 Cγ1 22.08 
E191 8.760 122.9 179.44 60.65 29.37 Cγ 36.57 
T192 8.135 114.1 178.27 65.55 68.44 Cγ2 22.78 
A193 8.495 124.8 178.55 55.58 18.35  
T194 8.104 114.1 175.06 68.01   
E195 7.344 119.5 179.08 59.57 29.54 Cγ 36.03 
L196 7.372 119.9 179.76 57.90 42.17 Cγ 25.51 
L197 7.847 121.0 178.77 57.35 40.83 Cγ 26.85, Cδ1 22.75 
L198 7.796 117.6 177.75 55.84 42.82 Cγ 26.30, Cδ1 22.61 
S199 7.635 115.0 173.50 59.18 64.10  
N200 7.736 125.8  55.09 40.85  
aReferenced to DSS at 0 ppm in 1H.  HIP2 NMR data was obtained at 30 °C in 200 mM NaCl, 5 
mM DTT, 1 mM EDTA, and 25 mM Tris-HCl pH 7.5.  Residues D33, P46, P70, P156, S159 and 
P160 were not assigned 
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3.3.6 Determination of HIP2 secondary structure 
The backbone chemical shift values of HIP2 (Table 3.1) were used to calculate the 
secondary structure to ensure that the C170S substitution caused no major structural 
changes.  The assigned chemical shift values for 13Cα, 13Cβ and 13C’ from HIP2 were 
utilized to predict the secondary structure using the Chemical Shift Index (CSI) protocol 
(12, 13).  The CSI compares chemical shift assignments to their deviation from random 
coil chemical shift values to determine if those particular atoms have a propensity to be 
α-helical or β-strand in structure.  Specifically, 13Cα and 13C’ chemical shifts are located 
more upfield if they are in a β-strand conformation and shifted more downfield in an α-
helical conformation, while 13Cβ atoms experience opposite field shifts when located in 
these secondary structures (12, 13).  The secondary structure calculated for each atom 
was combined by CSI to give a consensus for each residue.  The calculated secondary 
structure for HIP2 showed residues A5-S19, E20-K24, T105-A120, A128-Y152, P160-
M172, R176-W188, and V190-L198 were in an α-helical conformation and residues I27-
D30, E38-A44, and R55-K61 were in the β-strand conformation (Fig 3.6).  The positions 
of the CSI calculated α-helices and β-strands are in excellent agreement with secondary 
structural elements observed in the X-ray crystal structure of HIP2 (PDB: 1YLA) 
(unpublished).  This result indicates that there are no major secondary structural 
differences of HIP2 in solution compared to that observed in the X-ray crystal, and that 
the C170S substitution is non-perturbing. 
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Figure 3.6 Secondary structure calculation of HIP2 by the chemical shift index.  Chemical shift 
values for 13Cα, 13Cβ and 13C’ for each residue are compared to the chemical shift index to 
determine propensity for α-helical and β-strand secondary structure.  The calculated structure is 
labelled as NMR and is compared to the X-ray crystal structure for HIP2 (PDB: 1YLA) labelled 
as X-ray.  Secondary structural elements are shown pictorially as cylinders for α-helices and 
arrows for β-strands with the protein sequence listed above.  Secondary structure elements are 
numbered above the protein sequences according to the X-ray structure labelling. 
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3.4 Discussion 
3.4.1 Mutagenesis 
The purified His6-HIP2 fusion protein after thrombin cleavage undergoes 
degradation at high temperatures (>25 °C).  Commercially available thrombin is purified 
from blood and its purity is measured through specific activity as opposed to finding a 
single band in SDS-PAGE.  Therefore, the thrombin enzyme may contain trace amounts 
of other proteases.  To avoid possible HIP2 degradation from trace proteases, the 
thrombin cleavage site was replaced with TEV.  The use of a His6-tagged form of the 
TEV enzyme allows for higher quality purification.  The His6-tag on TEV also allows for 
efficient removal after His6-HIP2 cleavage by Ni2+-affinity chromatography.  
Unfortunately, degradation of HIP2 was still noticed after TEV use and removal, likely 
due to trace proteases from the E. coli. 
 
3.4.2 Optimization of purification protocols and NMR conditions 
There were specific changes to the HIP2 purification protocol (outlined in Section 
3.2.2) that were required to ensure protein stability for NMR data collection.  The first 
change involved lowering the pH of the buffer from 8.0 to 7.5 to slow the rate of amide 
exchange.  Amide exchange can be acid or base catalyzed and previous studies have 
shown that amide exchange of an exposed HN in a peptide backbone is minimized at 
roughly pH 4 depending on surrounding side chain groups (14).  The pH was reduced 
from 8.0 to 7.5 to minimize amide exchange and to increase NMR signal intensity.  
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Importantly, this lower pH was still several pH units away from HIP2’s isoelectric point 
at pH 5.33. 
During the purification of HIP2, TCEP was used instead of DTT and EDTA was 
omitted to ensure the proper functioning of the Ni2+-affinity column.  Once Ni2+-affinity 
chromatography was completed, it was important to substitute DTT for TCEP and to add 
EDTA to the buffer.  EDTA was essential for increased stability of HIP2 at the higher 
temperatures required to collect quality HSQC data.  This indicated that HIP2 
degradation was likely due to trace amounts of a metalloprotease from E. coli.  The 
addition of various serine and cysteine protease inhibitors (Roche tablets) had little effect 
on HIP2 stability.  The use of DTT in lieu of TCEP was required due to its more stable 
reducing activity, which was needed to maintain protein stability during NMR data 
collection.  Lastly, NMR data collection was significantly improved upon increasing the 
temperature to 30 °C.  The increase in temperature allows for an increased rate of protein 
tumbling.  Increased protein tumbling leads to increased signal intensity by decreasing 
the spin-spin (1/T2) relaxation rate.  The triple resonance experiments for HIP2 at 25 °C 
were too low in signal-to-noise to perform backbone assignments.  In contrast, the signal-
to-noise of triple resonance experiments at 30 °C was significantly increased.  The 
combination of lowering the pH, adding EDTA, using DTT and increasing experimental 
temperature to 30 °C allowed for the complete unambiguous assignment of HIP2 
backbone residues. 
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3.4.3 Resonance assignments for HIP2 
The triple resonance experiments allowed for assignment of the amide H and N, 
Cα and C’ protein backbone atoms, as well as many Cβ, Cγ, Cδ, and Cε atoms in each 
amino acid residue.  The 1H-15N HSQC spectra for HIP2 has every visible signal assigned 
to yield a 94% assignment (175 / 187) of non-proline residues.  NMR protein 
assignments can be used to study protein-protein interactions in solution.  Residue 
specific protein interaction surfaces can be detected using an assigned 1H-15N HSQC 
spectrum as specific residues will undergo chemical shift changes upon binding to 
another protein.  The 1H-15N HSQC spectrum of HIP2 will be utilized in this manner to 
characterize protein interactions in Chapter 4. 
 
3.4.4 Asparagine 83 in HIP2 displays a distinctly deshielded amide proton 
An interesting feature of the 1H-15N HSQC spectrum of HIP2 is the distinct 
downfield amide 1H chemical shift of N83 (1H: 11.296 ppm, 15N: 117.43 ppm).  The N83 
residue is structurally near the active site cysteine residue (C92) and is part of a highly 
conserved HPN motif found in many other E2 enzymes (15, 16).  To perform an in depth 
structural analysis to explain this unique chemical shift, a comparison of the active sites 
of other E2 enzymes containing the HPN motif was conducted.  Every E2 enzyme that 
has a high-resolution structure and NMR chemical shift assignment was investigated.  
Nine human E2 enzymes and the yeast HIP2 homolog Ubc1 have 1H-15N HSQC spectral 
assignments (Biological Magnetic Resonance Data Bank – BMRB) as well as a high-
resolution structures: HIP2 (PDB: 1YLA, 2BEP, 3E46) (unpublished) (2, 17), Ubc1 
(PDB: 1TTE, BMRB: 6202) (18), UbcH5A (PDB: 2C4P, BMRB: 6584) (unpublished), 
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UbcH5B (PDB: 2ESK, BMRB: 6277) (19), Ubc2b (PDB: 1JAS, BMRB: 5038) (20), 
Ubc9 (PDB: 1A3S, BMRB: 4132) (21), UbE2G2 (PDB: 2CYX, BMRB: 16404) (22), 
Ubc13 (PDB: 1J7D, BMRB: 15092) (23), UbcH7 (PDB: 1FBV, BMRB: 15498) (24), 
and UbcH8 (PDB: 1WZV and 2KJH, BMRB: 16321) (unpublished) (25).  A segment of 
the sequence alignment of these 10 proteins is shown in Figure 3.7A.  The HPN motif of 
these proteins can also be structurally aligned showing that the HPN motif adopts a tight 
turn adjacent to the active site cysteine in all of these proteins.  The important catalytic 
residues include the active site C92, which forms the thiolester linkage with the Ub C-
terminus, and the Asn residue in the HPN motif, which has been suggested to stabilize an 
oxyanion intermediate formed during nucleophilic attack by a substrate lysine (16, 26, 
27). 
Closer inspection of the structure of the HIP2 active site (PDB: 2BEP) (17) shows 
that the amide proton of N83 is involved in a hydrogen bond to the side chain δ nitrogen 
atom of H81 (Fig 3.7B).  Comparison to other HIP2 structures (PDB: 3E46, 1YLA) (2) 
(unpublished) shows that the H81 ring is flipped and a hydrogen bond can form between 
the H81 protonated ε nitrogen atom and the N83 side chain δ oxygen atom (Fig 3.7C).  
Although both of these orientations are possible, the purpose of side chain interactions of 
His and Asn residues in the HPN motif could possibly regulate the oxyanion hole by 
assuming acidic and basic states (15).  However, the fact that His is not solvent exposed 
argues against this acid/base catalysis function, and indicates that the N83 residue alone 
likely regulates the oxyanion hole (16).  Hydrogen bonds are known to have a 
deshielding effect on amide protons (28), indicating the highly deshielded N83 amide 
proton is consistent with the hydrogen bond depicted in Figure 3.7B and cannot 
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Figure 3.7 Structural analysis of the HPN motif in HIP2.  (A) Segment of a sequence alignment 
of 9 human E2 enzymes and Ubc1 (yeast HIP2 homolog) for which NMR chemical shift data and 
PDB structures exist.  Conserved residues are pink, and unique HIP2 residues are blue.  (B) HIP2  
(2BEP) structure and (C) HIP2 (3E46) structure showing variations in H81 ring orientation and 
hydrogen bonding in the HPN motif adjacent to the C92 active site.  (D) HIP2 (2BEP) structure 
showing hydrogen bonded water to the H81 amide and surrounding chemical groups (some 
sidechains hidden for clarity).  (E) Overlay of HIP2 (2BEP – orange) from (D) showing side 
chains from UbcH5A (2C4P - purple), Ubc13 (1J7D - magenta), and UbcH8 (1WZV - green) 
with backbone residues in grey.  Hydrogen bonds are shown as thick dashed green/grey lines, and 
distance measurements are shown in thin dashed red lines.  Colour scheme for atoms are nitrogen 
(blue), oxygen (red), carbon (grey) and protons are not shown. 
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be explained by the absence of the hydrogen bond depicted in Figure 3.7C.  In addition to 
the hydrogen bond, the deshielding of this amide proton is also affected by orientation of 
the H81 ring such that the deshielding effects of the ring current face the amide bond.  
This evidence suggests that the HIP2 structure depicted in Figure 3.7B contains the 
correct H81 orientation and protonation state, while the HIP2 structure depicted in Figure 
3.7C incorporates an incorrect orientation for H81 in the HPN motif. 
The structures of the other nine E2 enzymes analyzed also display little consensus 
on the HPN histidine ring orientation.  All of these nine proteins however, contain a 
significantly downfield shifted Asn amide proton in the HPN motif as in HIP2.  
Therefore, it is likely the His orientation and hydrogen bond depicted in Figure 3.7B is 
similar for all other E2 enzymes with the HPN motif.  Substitutions in the His or Pro 
residues in the HPN motif for Ubc13 resulted in the production of mostly insoluble 
protein (16).  These results indicate that the His side chain is not involved in stabilizing 
the oxyanion hole in any E2 enzyme’s HPN motif.  The purpose of the His hydrogen 
bond to the Asn amide is therefore very important in strengthening the HPN tight turn 
(Pro trans configuration) to stabilize the catalytic core domain fold.  This means the His 
in the HPN motif structurally stabilizes the active site.  The purpose of this important 
HPN motif structure near catalytic site is likely to properly position the Asn sidechain to 
stabilize the oxyanion hole.  Since all reported E2 enzymes contain this significantly 
downfield shifted Asn amide proton, the HPN tight turn motif must aid in proper Asn 
positioning to aid in the function of all E2 enzymes. 
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3.4.5 Histidine 81 in HIP2 displays a distinctly deshielded amide proton 
Another feature of the 1H-15N HSQC spectrum of HIP2 is the distinct downfield 
amide 1H chemical shift of H81 (1H: 10.570 ppm, 15N: 131.11 ppm) in the HPN motif.  
Unlike the highly downfield shifted amide proton of N83 that is common in all 10 E2s 
analyzed, the downfield shift of the H81 amide proton is unique to HIP2 and its yeast 
homolog Ubc1.  There was no observed hydrogen bonding of the H81 amide proton to 
any other amino acid backbone or side chain atoms.  However, the observation of a 
hydrogen bonded water molecule could account for the deshielded environment 
experienced by the H81 amide proton (Fig 3.7D).  The electronegative atoms from S86 
and D127 side chains are outside of hydrogen bonding distance but possibly affect the 
polar orientation of the water molecule, which would strengthen the hydrogen bond with 
the H81 amide proton.  This is supported by the fact that the D127 residue is unique to 
HIP2 and the S86 residue, although not unique, is very close to the unique T88 residue 
insertion in HIP2 that affects the positioning of S86 (Fig 3.7A, D).  Comparison to 
several other E2 enzymes (UbcH5A, Ubc13 and UbcH8) indicated that a hydrogen 
bonded water molecule was also present in these structures.  However, downfield shifted 
His amide protons were not observed in these other E2 enzymes.  To explain the lack of a 
similar His amide chemical shift, these E2 structures were aligned by the HPN motif and 
overlayed to display structural differences (Fig 3.7E).  There are no additional hydrogen 
bonds that explain why the HIP2 H81 amide is uniquely downfield shifted.  The most 
obvious difference between HIP2 and UbcH5A, Ubc13 and UbcH8, are the residue 
identities and geometry equivalent to S86 and D127 in HIP2.  In HIP2 S86 and D127 
provide electronegative groups that may aid in orientation of the hydrogen bonded water 
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molecule.  This may strengthen the hydrogen bond to H81.  The other three E2 enzymes 
do not retain these proximal electronegative groups.  The negative charge on D127 in 
HIP2 is replaced by positive R121, polar N123 and a hydrophobic V120 in UbcH8, 
Ubc13 and UbcH5A respectively, which accounts for an obvious change in environment 
that would not favorably interact with the positive side of a polar water molecule.  The 
insertion of T88 in HIP2 is unique and may cause the S86 sidechain to be moved into 
closer proximity of this water molecule than S80, K82 or E80 in UbcH5A, Ubc13, and 
UbcH8 respectively.  The proximity and location of electronegative atoms located 
opposite the hydrogen bonded water appears unique to HIP2 (and Ubc1) and thus 
hydrogen bond stabilization by these groups is the most reasonable explanation for the 
H81’s unique downfield shifted amide proton.  Although the H81 amide unique chemical 
shift does not seem to adversely affect the active site, these residues may be necessary for 
the structural stabilization of the active site of the HIP2 enzyme. 
Previous experimentation shows that a HIP2 S86Y substitution loses the ability to 
make poly-Ub chains (29).  The S86 residue is not adjacent to the active site cysteine or 
HPN asparagine side chain, but it is close to the HPN histidine backbone amide (Fig 
3.7D, E).  The S86Y substitution would likely disrupt the hydrogen bonded water 
depicted in Figure 3.7D, but this substitution will also affect the structure of the HPN 
motif through steric hindrance by the large hydrophobic Y86 residue with the H81 
backbone.  Therefore, the S86Y substitution may alter the HPN tight turn structure 
resulting in a changed orientation of N83 near the active site.  This may cause a 
destabilized oxyanion hole resulting in the loss of poly-Ub chain function. 
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3.4.6 The predicted secondary structure of HIP2 agrees with the crystal state 
Using the NMR chemical shift assignments, the secondary structure of HIP2 was 
determined and when compared to the secondary structure observed in the crystal state, 
all of the major α-helices and β-strands are retained in solution.  This is an important 
result supporting the validity of using the crystal structure as an accurate representation 
of HIP2 in solution.  The matching secondary structure also provides evidence that the 
C170S substitution is non-perturbing, supporting previous enzymatic evidence that this 
substitution remains fully functional (30).  The resonance assignments of HIP2 can now 
be used to perform studies where interacting residues can be identified. 
 
3.4.7 General conclusions 
The E2 conjugating enzymes are crucial components involved in both Ub transfer 
and poly-Ub chain formation in the ubiquitin proteosome pathway.  Although all of the 
enzymes involved in these processes have been identified, the understanding of the 
structural mechanisms detailing how Ub is built into chains is still poorly explained.  The 
structure of the HIP2 enzyme was solved through X-ray crystallography (unpublished) 
(2), but there were no NMR experiments or data for HIP2 available in the literature.  To 
expand the structural knowledge of HIP2 and its function, the backbone resonances were 
assigned for the purpose of interaction studies between attached Ub and Ub2 (Chapter 4).  
Since NMR provides residue specific details, these interactions can be mapped onto the 
high-resolution structure of HIP2 that will provide important information on the 
mechanisms of HIP2 function in Ub transfer and poly-Ub chain formation. 
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Chapter 4 
Novel Intramolecular Contacts Observed Between the HIP2 
UBA Domain and Ubiquitin within a HIP2-Ub2 Thiolester 
Mimic 
4.1 Introduction 
The enzyme HIP2 (E2-25K) is known to produce unanchored K48-linked poly-
Ub chains in solution using only the E1 activating enzyme and ubiquitin (Ub) molecules 
as substrates (1).  The biological significance of unanchored chain building by HIP2 
remains debatable, but a better understanding of how HIP2 accomplishes this activity 
should shed light on how K48-linked poly-Ub chains are constructed.  Experiments in 
Chapter 2 demonstrate that HIP2 and its thiolester mimic do not significantly dimerize.  It 
was also demonstrated that the HIP2~Ub thiolester is the sole reactive species needed to 
form poly-Ub chains.  Therefore, further studies with HIP2 thiolesters should help clarify 
the mechanisms for HIP2 function.  Multiple mechanisms have been proposed for the 
assembly of poly-Ub chains in various ubiquitination pathways.  These mechanisms 
include the formation of poly-Ub chains on the E2 enzyme, formation of free poly-Ub 
chains in solution that could then be loaded onto E2 enzymes for transfer to the substrate 
in a single transfer reaction, and a sequential addition mechanism where a poly-Ub chain 
bound to a substrate is sequentially extended through a series of transfer reactions.  HIP2 
may function biologically by any of these mechanisms.  Results from Chapter 2 
demonstrated that free Ub and HIP2-Ub disulphide could act as Ub acceptors in poly-Ub 
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chain formation.  This indicates that mechanisms of preassembly of poly-Ub chains built 
on HIP2 or freely in solution and followed by loading these chains onto HIP2 could result 
in the creation of HIP2~Ubn thiolester intermediates. 
In order to study these possible intermediates, HIP2~Ub and HIP2~Ub2 thiolester 
mimics were produced for structural investigation.  The backbone assignment of HIP2 
from Chapter 3 was essential to determine residue specific chemical shift values for the 
HIP2 enzyme.  NMR studies can provide residue specific information that allows 
determination of interaction surfaces within HIP2-Ub and HIP2-Ub2.  These studies will 
help clarify possible mechanisms of HIP2 function. 
 
4.2 Materials and Methods 
4.2.1 Protein expression and purification 
Ubiquitin variants UbK48R and UbG76C were overexpressed as either unlabelled or 
15N, 13C-labelled proteins and purified as described previously (2).  HIP2C170S (simply 
referred to as HIP2) was overexpressed as either unlabelled, uniform 15N, or 15N, 13C-
labelled and purified as described previously (Section 3.2.2).  The identity of purified 
HIP2 was confirmed by mass spectrometry (HIP2 – MWobs 22534.8 ± 0.3 Da, MWcalc 
22534.7; 15N, 13C-labelled HIP2 (*HIP2) – MWobs 23778.9 ± 1.4 Da, MWcalc 23812.8 
Da). 
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4.2.2 Diubiquitin synthesis 
A K48-linked diubiquitin chain was constructed using purified UbG76C (UbP) and 
UbK48R (UbD) proteins.  HIP2 was utilized in a free poly-Ub chain reaction with the 
reactants UbP and UbD to yield predominantly a blocked diubiquitin species (UbP-UbD).  
The formation of UbP-UbD was catalyzed by human E1 activating enzyme (UBE1) 
(BostonBiochem) and HIP2 as previously described (3).  Purified 15N, 13C-labelled UbP 
and UbD (*UbP and *UbD) were utilized to alternatively label diubiquitin products (*UbP-
UbD and UbP-*UbD).  The purity of UbP-UbD, and thus the purity of each individual 
ubiquitin variant, was confirmed with electrospray ionization mass spectrometry 
(unlabelled UbP-UbD: MWobs 17169.2 ± 0.7, MWcalc 17169.7).  The correct mass of 
*UbP-UbD and UbP-*UbD was confirmed with mass spectrometry on their disulphide 
complexes with HIP2 (Section 4.2.3). 
 
4.2.3 HIP2-diubiquitin disulphide complex formation 
Stock solutions of UbP, UbP-UbD and HIP2 (0.1 mM each) were reduced using 
freshly made 5 mM TCEP.  HIP2 was combined with a 2-fold excess of UbP or UbP-UbD 
and dialyzed against several changes of 100 mM Na2HPO4/NaH2PO4, 200 mM NaCl, 10 
µM CuCl2 at pH 7.4 and 4 °C.  This mild oxidation buffer drives the creation of 
disulphide bonds between the active site C92 of HIP2 and C76 of UbP mimicking a 
thiolester bond.  The progress of the disulphide complex formation was monitored by 
non-reducing SDS-PAGE and was considered complete when the reduced HIP2 was 
exhausted.  The protein solution was concentrated and purified by size exclusion 
chromatography on a Sephadex G-75 column with 100 mM Na2HPO4/NaH2PO4, 200 mM 
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NaCl, 3 mM EDTA at pH 7.4.  Fractions containing pure HIP2-UbP or HIP2-UbP-UbD 
were pooled and extensively dialyzed against 100 mM Na2HPO4/NaH2PO4, 400 mM 
NaCl and 3 mM EDTA buffer at pH 7.4 for NMR experiments.  Complex formations 
were confirmed by mass spectrometry for [15N]HIP2-UbP (MWobs 31402.9 ± 2.3 Da, 
MWcalc 31402.6 Da), HIP2-UbP-*UbD (MWobs 40165.56 ± 4.6 Da, MWcalc 40184.4), 
HIP2-*UbP (MWobs 31602.5 ± 0.8 Da, MWcalc 31616.6 Da) and HIP2-*UbP-UbD (MWobs 
40169.1 ± 2.3 Da, MWcalc 40183.4 Da). 
 
4.2.4 NMR sample preparation 
In order to properly compare NMR spectra for variably labelled HIP2, UbP, UbD, 
UbP-UbD, HIP2-UbP and HIP2-UbP-UbD complexes, all proteins were extensively 
dialyzed into identical buffer conditions of 100 mM Na2HPO4/NaH2PO4, 400 mM NaCl 
and 3 mM EDTA buffer at pH 7.4.  The proteins HIP2, UbP and UbP-UbD include the 
addition of freshly made 1 mM DTT to ensure cysteine residues remain reduced.  The 
400 mM NaCl was optimized to maximize solubility of the HIP2-UbP complex.  All 
proteins were concentrated using a 10000 MWCO Amicon spin concentrator (Millipore).  
NMR samples were prepared using concentrated stock solutions of each protein by 
adding 10% D2O (v/v), 1% 10 mM DSS (v/v), 0.05% NaN3 (v/v), and 0.8% Complete 
MINI EDTA-free protease inhibitor tablet (Roche) solubilized with 1 mL H2O (v/v).  The 
final concentrations in each NMR sample were 525 µM *HIP2, 357 µM *HIP2-UbP, 550 
µM *HIP2-UbP-UbD, 600 µM *UbD, 350 µM UbP-*UbD, 340 µM HIP2-UbP-*UbD, 600 
µM *UbP, 600 µM *UbP-UbD, 433 µM HIP2-*UbP, and 325 µM HIP2-*UbP-UbD. 
Protein concentrations of Ub were determined by weight of lyophilized proteins and UbP-
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UbD concentrations were estimated by comparison to lyophilized weights and estimating 
30% loss of material in reactions.  HIP2, HIP2-UbP and HIP2-UbP-UbD protein 
concentrations were determined with Bradford (BioRad) reactions performed in triplicate. 
 
4.2.5 NMR spectroscopy 
The uncomplexed proteins HIP2, UbP, UbD and UbP-UbD as well as the HIP2-UbP 
and HIP2-UbP-UbD disulphide complexes were characterized by NMR spectroscopy by 
isotopic labelling of only one protein component at a time.  In this way *UbP, *UbD and 
*HIP2 components allowed for residue specific interaction surfaces to be determined in 
the larger protein complexes.  All NMR data was acquired using a Varian INOVA 600 
MHz spectrometer equipped with a triple resonance cold probe with z gradients 
(Biomolecular NMR Facility, University of Western Ontario).  Sequential assignments 
for the backbone residues of *UbD, *UbP, *UbP-UbD and UbP-*UbD were performed 
utilizing 1H-15N HSQC (4) and HNCA (5) experiments at 30 °C.  Disulphide protein 
complexes with labelled Ub (HIP2-*UbP, HIP2-*UbP-UbD and HIP2–UbP-*UbD) were 
used to collect 1H-15N HSQC spectra at 30 °C and assigned by comparison to the 
uncomplexed proximal or distal labeled Ub and Ub2.  Protein complexes with labelled 
HIP2 (*HIP2, *HIP2–UbP, and *HIP2–UbP-UbD) were used to collect 1H-15N TROSY-
HSQC (6) spectra at 35 °C, and assigned by comparison to HIP2 assignments from 
Chapter 3.  Chemical shift perturbations were calculated according to ∑Δδ = [Δδ(1H)2 + 
((0.2)Δδ(15N))2]0.5, where Δδ(1H) and Δδ(15N) represent the change in chemical shift in 
1H (proton) and 15N (nitrogen) atoms within a protein backbone amide bond (7). 
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4.2.6 Sedimentation equilibrium 
Sedimentation equilibrium experiments were performed in a Beckman Optima 
XL-A analytical ultracentrifuge with UV/VIS optics.  An An-60 Ti analytical rotor was 
used with a 12 mm thick six-channel equilibrium double sector Epon-charcoal 
centerpiece with quartz windows.  Protein samples were loaded in triplicate (100 µL 
protein) with matching reference samples containing dialysis buffer (110 µL).  
Absorbance measurements were collected at 280 nm in 0.002 cm radial steps and 
averaged over 10 readings.  Experiments were performed at 5 °C and at rotor speeds of 
12, 15, 18 and 21000 rpm.  A delay of 20 hours at the first speed was used to allow the 
sample to reach equilibrium, and further increases in speed were allowed 8 hours to reach 
equilibrium before readings were measured.  At each speed two scans were performed 
two hours apart and superimposed to confirm that equilibrium had been properly 
achieved.  Prior to centrifugation HIP2-UbP-*UbD was dialyzed into 100 mM 
Na2HPO4/NaH2PO4, 400 mM NaCl and 3 mM EDTA at pH 7.33 for 24 hours.  Sample 
concentrations (10.9 µM, 8.7 µM and 5.7 µM) were determined by dilution of a higher 
concentration stock solution using dialysis buffer.  The protein integrity was confirmed 
after the experiments using electrospray mass spectrometry (MWobs 40162.2 ± 2.6 Da; 
MWcalc 40184.4 Da)  
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4.3 Results 
4.3.1 Protein expression and purification 
Ubiquitin variants UbK48R, UbG76C and HIP2C170S (henceforth referred to as HIP2) 
were overexpressed as either unlabelled, or uniform 15N, or 15N, 13C-labelled proteins and 
purified as described previously (Section 2.2.1, 3.2.2).  The molecular weight of 
unlabelled HIP2 was confirmed using electrospray ionization mass spectrometry whereby 
a major peak was observed (MWobs 22534.8 ± 0.3 Da) at the expected molecular weight 
(MWcalc 22534.7).  The molecular weight of 15N, 13C-labelled HIP2 (*HIP2) was also 
confirmed with mass spectrometry to have 97.3% isotopic label incorporation with a 
single major peak observed (MWobs 23778.9 ± 1.4 Da) at the expected molecular weight 
(MWcalc 23812.8 Da).  The correct molecular weight of ubiquitin variants was confirmed 
in Ub2 complexes (Section 4.3.2). 
 
4.3.2 Creation of lysine-48 linked diubiquitin using ubiquitin variants 
The enzyme HIP2 is known to produce unanchored K48-linked poly-ubiquitin (poly-Ub) 
chains in solution using only the E1 activating enzyme and free ubiquitin (Ub) molecules 
as substrates (1).  Utilization of the ubiquitin variants UbG76C (UbP) and UbK48R (UbD) 
allows K48-linked poly-Ub chain extension to be blocked on both sides such that a Ub2 
(UbP-UbD) product accumulates in solution.  The predominant product from this poly-Ub 
chain reaction is UbP-UbD since UbP is blocked from C-terminal chain extension by the 
G76C substitution, and UbD is blocked from K48 extension by the K48R substitution.  
The abbreviation UbP is used to denote the proximal Ub that can be directly attached to 
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the E2 enzyme through a disulphide bond.  The abbreviation UbD is used to denote the 
distal Ub in Ub2 that forms a peptide bond to K48 of UbP.  The formation of the 
diubiquitin (UbP-UbD) species was catalyzed by the E1 activating enzyme and HIP2 and 
purified using anion exchange followed by cation exchange to yield purified diubiquitin 
as described previously (Fig 4.1) (3).  The larger Ubn by-products are likely the result of 
very low amounts of non K48-linked chains that form after all Ub K48 residues are 
exhausted.  Purified 15N, 13C-labelled UbP (*UbP) and 15N, 13C-labelled UbD (*UbD) 
proteins were utilized in conjunction with unlabelled UbP and unlabelled UbD to produce 
*UbP-UbD and UbP-*UbD.  The molecular weight of UbP-UbD was confirmed using 
electrospray ionization mass spectrometry as a single major peak was observed (MWobs 
17169.2 ± 0.7 Da) at the expected molecular weight (MWcalc 17169.7 Da) (Fig 4.1).  The 
correct molecular weight of *UbP-UbD and UbP-*UbD was confirmed with mass 
spectrometry on their disulphide complexes with HIP2 (Section 4.3.3). 
 
4.3.3 HIP2-Ub and HIP2-Ub2 disulphide complex formation 
In order to examine the mechanisms of assembly of a poly-Ub chain at the active 
site cysteine and/or the transfer of preassembled chains thiolester linked to the active site, 
HIP2 complexes were synthesized carrying either one or two Ub molecules at the active 
site.  To mimic the HIP2~Ub thiolester a disulphide complex was formed between the 
catalytic cysteine (C92) and ubiquitin carrying a C-terminal cysteine substitution UbG76C 
(UbP).  A C170S substitution in HIP2, shown to retain all activity in comparison to the 
wild type protein (8), was used to provide specificity for the disulphide formation.  A 
single ubiquitin (UbP) or diubiquitin (UbP-UbD) was linked to the catalytic cysteine 
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of HIP2 using mild oxidation, and the HIP2-UbP and HIP2-UbP-UbD products were 
purified from other disulphide by-products using size exclusion chromatography (Fig 
4.2A).  This approach allowed for selective isotopic labeling (15N and/or 13C) of each 
individual protein component in HIP2-UbP (*HIP2-UbP, HIP2-*UbP) or HIP2-UbP-UbD 
(*HIP2-UbP-UbD, HIP2-*UbP-UbD, HIP2-UbP-*UbD) complexes for NMR 
characterization.  The creation of HIP2-*UbP and HIP2-*UbP-UbD and purification was 
monitored with SDS-PAGE in Figure 4.2B.  Electrospray ionization mass spectrometry 
was used to confirm labelled molecular masses of protein complexes.  The molecular 
weight of N15, C13 labelled HIP2 (*HIP2) complexes was confirmed with mass 
spectrometry to have 100% isotopic label incorporation for *HIP2-UbP (MWobs 31402.9 
± 2.3 Da, MWcalc 31402.6 Da), while the correct molecular weight of *HIP2-UbP-UbD 
was confirmed by mass spectrometry on the reactants *HIP2 and UbP-UbD (Section 4.3.1, 
4.3.2).  The molecular weight of N15, C13 labelled UbP (*UbP) complexes was confirmed 
with mass spectrometry to have an isotopic incorporation of 97% for both HIP2-*UbP 
(MWobs 31602.5 ± 0.8 Da, MWcalc 31616.6 Da) and HIP2-*UbP-UbD (MWobs 40169.1 ± 
2.3 Da, MWcalc 40183.4 Da).  The molecular weight of HIP2-UbP-*UbD was confirmed 
with mass spectrometry to have an isotopic incorporation of 96% (MWobs 40165.56 ± 4.6 
Da, MWcalc 40184.4). 
 
4.3.4 Backbone resonance assignment of HIP2 and diubiquitin 
In order to identify residues in HIP2 that interact with Ub or Ub2 in the disulphide linked 
HIP2-Ub or HIP2-Ub2 species, the backbone resonance assignments for HIP2 were 
completed using standard triple resonance experiments (Chapter 3).  To maximize 
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Figure 4.1 Formation and purification of K48-linked diubiquitin (UbP-UbD). 
 
 
              
 
Figure 4.2 Schematic representation of disulphide complex creation.  (A) The 
diagram shows the reaction mechanism used to create a disulphide bond (-S-S-) 
between the E2 conjugating enzyme HIP2 and either a single UbG76C (UbP) or 
diubiquitin UbG76C-UbK48R (UbP-UbD).  (B) An SDS-PAGE gel was used to monitor 
the specific disulphide complex formation with dual labelled proximal Ub (*UbP).  
Displayed in the gel are molecular weight ladders (lane 1, 7), purified HIP2 (lane 
2), purified *UbP (lane 3), purified K48-linked diubiquitin (*UbP-UbD) (lane 4), 
complexation reaction for HIP2-*UbP (lane 5), complexation reaction for HIP2- 
*UbP-UbD (lane 6).  Disulphide by-products were removed from disulphide 
complexes by extensive size exclusion chromatography yielding purified HIP2-
*UbP (lane 8), and purified HIP2-*UbP-UbD (lane 9).  Molecular weights of 
standards are listed to the left of the gel, and protein species are listed to the right 
of the gel. 
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the NMR signal-to-noise of HIP2 in these large protein complexes, collection of a high 
quality 1H-15N TROSY-HSQC and HNCA spectra of HIP2 was performed at 35 °C.  This 
higher temperature allowed for the assignment of one additional residue, V157 (not seen 
in Chapter 3), to yield assignment of 176 out of 187 (94%) non-proline 1H and 15N amide 
resonances (Fig 4.3).  Many of the remaining unassigned residues are located in the N-
terminus (M1, N3), the loop between α1 and β1 (E20, T22), the loop between β1 and β2 
(D33, E34, F36) as well as the proposed flexible linker between the catalytic core α4 and 
the UBA domain α5 (S159, E161).  These residues are likely in highly flexible and 
solvent exposed regions, resulting in their 1H and 15N amide resonances being 
unobservable due to fast amide exchange with water. 
In order to identify the residues in the proximal and distal Ub moieties that 
interact within HIP2-Ub and HIP2-Ub2 complexes the backbone chemical shift 
assignments were also completed for *UbP, *UbD, *UbP-UbD and UbP-*UbD using HSQC 
and HNCA experiments to compare to a previous Ub HSQC spectrum (9).  The 
remaining spectra of larger HIP2 complexes (*HIP2-UbP, *HIP2-UbP-UbD, HIP2-*UbP, 
HIP2-*UbP-UbD, HIP2-UbP-*UbD) were assigned by HSQC or TROSY-HSQC 
comparison to the assigned smaller precursor species (*UbP, *UbD, *UbP-UbD, UbP-
*UbD, *HIP2). 
 
4.3.5 HIP2 interactions with UbP within HIP2-UbP 
In the HIP2-UbP disulphide, UbP is covalently linked to the active site cysteine (C92) of 
HIP2.  Using 1H-15N TROSY-HSQC spectra and the assigned backbone resonances for 
HIP2, the position of each residue in HIP2 was assigned upon formation of HIP2-UbP to 
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Figure 4.3 1H-15N TROSY-HSQC spectrum of HIP2.  Backbone amide signals are labelled with 
amino acid single letter codes and sequence numbers.  Signals connected by lines indicate side 
chain amide resonances from Asn and Gln residues.  The signals marked with (*) represent side 
chain amides from Trp residues, while arrows indicate signals that are shifted further downfield 
in 1H than 10ppm.  The spectra was collected on a 15N, 13C-labelled HIP2 sample (525 µM) in 
10% D2O, 400 mM NaCl, 1 mM DTT, 3 mM EDTA, 100 mM Na2HPO4/NaH2PO4 pH 7.4 at 35 
°C. 
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determine how the Ub moiety interacts with HIP2 (Fig 4.4A).  These experiments 
showed that the largest changes in chemical shift upon formation of HIP2-UbP occur in 
residues found in α1 (R8, I9, R11, F13, K18), β1 (K28, V29, D30), β2 (G41, I43), β3 
(K61), the loop containing the active site between β4 and α2 (F75, K78, I79, I84, S85, 
S86, T88, G89, M104), α2 (L110), the loop between α2 and α3 (E121, D124) and α3 
(V129) (Fig 4.4B).  Other regions experiencing significant line broadening include the 
loop between α1 and β1 (K24, I27), β4 (V73), the loop containing the active site between 
β4 and α2 (H81, V87, I91-D98 (surrounding the active site cysteine C92), A101), α2 
(T105, L106, V109), the loop between α2 and α3 (Q126, D127), and α3 (V130) (Fig 
4.4B).  This significant line broadening is likely due to a decrease in mobility of these 
residues at the HIP2-UbP interface or due to intermediate exchange between structures 
where the UbP might occupy several different locations on HIP2.  The residues with the 
largest changes in chemical shift and line broadening upon formation of HIP2-UbP were 
mapped onto the surface of HIP2 (Fig 4.4C).  The most highly affected residues straddle 
the active site C92 between β4 and α2.  Residues I84-G89 undergo the largest chemical 
shift changes and residues I91-D98 containing a very short 310 helix structure (I95-D98 – 
hence forward the ‘active site’ helix) undergo severe line broadening.  Another highly 
affected region near the active site includes residues in the loop between α2 and α3 and 
the N-terminus of α3.  Together all of these residues combine to account for the major 
surface of HIP2 that is likely in direct contact with the covalently bound UbP (Fig 4.4C).  
It is also evident that there are minimal chemical shift changes in the UBA domain of 
HIP2 upon formation of HIP2-UbP.  Although the HIP2 UBA domain has been 
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shown to interact non-covalently with Ub (10, 11), the results shown here indicate a UBA 
interaction with the disulphide bound Ub in HIP2-UbP does not occur. 
 
4.3.6 Intramolecular interactions within HIP2-UbP-UbD 
In order to understand the effects of placing a second ubiquitin molecule on the 
growing poly-Ub chain linked to the catalytic cysteine, the 1H-15N TROSY-HSQC 
spectra of *HIP2-UbP-UbD was compared with that of *HIP2-UbP.  A structural analysis 
of HIP2-UbP-UbD could provide important insights into both the assembly and the 
mechanism of transfer of prebuilt ubiquitin chains onto substrate molecules.  Comparison 
of *HIP2-UbP-UbD and *HIP2-UbP demonstrate large differences in chemical shift 
involving residues in α1 (F13), the active site loop between β4 and α2 (I76, N83, I84, 
G89, A90, A102), the loop between α2 and α3 (A119, D124, Q126), the loop between 
α5 and α6 (M172, G173, F174), the N-terminus of α6 (N177), and the C-terminus of α7 
(V190) (Fig 4.5A).  Most of the large chemical shift changes upon diubiquitin attachment 
occur on the UBA domain of HIP2 (Fig 4.5B), something that was not observed with a 
single Ub thiolester mimic.  Residues M172, G173, F174 and V190 form an exposed 
hydrophobic interaction surface on the UBA domain in the loop connecting α5 and α6 
(Fig 4.5C).  Since this hydrophobic MGF patch was not affected upon attachment of UbP, 
these residues must interact with the UbD molecule.  This hydrophobic patch on the UBA 
domain has been previously shown to bind free Ub in both HIP2 and Ubc1 (11, 12).  The 
same hydrophobic patch on the UBA domain is therefore used to contact both free Ub, 
and UbD in HIP2-Ub2. 
Several residues from the catalytic core of HIP2 are also undergoing  
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significant line broadening following attachment of the UbD.  This includes residues in 
the loop between the ‘active site helix’ and α2 (M104), in α2 (L113, A115), and in the 
loop between α2 and α3 (A120, E121, D123) and α3 (A131).  Chemical shift changes on 
the loop between α2 and α3 (A119, D124, Q126) comprise a small but distinct surface 
that is interacting with Ub2 in HIP2-UbP-UbD but not in HIP2-UbP.  These chemical shift 
changes measured around the active site may indicate a slight change in the position of 
UbP upon addition of the second UbD.  Residues I91-D98 that were significantly line 
broadened in HIP2-UbP remain significantly line broadened in HIP2-UbP-UbD.  This 
indicates that the surface of interaction previously seen in HIP2-UbP is primarily 
maintained.  The loop between α2 and α3 could therefore be in contact with either a 
slightly repositioned UbP that maintains most of the previous interactions or be in contact 
with a small portion of UbD.  In either case, the UBA domain is predominantly 
interacting with the UbD and minimal changes are noticed in the vicinity of the active site 
in HIP2-Ub2. 
 
4.3.7 HIP2-Ub2 does not significantly dimerize 
The HIP2 UBA domain has been shown to preferentially bind poly-Ub chains 
over mono Ub in solution (10).  The structure of another UBA domain that binds K48-
linked Ub2 indicated that this specific UBA domain could contact the hydrophobic face 
of both Ub moieties at once (13).  If the HIP2 UBA domain could interact freely with an 
attached Ub or Ub2 molecule on neighbouring HIP2 molecules, it is conceivable that 
UBA binding could result in dimerization and/or oligomerization of HIP2-Ub2.  To test 
this possibility, sedimentation equilibrium studies were performed with HIP2-Ub2 (HIP2-
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UbP-*UbD) in solution at 10.9, 8.7 and 5.7 µM giving masses of 41998 ± 798, 43420 ± 
387 and 42810 ± 464 Da respectively.  These values range from 4.5% to 8% larger than 
the expected mass of 40184.37 Da.  These molecular weights are very close to the 
approximate error (5%) for this technique, indicating that HIP2-Ub2 is predominantly 
monomeric at these three concentrations.  These results are consistent with previous 
dimerization studies on HIP2 and HIP2-Ub (Chapter 2).  Previous experimentation on the 
UbcH5c-Ub construct has shown that oligomerization produces a completely line 
broadened HSQC spectrum (14, 15).  HIP2-Ub2 does not produce a similar NMR 
spectrum, therefore oligomerization at higher concentrations used in NMR studies was 
not observed.  The UBA interactions observed here are therefore the result of 
intramolecular interactions and not intermolecular interactions involving oligomeric 
species. 
 
4.3.8 Combined interactions of both UbP and UbD within HIP2-Ub2 
As a control for the comparison of HIP2 to HIP2-Ub and HIP2-Ub to HIP2-Ub2, 
the chemical position of each residue in HIP2 was evaluated in comparison to HIP2-Ub2 
to determine if the combined addition of Ub2 is consistent with the individual additions of 
UbP and UbD.  Comparison of 1H-15N TROSY-HSQC spectra of *HIP2 with that of the 
*HIP2-UbP-UbD identified residues affected by addition of UbP-UbD (Fig 4.6A).  
Significant chemical changes were observed for residues in α1 (R11, F13, V16), β1 
(V29), the loop between β3 and β4 (N69), the loop containing the active site between β4 
and α2 (I79, N83, S85, G89, A90, A102), α2 (T108), the loop between α5 and α6 
(M172, G173, F174), the N-terminus of α6 (N177), and the C-terminus of 
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α7 (V190) (Fig 4.6B).  Residues that undergo significant line broadening were identified 
in the loop between α1 and β1 (K24, I27), β4 (V73), the loop containing the active site 
between β4 and α2 (H81, V87, I91-D98, M104), α2 (T105, L106, V109, L113, A115), 
the loop between α2 and α3 (A120, E121, D123, D127), and α3 (V130, A131) (Fig 
4.6B).  The chemical shift changes observed upon Ub2 attachment to HIP2 occur at the 
catalytic core of HIP2 and in the UBA domain of HIP2 that contacts UbD (Fig 4.6C).  
Highly affected residues are consistent with individual residue changes noticed between 
*HIP2 and *HIP2-UbP combined with changes observed between *HIP2-UbP and *HIP2-
UbP-UbD. 
 
4.3.9 UbD and UbP interactions within Ub2 
In order to identify residues in UbP or UbD that interact with the covalently-linked 
HIP2 species, the backbone resonance assignments for *UbP, *UbD, *UbP-UbD, and UbP-
*UbD were completed using 1H-15N HSQC and HNCA NMR spectra at 30 °C.  The 
assignment of UbP was 95% complete (72 / 76) for 1H and 15N amide resonances, while 
the assignment of UbD was 93% complete (71 / 76) for 1H and 15N amide resonances.  All 
assigned residues in UbP and UbD were reassigned in *UbP-UbD and UbP-*UbD except for 
G76 and R74 which broadened in UbD upon the formation of UbP-*UbD. 
Comparison of *UbD and UbP-*UbD spectra indicated that large chemical shift 
changes occurred in UbD for residues in β1 (T7), β2 (G10, I13), the loop between β3 and 
β4 (G47), β4 (R48, L50), the loop between β4 and α2 (G53), β5 (H68, V70), and the 
unstructured C-terminus (L73) (Fig 4.7A).  Comparison of *UbP and *UbP-UbD spectra 
demonstrated that large chemical shift changes occur in UbP for residues in β1 (T7), 
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Figure 4.7 Identification of chemical shift changes between UbD and UbP within Ub2.  (A) 
Expanded region of 600 MHz 1H-15N HSQC spectra displayed for *UbD (black) and UbP-*UbD 
(cyan).  (B) Expanded region of 600 MHz 1H-15N HSQC spectra displayed for *UbP (black) and 
*UbP-UbD (cyan).  Signals that undergo significant chemical shift changes (mean + one standard 
deviation) are labelled by residue and shifts are indicated with arrows.  Chemical shift changes 
are calculated using the equation in 4.2.5, and sample conditions are listed in Section 4.2.4.  
Ribbon and surface representation for (C) a structure for ‘closed’ UbP-UbD (PDB: 1AAR) and (D) 
a structure for ‘open’ UbP-UbD (PDB: 3AUL).  The Ub structure 1UBQ was used to map the 
interacting residues onto UbP and UbD.  Residues are coloured to indicate residues undergoing 
significant chemical shift changes (cyan) and residues experiencing significant line broadening 
(purple).  The secondary structure of individual Ub components are fully labelled, while ‘open’ 
and ‘closed’ Ub2 are only partially labelled.  The ‘open’ Ub2 is missing residues 74-76 on UbP so 
L73 represents the C-terminus.  K48* represents the new isopeptide bond that resembles a 
backbone amide resonance. 
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β2 (G10, I13), the loop between β3 and β4 (A46, G47), β4 (R48, L50), the loop between 
β4 and α2 (G53), β5 (H68, V70, R72), and the unstructured C-terminus (L73) (Fig 4.7B).  
For both UbP and UbD, these residues are predominantly located on the same β-sheet of 
Ub that makes up the classic hydrophobic patch centered on residues L8, I44, and V70.  
This hydrophobic patch is the main surface utilized by most Ub-binding domains to 
interact with Ub (16).  Nearly identical residues in the hydrophobic patch of UbP and UbD 
are utilized to interact with each other within the Ub2 complex.  These chemical shift 
changes are consistent with results obtained by a previous NMR analysis of Ub and Ub2 
(13) as well as with the ‘closed’ Ub2 conformation observed in the Ub2 crystal structure 
(Fig 4.7C) (17).  This ‘closed’ conformation was shown to be in equilibrium with an 
‘open’ conformation in solution since relaxation agents can interact with the residues at 
the buried interface showing they are solvent accessible (13).  Very recent 
experimentation has shown the ‘open’ conformation to be populated approximately 85% 
of the time (Dr. Kato personal communication).  These results indicate that although 
there are chemical shift changes supporting the presence of a ‘closed’ Ub2 structure, this 
structure is likely populated to a lesser extent than the preferred ‘open’ state.  A structure 
for this ‘open’ conformation has been solved in the Kato lab (PDB: 3AUL – personal 
communication) where the hydrophobic faces of both UbP and UbD are exposed to 
solution and point in the same direction (Fig 4.7D).  Assuming there is an equilibrium 
between the ‘open’ and ‘closed’ conformation of Ub2, when the ‘open’ structure is 
adopted, the hydrophobic faces of UbP and UbD would be exposed and accessible for 
interaction with HIP2 within HIP2-Ub2. 
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4.3.10 Distal UbD interactions within HIP2-Ub2 
In order to study the distal UbD in HIP2-Ub2, the NMR spectra of UbP-*UbD was 
compared to that of the HIP2-UbP-*UbD complex (Fig 4.8A).  Since the size of the 
compared molecules increases from 17651.7 Da (UbP-*UbD) to 40184.4 Da (HIP2-UbP-
*UbD), line broadening of signals in the spectra was expected and observed.  Comparison 
of UbP-*UbD with HIP2-UbP-*UbD indicates the distal Ub experiences significant 
chemical shift changes in β1 (T7), the loop between β1 and β2 (L8), β2 (I13, T14), the 
loop between β4 and α2 (R54), α2 (D58), the loop between α2 and β5 (Q62), β5 (L67, 
V70), and the unstructured C-terminus (L73) (Fig 4.8B).  Significant line broadening was 
also observed for residues in β3 (I44), β4 (R48, Q49, L50), the loop between β4 and α2 
(E51), and β5 (L69, L71) (Fig 4.8B).  A significant chemical shift and line broadening of 
residues on the classic hydrophobic patch of UbD indicates that this surface is interacting 
with HIP2 (Fig 4.8C).  Previous analysis of *HIP2-Ub2 indicated that the hydrophobic 
MGF patch on the UBA domain of HIP2 was responsible for this interaction.  This 
indicates that the MGF patch of the UBA domain binds to the classic hydrophobic patch 
of UbD in HIP2-Ub2.  The significant line broadening of residues around R48 also 
indicates that UBA interaction with UbD likely blocks accessibility of R48 (naturally 
K48) to additional protein interactions. 
A second observable effect on the distal Ub is the apparent doubling of certain 
signals.  This means that two signals can be observed in relatively close proximity where 
there used to be a single signal.  Two signals were observable for residues in β2 (T14), 
β3 (L43), the loop between β4 and α2 (R54, T55), α2 (D58, Y59), the loop between α2 
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and β5 (N60, Q62, K63) and β5 (S65).  Most of these ‘dual’ signals occur with the first 
signal having no change in chemical shift, and the second signal with a moderate change 
in chemical shift.  These ‘dual’ signals therefore likely represent an interaction in slow 
exchange between the UbD moiety and a region of HIP2 in HIP2-Ub2.  When mapped 
onto the surface of UbD, the residues associated with the ‘dual’ signal are all located on 
the N-terminal side, above the hydrophobic patch centered around α2 (Figure 4.8D).  
Chemical shift changes between the each set of ‘dual’ signals were often measured to be 
insignificant.  Therefore, these ‘dual’ signal surfaces were considered to be a fairly weak 
interaction.  These ‘dual’ signals were also observed on only a small region (R54-S65) of 
UbD.  This region is relatively exposed to solution in both free Ub and in either the ‘open’ 
or ‘closed’ Ub2 structure and does not overlap with the hydrophobic face of Ub.  The lack 
of observable equivalent signal doubling on HIP2 means the exact complementary 
interaction surface cannot be confirmed. 
When analyzing the data for significant chemical shift changes, the main 
interaction is clearly on the hydrophobic patch of UbD.  Therefore, UbD likely contacts 
the MGF hydrophobic region of the UBA domain of HIP2 in HIP2-UbP-UbD. 
 
4.3.11 Proximal UbP Interactions within HIP2-Ub and HIP2-Ub2 
The hydrophobic face of UbP was previously identified to interact with UbD in the Ub2 
(*UbP-UbD) complex.  In order to study the interactions of UbP within HIP2 complexes, 
the spectra of *UbP and *UbP-UbD were compared to that of HIP2-*UbP and HIP2-*UbP-
UbD.  Analysis of the labelled UbP demonstrated how HIP2 interacts with the surface of 
UbP.  This was first accomplished by comparing the *UbP spectrum to the HIP2-*UbP 
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spectrum.  In this comparison, significant chemical shift changes (>1SD) were observed 
for residues in β2 (I13), β3 (L43), β4 (K48), and β5 (L67, H68) as well as significant line 
broadening in the loop between β1 and β2 (L8), β3 (I44), β4 (Q49, L50), β5 (L69-R72), 
and the unstructured C-terminal residues L73 and G76 (Fig 4.9A).  The main conclusion 
from these results is that the hydrophobic face of Ub clearly rests against the HIP2 core 
domain upon attachment to the active site of HIP2 (Fig 4.9A – surface diagram).  It is 
interesting that residue K48 is the most highly shifted residue upon single UbP attachment 
to HIP2, as this residue is the key reactive residue in acceptor Ub molecules during poly-
Ub chain formation, only this UbP represents the donor Ub in poly-Ub chain formation. 
Comparison of *UbP-UbD and HIP2-*UbP-UbD was utilized to show how UbP in 
*UbP-UbD was affected through its direct attachment to HIP2.  Chemical shift changes 
were observed for residues in β1 (T7), β3 (R42, I44), the loop between β3 and β4 (G47), 
β5 (R72), and the unstructured C-terminal L73 (Fig 4.9B).  Residues experiencing 
significant line broadening were observed in β5 (V70, L71) and the unstructured C-
terminal G75, G76 (Fig 4.9B).  The major changes seen at the C-terminal residues were 
expected as this is the main attachment point for Ub2 to the HIP2 core.  It is interesting 
that there are less residues affected at the hydrophobic interface upon Ub2 attachment to 
HIP2 (Fig 4.9B) than following attachment of a single ubiquitin to HIP2 (Fig 4.9A).  This 
result indicates that the addition of UbD alters the interface between UbP and HIP2. 
Comparison of HIP2-*UbP and HIP2-*UbP-UbD was utilized to show how the 
attachment of UbD affects binding of the proximal UbP to the HIP2 catalytic core.  
Comparison of these spectra resulted in the observation that significant chemical shift 
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changes are occurring for residues in β1 (T7), β3 (F45), β4 (K48), the loop connecting β4 
and α2 (E51), and β5 (L67, H68).  The large chemical shift change for K48 is expected 
on UbP as this residue is the attachment site for UbD.  Significant chemical shift changes 
are also seen on the N-terminal region of the UbP hydrophobic face due to direct contact 
with UbD (Fig 4.9C).  Many signals previously line broadened when a single Ub was 
attached to the HIP2 core were also observed to ‘reappear’.  These ‘reappearing’ signals 
were observed for residues in the loop between β1 and β2 (L8), β3 (I44), β4 (Q49, L50), 
β5 (L69, R72), and the unstructured C-terminal L73 (Fig 4.9C).  These residues are 
located in the C-terminal region of the UbP hydrophobic face showing that this 
interaction surface that was previously line broadened in HIP2-UbP spectra is now visible 
in the HIP2-UbP-UbD spectra (Fig 4.9A, C).  The cause for the reappearance of signals is 
likely due to the disruption of protein interactions between HIP2 and UbP upon the 
addition of UbD.  The resulting UbP is therefore less closely associated with the HIP2 
core domain. 
 
4.4 Discussion 
4.4.1 HIP2 surface involved in interaction with UbP 
The surface of HIP2 utilized to contact UbP was determined by comparing the 1H-
15N TROSY-HSQC spectra of *HIP2 and *HIP2-UbP.  The residues highly affected in 
HIP2 upon attachment of UbP are located predominantly near the active site cysteine on 
the catalytic core of HIP2.  It is also clear that there are minimal chemical shift changes 
in the UBA domain of HIP2 upon formation of HIP2-UbP.  Previous studies support this 
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observation, as the Ubc1-UbP disulphide also shows no contacts between UbP and the 
UBA domain (2).  Although free Ub has been shown to interact with the UBA domain of 
HIP2 in solution (10, 11, 18), an interaction between the UBA domain and covalently 
bound Ub in HIP2-UbP does not occur (Fig 4.10A). 
Models of E2-Ub have been developed for Ubc1-Ub (20), and UbcH8-Ub (19), 
and structures have been presented for hUbc13-Ub (21), and UbcH5b-Ub (22, 23).  The 
positioning of Ub is different for each E2 enzyme.  Recent experiments with Ubc13-Ub 
and UbcH5b-Ub have shown the covalently attached Ub to be highly mobile, indicating 
the Ub molecule likely does not adopt a single conformation on the surface of these E2 
enzymes (24).  Therefore, the high-resolution models and structures of all E2-Ub 
complexes may represent ‘snap shots’ showing a preferential position of an otherwise 
highly mobile attached Ub that can adopt several orientations when bound to an E2.  The 
interaction surface for Ub on the HIP2 catalytic core seems to include residues radiating 
out in all directions from the attachment point of C92.  No single Ub position can account 
for all of these chemical shift changes and line broadening signals.  This indicates that 
UbP may be sampling various bound positions on the HIP2 core (Fig 4.10A).  The 
missing signals from significantly line broadened residues (I91-D98) may actually 
represent the strongest interaction surface between HIP2 and UbP.  Signal broadening 
may be the result of intermediate exchange between the bound and the unbound position 
of Ub on HIP2, which could indicate that these residues at the active site and in the 
‘active site helix’ represent the main contact surface between HIP2 and UbP in HIP2-UbP. 
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Figure 4.10 Models of combined interaction surfaces within HIP2-UbP and HIP2-UbP-UbD.  (A) 
Model of *HIP2-UbP indicating interactions on HIP2.  (B) Model of HIP2-*UbP indicating 
interactions on UbP.  (C) Combined model of HIP2-UbP indicating interactions between HIP2 and 
UbP derived from interactions shown in (A) and (B).  (D) Model of *HIP2-UbP-UbD indicating 
interactions on HIP2 upon addition of Ub2.  (E) Model of HIP2-UbP-UbD indicating surfaces on 
UbP and UbD that are affected by interaction with HIP2 derived from *UbP-UbD versus HIP2-
*UbP-UbD and UbP-*UbD versus HIP2-UbP-*UbD.  (F) Combined model of HIP2-UbP-UbD 
derived from interactions observed in (D) and (E). Models in (D) and (E) are depicted 
simplistically, while the slightly altered model in (F) is depicted to better represent protein 
positioning.  The UBA domain was rotated to visualize the hydrophobic patch.  Ribbon and 
surface representations are based on previous structures of HIP2-UbP (HIP2 PDB:1YLA with 
altered UBA positioning and PDB:2GMI for UbP positioning to match Ubc13~Ub) and HIP2-
UbP-UbD (PDB:3AUL bound manually to HIP2).  Residues are coloured for the active site 
cysteine (orange), significant chemical shift changes (cyan), and significant line broadening 
(purple).  Shaded area of simplistic models indicates interaction surfaces and two sided arrows in 
ribbon models are coloured identically to indicate these interaction surfaces.  The orange arrow 
and circled region in (F) indicates the region of UbD that undergoes signal doubling and the 
probable region of the HIP2 catalytic core that interacts with UbD. 
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Previous experiments with the Ubc1Δ~Ub thiolester (no UBA) indicates Ub interacts 
with Ubc1Δ α2 helix and is the basis of the ‘compact’ E2-Ub model (20).  The results on 
HIP2 show α2 to be less affected upon UbP attachment, indicating a HIP2-UbP structure 
likely would not be identical to the previously reported structure for Ubc1-UbP. 
Recent studies on Ubc1 found that residues T84 and Q122 were instrumental in 
poly-Ub chain formation (25).  The equivalent residues in HIP2, T88 and Q126, undergo 
either a significant chemical shift (T88) or significant line broadening (Q126) upon UbP 
attachment.  This demonstrates that these residues are affected by the attachment of a 
disulphide bound Ub at the active site.  This may indicate these residues are important for 
the correct positioning of the thiolester bound Ub to aid in poly-ubiquitination activity. 
 
4.4.2 UbP surface involved in interaction with HIP2 
Comparison of the 1H-15N HSQC spectra of *UbP and HIP2-*UbP indicates that 
the hydrophobic patch on UbP binds to the HIP2 catalytic core domain.  This interaction 
was observed through the extreme line broadening of signals from residues on the 
hydrophobic patch of UbP, and confirms the corresponding interaction surface observed 
around the HIP2 active site (Fig 4.10B).  The combined interaction surfaces between 
HIP2 and UbP are depicted in Figure 4.10C whereby the HIP2-UbP structure was built by 
alignment to the Ubc13-Ub structure.  This structure is consistent with SAXS data 
(Chapter 2) indicating that it best represents the average position of Ub within HIP2-UbP.  
It is clear that the UbP depicted in Figure 4.10C must undergo a rotation to bury its 
exposed yet interacting hydrophobic patch, while retaining the same general Ub position 
to agree with the average SAXS structure.  Although Figure 4.10C represents a ‘snap 
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shot’ of the average HIP2-UbP structure, UbP may be mobile allowing for a mixture of 
elongated and compact structures.  A highly mobile UbP may transiently bind to several 
locations on HIP2, which may explain why the interaction surface on HIP2 is located 
both above and below the UbP attachment point (Fig 4.4C).  The severe line broadening 
in select residues is likely due to intermediate exchange between the association and 
dissociation of UbP with the catalytic core of HIP2.  Intermediate exchange is consistent 
with a highly mobile Ub in HIP2-UbP that could oscillate between an unbound and at 
least one bound position for UbP. 
The hydrophobic patch on UbP has been shown to be affected by attachment to 
other E2 enzyme catalytic cores from Ubc1 (20), Ubc13 (24), Ubc2b (26), and Ube2S 
(27).  However, the hydrophobic surface of Ub is not always utilized in E2-Ub contacts.  
For example, UbcH8 utilizes a different contact surface on UbP (19), and UbcH5c does 
not seem to bind UbP (14, 15).  Thus, HIP2 associates with the hydrophobic face of UbP 
while some other E2 enzymes do not.  Regardless of high mobility, differences in 
preferred Ub orientations in E2~Ub thiolester structures may play a role in E3 ligase and 
substrate specificity by presenting alternate available interaction surfaces on various 
E2~Ub structures. 
 
4.4.3 HIP2 UBA binds UbD 
The surface of HIP2 utilized to contact Ub2 was determined by comparing the 1H-
15N TROSY-HSQC spectra of *HIP2 and *HIP2-UbP-UbD.  Additional changes in HIP2 
were observed with the addition of UbD.  Some chemical shift changes were observed 
around the active site, but the most significant changes occurred in residues that form a 
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hydrophobic patch (M172, G173, F174 and V190) on the UBA domain of HIP2.  The 
importance of this MGF hydrophobic patch is demonstrated by the high conservation of 
this sequence across many UBA domain alignments (28).  Recent studies on HIP2 show 
this hydrophobic patch (M172-F174, V190, T194, L198) on the UBA domain binds free 
Ub (11, 18).  This result indicates the UBA hydrophobic patch used to bind free Ub in 
solution is also used to contact UbD in a covalently attached HIP2-Ub2 complex (Fig 
4.10D).  Ubc1 was also observed to bind free Ub through the UBA domain utilizing the 
similar QGF residues in the loop between α5 and α6 as well as many residues in α7 (12).  
HIP2 binding to free Ub also involved some α7 residues (T194, L198) (11).  These 
residues in α7 that interact with free Ub were not seen to interact with UbD of the HIP2-
UbP-UbD construct.  The lack of full interaction of the UBA α7 residues with UbD may be 
due to intramolecular steric constraints within the HIP2-Ub2 complex that allows only a 
limited surface of the UBA to contact the UbD. 
Previous experiments with a similar UBA2 domain from hHR23A demonstrated 
UBA binding to free K48-linked Ub2 chains (13).  This UBA2 binding to Ub2 utilized the 
end of α2 (α6 in HIP2) and most of α3 (α7 in HIP2) to simultaneously contact both the 
proximal and distal Ub (13).  The HIP2 UBA domain has also been shown to bind Ub2 
chains more strongly than a single Ub moiety and thus may bind Ub2 through the same 
residues used with UBA2 (10).  In HIP2-Ub2, however, very few chemical shift changes 
in the UBA domain were observed to match the pattern of Ub2 binding identified in the 
hHR23A UBA2 domain (13).  These results indicate that the UBA domain does not 
position itself in a similar fashion to bind both UbP and UbD in HIP2-UbP-UbD as it likely 
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could with free Ub2.  This is likely the result of intramolecular steric constraints that do 
not allow UbP to contact the UBA domain. 
Residue N177 at the beginning of α6 was also affected upon UbD attachment, but 
faces the opposite direction of the hydrophobic patch.  This residue was not observed in 
binding to free Ub or Ub2 in the UBA2 domain of hHR23A (13), to free Ub in Ubc1 (12), 
or to free Ub in the HIP2 UBA domain (11).  N177 therefore represents a novel 
interaction point in the HIP2-Ub2 complex, and its shifting cannot be explained by 
comparison to other UBA-Ub interactions.  It is not immediately apparent what region of 
the HIP2-Ub2 complex contacts UBA domain residue N177. 
 
4.4.4 HIP2-Ub2 does not dimerize 
The HIP2 UBA domain has been shown to bind Ub (11, 18), and poly-Ub chains 
with even higher affinity (10).  These interactions clearly allow for the possibility that 
two HIP2-Ub2 thiolesters could homodimerize.  However, sedimentation equilibrium 
results indicated HIP2-Ub2 had very little tendency to oligomerize in solution.  
Oligomerization has previously been seen with the UbcH5c-Ub complex that resulted in a 
completely line broadened NMR spectrum (14, 15).  The NMR spectrum of HIP2-Ub2 
did not show similar line broadening of all signals indicating that oligomerization does 
not occur.  The mechanism of a UBA driven dimerization is not favoured by the 
observation that intramolecular contacts occlude the Ub hydrophobic patch within the 
HIP2-Ub and HIP2-Ub2 complexes.  In HIP2-UbP, the hydrophobic surface of UbP 
interacts with the catalytic core of HIP2 and is not easily accessible to the UBA domain 
of another HIP2 enzyme.  Upon formation of HIP2-UbP-UbD, the UBA domain involves 
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itself in an intramolecular interaction with the UbD.  These uni-molecular interactions are 
likely to be much stronger than a bi-molecular interaction and thus association between 
different HIP2 molecules (dimerization) is not preferred.  Extrapolating from these 
results, it is expected that the UBA domain will also bind longer chains attached to the E2 
enzyme and thus UBA driven dimerization of HIP2 should not be favoured regardless of 
covalently attached poly-Ub chain length.  This knowledge further supports the 
conclusion that HIP2 poly-Ub chain activity functions in a monomeric fashion as was 
suggested in Chapter 2.  Since no E3 ligase was used in these studies, E3 assisted 
dimerization of HIP2 cannot be ruled out as a possible function of this enzyme in vivo. 
 
4.4.5 The hydrophobic face of UbD binds the HIP2 UBA domain 
Analysis of the *HIP2-Ub2 complex indicated that the hydrophobic MGF patch 
on the HIP2 UBA domain was significantly affected upon addition of UbD (Fig 4.10D).  
Investigation of *UbD in the same HIP2-Ub2 complex identified chemical shift changes 
involving residues on the classic hydrophobic patch of *UbD indicating that this surface 
was reciprocally affected within this complex (Fig 4.10E).  These results indicate that the 
MGF patch on the HIP2 UBA domain directly interacts with the hydrophobic patch on 
UbD within the HIP2-Ub2 complex (Fig 4.10F – green shaded areas and arrow).  These 
same interaction surfaces used between UbD and the UBA were previously identified 
upon interaction of free Ub with the HIP2 UBA domain (11, 18).  This indicates that UbD 
is bound by the UBA in the same manner to which it would interact with free Ub. 
In order to allow the UBA domain to contact UbD within the HIP2-Ub2 complex, 
the hydrophobic face of UbD must be exposed.  This would only be possible when Ub2 
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adopts the ‘open’ structure allowing for the hydrophobic patch of both UbP and UbD to be 
available for interactions with HIP2 (Fig 4.10F).  Due to the complex nature of the 
interactions involving numerous protein species, computational modelling of HIP2-Ub2 
was not performed.  However, visual depiction of the protein interaction surfaces are 
detailed in Figure 4.10F by manual alignments of Figure 4.10C and the ‘open’ Ub2 
structure.  Figure 4.10F should be treated as a visual aid only, and rotation of these 
proteins to bury the interaction surfaces indicated by double-sided arrows to form a more 
globular structure likely represents the true form of the HIP2-Ub2 complex.  Visual 
interpretation of interaction surfaces and use of the ‘open’ Ub2 structure appears to place 
UbD above the loop between α2 and α3 on the HIP2 catalytic core (Fig 4.10F).  This 
leaves the N-terminal ‘dual’ signal surface of UbD pointing towards the loop between α2 
and α3 on HIP2 (Fig 4.10F – orange arrow), while the UBA domain would interact with 
the hydrophobic face of UbD (Fig 4.10F – green arrow).  The N-terminal ‘dual’ signal 
region of UbD was observed to experience a slow exchange between UbD and an 
unknown region of HIP2 in HIP2-Ub2.  Since many residues in the loop between α2 and 
α3 on HIP2 were affected upon addition of UbD, it is likely that this region contacts the 
N-terminal ‘dual’ signal region of UbD, although this is only an assumption since 
equivalent signal doubling was not observed in the HIP2 spectrum (Fig 4.10F – orange 
arrow and circled region). 
The structure of the Ub2 moiety has been shown to be in equilibrium between the 
‘open’ and ‘closed’ structures.  The incorporation of the ‘closed’ structure of Ub2, cannot 
be fully discounted but appears unlikely.  If the HIP2-Ub2 complex utilized the ‘closed’ 
structure of Ub2, this would leave the UBA domain to interact weakly through an on and 
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off binding equilibrium to the exposed N-terminal region of UbD presumably causing 
signal doubling in UbD.  The chemical shift changes and line broadening observed for 
residues on the buried hydrophobic patch on UbD upon attachment of Ub2 to HIP2 would 
then be due to a slight rearrangement of UbD on the face of UbP.  This binding mode is 
unlikely as the highly affected MGF residues in the UBA domain appear significantly 
shifted and contain no trace of equivalent signal doubling, as would be expected if this 
region were oscillating between UbD bound and unbound states.  It is therefore more 
likely that the weak signal doubling involves a weak interaction between UbD and HIP2 
within HIP2-Ub2.  This interaction on UbD aligns quite nicely with the additional line 
broadened signals observed on HIP2 within HIP2-Ub2 (Fig 4.5C, orange arrow in 4.10F). 
 
4.4.6 UbP interaction with HIP2 is altered within HIP2-Ub2 
Analysis of UbP within HIP2-Ub2 is complicated in that there are several sub-
complexes to be compared to fully understand the interacting proteins.  These complexes 
include both UbP-UbD and HIP2-UbP compared to HIP2-UbP-UbD allowing for the 
identification of individual contacts from HIP2 and UbD on UbP.  The spectral 
comparison of *UbP-UbD and HIP2-*UbP-UbD indicates that only the C-terminal residues 
of UbP are affected following attachment of Ub2 to HIP2.  The presence of UbD has 
significantly altered the interaction between HIP2 and UbP such that the full hydrophobic 
patch of UbP no longer interacts with HIP2 to yield highly line broadened signals (Fig 
4.10B, C versus Fig 4.10E, F – focus on UbP surface changes).  The weakening of the 
HIP2 interaction with UbP must be caused by either the steric strain of the UBA 
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interaction with UbD, or the simple steric strain caused by the presence of UbD that 
interferes with the HIP2-UbP interacting surfaces. 
The spectral comparison of HIP2-*UbP and HIP2-*UbP-UbD indicates the effects 
that addition of UbD will have on HIP2-UbP.  The N-terminal region of the UbP 
hydrophobic face undergoes chemical shift changes due to direct contact with UbD.  
Residues in the C-terminal region of the UbP hydrophobic face that were previously line 
broadened in HIP2-UbP were observed to reappear in the spectrum upon addition of UbD 
(Fig 4.10C versus Fig 4.10F – purple signals change to cyan).  This reappearance is 
significant as the size of the molecule is larger and thus increased signal decay would be 
expected to cause weaker signals, not stronger signals.  Increased signal intensities also 
cannot be explained by differences in protein concentration, as the larger complex is less 
concentrated than the smaller complex (433 µM HIP2-*UbP, 325 µM HIP2-*UbP-UbD).  
These results may show that the UbP residues are no longer strongly associated with the 
HIP2 catalytic core domain upon the addition of UbD, or it may show that UbP no longer 
samples various bound positions against the HIP2 catalytic core within HIP2-UbP-UbD. 
 
4.4.7 HIP2-UbP and HIP2-Ub2 model analysis 
The ribbon/surface structures depicted for HIP2-UbP and HIP2-Ub2 were 
developed to aid in visualizing the interaction surfaces (Figure 4.10C, F).  SAXS analysis 
has indicated the structure in Figure 4.10C accurately represents the general shape of 
HIP2-UbP in solution (Chapter 2).  This structure shows UbP to be fully exposed to 
solution, but line broadening for the residues on the hydrophobic face of UbP and HIP2 
indicate these residues are at least transiently interacting (Fig 4.10C).  The association of 
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the HIP2 catalytic core and the hydrophobic surface of UbP indicates that UbP is at least 
intermittently blocked from other protein interactions. 
The HIP2-Ub2 structure was constructed through manual alignment of HIP2 
(PDB: 1YLA with ‘relaxed’ UBA position) and the ‘open’ structure of Ub2 (PDB: 
3AUL).  The position of UbP within Ub2 was aligned to that of HIP2-UbP depicted in 
Figure 4.10C.  This HIP2-Ub2 structure is shown only for illustrative purposes (Fig 
4.10F), and the true structure likely adopts a much more compact form whereby the HIP2 
UBA domain is in contact with UbD altering the position of the Ub2 to create a more 
globular structure. 
 
4.4.8 Occlusion of K48 within HIP2-UbP and HIP2-Ub2 
Upon analysis of HIP2-*UbP, it is interesting that residue K48 on UbP experiences 
the most significant chemical shift following attachment to HIP2.  Residue R48 was 
correspondingly seen to shift significantly in the E2-Ub complex of Ubc1, the yeast 
homolog of HIP2 (20).  This result likely indicates that the K48 residue on a thiolester 
bound Ub would be buried on the surface of HIP2 and not be available to serve as an 
acceptor Ub in chain elongation.  Alternatively, this large chemical shift change occurs 
on the edge of the interaction interface, which could indicate an increased acceptor 
reactivity of residue K48.  The use of HIP2~Ub as a Ub acceptor would require another 
HIP2~Ub as the Ub donor.  A poly-ubiquitination reaction using HIP2-UbP as an 
acceptor was observed to proceed forming HIP2-Ub2 when no other acceptors were 
supplied (Chapter 2).  This reaction would require a dimeric HIP2 mechanism.  The 
HIP2-Ub/HIP2-Ub association was measured to have a dimerization Kd >1000 µM, while 
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HIP2 UBA association with Ub and Ub4 was reported to have a Kd of 400 µM and 155 
µM respectively (Chapter 2) (10).  These results indicate that the HIP2~Ub thiolester (Ub 
donor) preferably binds free Ub or poly-Ub chains as acceptors as opposed to the HIP2-
Ub complex.  The reason the HIP2-Ub complex makes a poor Ub acceptor may be related 
to the hydrophobic surface of Ub interacting with the HIP2 catalytic core.  This 
interaction would make the surface on Ub within HIP2-Ub less accessible to interact with 
the UBA domain of a second HIP2~Ub thiolester (Ub donor).  HIP2-Ub likely still reacts 
as a Ub acceptor (Chapter 2) due to a mobile UbP that can expose its hydrophobic surface 
and K48 residue.  When HIP2-Ub is in its extended (exposed Ub) form the Ub can act as 
a Ub acceptor by interacting with the UBA domain of another HIP2~Ub thiolester 
driving poly-Ub chain extension.  These results indicate that the large chemical shift in 
K48 of UbP within HIP2-UbP is likely based on occlusion of the K48 residue due to it 
being predominantly buried as opposed to increasing its reactivity as a Ub acceptor. 
Upon analysis of HIP2-UbP-*UbD, significant line broadening of residues I44, 
R48, Q49, L50 and E51 indicates that the UBA interaction with UbD involves direct 
contacts of R48 (normally K48).  Recent experiments examining the UBA domain of 
HIP2 binding to free Ub showed residues I44, K48 and Q49 to be highly affected (11, 
18), but residues L50 and E51 were minimally affected.  In contrast, L50 and E51 were 
completely line broadened in UBA binding to UbD within HIP2-UbP-UbD.  These results 
indicate that while residue K48 is on the edge of the interaction surface between free Ub 
and the UBA domain, it is likely more buried on the interaction between the UBA and 
UbD.  The occlusion of K48 on UbD within HIP2-Ub2 would block UbD as an acceptor Ub 
in chain elongation.  The blockage of K48 in both HIP2~Ub and HIP2~Ub2 thiolesters 
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would make these intermediates act poorly as Ub acceptors for poly-Ub chain extension.  
The predominantly buried K48 residues should make HIP2~Ub and HIP2~Ub2 thiolesters 
act only as Ub donors in poly-Ub chain extension.  Previous experiments with the E2 
enzyme Ube2g2 have shown that E3 ligase dimerization leads to proposed dimerization 
of Ube2g2 responsible for active site linked poly-Ub chain formation (29).  A similar E3 
induced dimerization of HIP2-Ub and/or HIP2-Ub2 complexes is unlikely to aid poly-Ub 
chain formation as long as the Ub K48 residues remain occluded.  These results indicate 
E3 assisted dimerization is unlikely for HIP2, although this possibility cannot be 
completely excluded. 
 
4.4.9 HIP2-Ub2 models can rationalize previous activity assays on Ubc1 
The HIP2 UBA domain blockage of K48 residues in UbD within HIP2-Ub2 can be 
used to explain previous studies investigating auto-ubiquitination of Ubc1 where UBA 
removal resulted in increased poly-Ub chain length (30).  In this study, poly-Ub chain 
activity of wild type Ubc1 was measured through auto-ubiquitination on residue K93 that 
likely forms through the direct transfer of Ub from the active site C88 to the nearby K93 
residue.  This auto-ubiquitinated Ubc1 likely undergoes chain extension with Ubc1-K93-
Ub acting as a Ub acceptor through a reactive Ub K48 residue.  Experiments on full 
length Ubc1 resulted in K93 attached poly-Ub chains of roughly four Ub’s in length, 
while Ubc1Δ (Ubc1 with no UBA domain) produced much longer poly-Ub chains up to 
12 Ub’s in length (30).  On the assumption that the UBA domain in Ubc1 behaves 
similarly to the UBA domain in HIP2, once Ubc1 has a chain of Ub2 or longer, the UBA 
domain should interact with UbD and at least temporarily occlude K48 resulting in the 
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blocking of chain extension.  Removal of the UBA domain would increase the exposure 
of K48 residues making the attached poly-Ub chains better Ub acceptors and therefore 
increasing the resultant chain length of auto-ubiquitination of Ubc1.  The purpose of 
auto-ubiquitination of Ubc1 remains unknown, and the long reaction time (16 hours) may 
indicate this activity is not biologically significant, but the model for HIP2-Ub2 indicating 
the K48 residue in Ub is occluded can be used to rationalize the experimental results for 
Ubc1.  These results show that the Ubc1 UBA domain inhibits poly-Ub chain extension 
by blocking the terminal Ub.  It is therefore reasonable to assume that the Ubc1 UBA 
domain likely behaves in a similar manner to the HIP2 UBA domain, as both enzymes 
likely block Ub K48 residues in thiolester attached poly-Ub chains. 
 
4.4.10 Conclusions 
HIP2 can produce unanchored K48-linked poly-Ub chains in solution using only 
the E1 activating enzyme and ubiquitin (Ub) (1).  The biological significance of 
unanchored chain building by HIP2 remains unknown, but the observation that Ub2 can 
be loaded onto HIP2 just as easily as Ub indicates these chains can be used to create 
HIP2~Ub and HIP2~Ub2 thiolesters and probably HIP2~Ubn thiolesters (1).  These 
intermediates can form in vitro but their presence in vivo is unconfirmed.  These 
observations are consistent with a poly-Ub chain preassembly mechanism for the 
labelling of protein substrates.  The NMR investigation of HIP2~Ub and HIP2~Ub2 
thiolester mimics has led to a better understanding of the structure of these intermediates.  
It has been observed that there is a significant interaction between HIP2 and Ub within 
the HIP2-UbP complex.  It was also observed that the UBA domain contacts UbD within 
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the HIP2-UbP-UbD complex.  These interactions have resulted in the Ub K48 residues 
being occluded in these structures.  This indicates that HIP2~Ub and HIP2~Ub2 
intermediates should act preferably as Ub donors for poly-Ub chain extension. 
The intramolecular interaction of UBA/UbD within HIP2-Ub2 would make the 
UBA domain less available for interaction with Ub acceptors.  If the UBA domain drives 
poly-Ub chain assembly by affinity to Ub acceptors, then the HIP2-Ub2 would be 
resistant to continued poly-Ub chain extension since the UBA is blocked.  The 
intramolecular UBA/UbD interaction also explains why HIP2-Ub2 was observed to be 
predominantly monomeric, as the HIP2~Ub2 molecule would have neither the UBA 
hydrophobic surface nor the UbD hydrophobic surface available for interactions with 
another HIP2-Ub2.  The HIP2 N-terminal region in HIP2-Ub2 is still available for 
interaction with both E1 and E3 enzymes in these structures.  The available E1 and E3 
interaction could allow a HIP2~Ubn intermediate to connect Ubn to a substrate through 
the standard E1-E2-E3 enzyme cascade.  The biological presence of E2~Ubn thiolesters is 
unknown, although the ability of the HIP2 UBA domain to interact with thiolester 
attached poly-Ub chains will aid in the clarification of HIP2 functional mechanisms. 
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Chapter 5 
Summary and Discussion 
5.1 Introduction 
The ubiquitin proteolysis pathway is an essential regulatory mechanism used for 
the degradation of short-lived, damaged, misfolded or denatured proteins within the cell 
(1).  Ubiquitination utilizes three enzymes, E1, E2 and E3 to respectively activate, 
transfer and ligate ubiquitin (Ub) onto a substrate protein.  The creation of K48-linked 
poly-Ub chains on a substrate will target this protein to be degraded by the 26S 
proteosome (1).  Ubiquitination is crucial for maintaining cell homeostasis.  Specific 
mutations in ubiquitination enzymes and interactors can cause disruption of cell 
homeostasis, leading to several diseases including cancer and neurodegenerative 
disorders (2).  The E2 conjugating enzyme is the central enzyme in the ubiquitin 
proteolysis pathway.  Previous studies examining the structural details of E1/E2 and 
E2/E3 interactions has characterized the general mechanism for Ub transfer through the 
E1-E2-E3 enzyme cascade.  However, how poly-Ub chains are created is much less well 
understood.  Several poly-Ub chain assembly mechanisms have been proposed in various 
ubiquitination pathways (3).  The main competing mechanisms include the sequential 
addition model where poly-Ub chains are built on the substrate one at a time, and the 
preassembly model where poly-Ub chains are formed prior to attachment to substrate (3). 
In this thesis, HIP2 and its yeast homolog Ubc1 were investigated to determine 
their mechanism of poly-Ub chain formation.  These enzymes have been observed to 
have poly-Ub chain activity in the absence of E3 enzymes and substrates (4, 5).  These 
  
205 
E2 enzymes are also unique in that they contain a C-terminal UBA domain known to 
bind Ub non-covalently (6, 7).  The ability of these enzymes to produce poly-Ub chains 
unattached to substrates suggests poly-Ub chains may be preassembled in vivo.  The 
Ubc1 enzyme has recently been shown to preferably extend chains on mono-
ubiquitinated substrates indicating it may function through a sequential addition model 
(8).  The HIP2 enzyme has very few identified E3 enzyme partners and substrates and 
therefore has a very poorly understood biological role, although its function has been 
implicated in the progression of both Huntingtin’s and Alzheimer’s disease (9-12).  
Experimental investigations on both Ubc1 and HIP2 were performed to help clarify their 
mechanism of poly-Ub chain formation. 
 
5.2 Previous studies on poly-Ub chain mechanisms 
The only structural evidence for the formation of poly-Ub chains comes from the 
Ubc13/Mms2 E2 heterodimer that is responsible for K63-linked poly-Ub chain assembly 
(13).  The main discovery from this structure was that two E2 enzymes could position 
two Ub molecules to be directly reacted to create a Ub-Ub connection.  Many other E2 
enzymes have also been implied to either homodimerize or be brought into close 
proximity through E3 dimerization.  Strong evidence for E2 dimerization has been 
acquired through differentially tagged Ube2g2~Ub thiolesters that can directly react with 
each other to create a thiolester linked Ube2g2~Ub2 (14).  This activity required its 
cognate E3 enzyme that has been found to dimerize indicating poly-Ub chain assembly in 
Ube2g2 may occur through E3 assisted dimerization (15).  These previous experiments 
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have provided strong evidence that dimerization of E2 or E3 enzymes may be very 
important in the formation of poly-Ub chains within many ubiquitination pathways. 
The non-covalent binding of Ub has also provided another mechanism for poly-
Ub chain formation.  This was observed on the HECT E3 KIAA10 that was found to bind 
one Ub through a thiolester, and a second Ub non-covalently.  The mechanism of poly-
Ub chain assembly is presumably accomplished through the positioning of these 2 Ub 
molecules in close proximity to allow the C-terminal thiolester of one Ub to react with 
the lysine side chain of the other Ub (16).  The ability of KIAA10 to bind two Ub 
molecules indicates it may function through a monomeric mechanism. 
The homologous enzymes Ubc1 and HIP2 have both been shown to have poly-Ub 
chain activity without E3 enzymes, and have both been shown to bind Ub non-covalently 
(4-6, 17).  These results allow for the possibility that Ubc1 and HIP2 may function by 
either the proposed monomeric or dimeric mechanisms used by KIAA10 and Ube2g2 
respectively.  This thesis has focused on using physical and structural studies as well as 
activity assays to clarify the mechanism of poly-Ub chain assembly utilized by HIP2 and 
Ubc1. 
 
5.3 Dimerization of HIP2 and Ubc1 is not a major determinant for poly-
Ub chain activity 
HIP2 and Ubc1 both have K48-linked poly-Ub chain activity that is independent 
of an E3 ligase or substrate (4, 5).  Since E2 dimerization has been suggested to drive 
poly-Ub chain formation, the Ubc1 and HIP2 enzymes were investigated for their ability 
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to dimerize.  The Ubc1-Ub, HIP2-Ub and HIP2-Ub2 thiolester mimic complexes were 
also studied since previous work on the E2 enzyme Cdc34 indicated that formation of 
thiolesters may assist dimerization (18).  Sedimentation equilibrium was performed on 
low concentrations of Ubc1, Ubc1-Ub, HIP2, HIP2-Ub and HIP2-Ub2 to determine 
accurate molecular weights (MW).  HIP2 and Ubc1 were found to be very close to their 
expected monomeric molecular weight.  The addition of Ub to these enzymes can result 
in the reported MW to be as much as 7-11% larger than expected, while the addition of 
Ub2 to HIP2 can result in the reported MW to be as much as 8% larger than expected.  
These values are close to the 5% error range of this technique indicating that the proteins 
are predominantly monomeric.  If dimerization is occurring, a self-association model can 
be used to estimate the Kd of dimerization, but since dimerization is very weak, a reliable 
Kd cannot be acquired for these enzymes at low concentrations.  Therefore, higher 
concentrations of Ubc1, Ubc1-Ub, HIP2, and HIP2-Ub proteins were studied with SAXS 
to determine their dimerization capacity.  The SAXS analysis also found these proteins to 
be predominantly monomeric at concentrations up to 200 µM.  Since minimal 
dimerization was observed even at these higher concentrations, only an estimation of Kd 
limitations is possible through comparison to theoretical Kd curves.  These calculations 
indicate the Kd values for Ubc1-Ub and HIP2-Ub self-association must be >1000 µM.  Kd 
values of >1000 µM confirm very weak self-association of the Ubc1-Ub and HIP2-Ub 
indicating thiolester formation did not greatly assist dimerization. 
The HIP2 enzyme was further studied with NMR spectroscopy.  NMR 1H-15N 
TROSY-HSQC spectra collected on HIP2, HIP2-Ub and HIP2-Ub2 did not experience 
severe line broadening of all amide protons, as was observed for UbcH5c-Ub complex 
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known to oligomerize (19), indicating HIP2 and its thiolester mimics are likely 
monomeric even at higher NMR concentrations of ~350-550 µM.  NMR chemical shift 
perturbation experiments were used to determine and characterize any protein 
interactions within HIP2, HIP2-Ub and HIP2-Ub2.  These results indicate that 
intramolecular interactions occur within both HIP2-Ub and HIP2-Ub2.  These 
intramolecular interactions occur between the HIP2 catalytic core and UbP within HIP2-
UbP, and between the HIP2 UBA domain and UbD within HIP2-UbP-UbD.  These 
interactions block the hydrophobic surface of UbP and UbD in HIP2-Ub and HIP2-Ub2 
respectively.  The presence of a UBA domain in HIP2 that binds Ub non-covalently 
could theoretically bind the thiolester bound Ub of another HIP2-Ub complex to cause 
dimerization.  The observed intramolecular interaction within HIP2-Ub and HIP2-Ub2 
limits the availability of these attached Ub and Ub2 moieties to interact with a second 
HIP2 UBA domain.  As a result, the intramolecular interactions within HIP2-Ub and 
HIP2-Ub2 are preferred over any intermolecular interactions between HIP2-Ub and HIP2-
Ub2.  These structural observations explain why possible UBA/Ub binding does not result 
in dimerization of HIP2-Ub or HIP2-Ub2.  Additionally, a dimeric mechanism would also 
require reactive K48 residues on Ub in either HIP2-Ub or HIP2-Ub2, and these residues 
appear buried against HIP2 making them unlikely to act as Ub acceptors (Fig 5.1A).  
These combined results indicate that Ubc1 and HIP2 very likely do not function using a 
dimeric mechanism for unanchored poly-Ub chain formation. 
Previous experiments on Ubc1Δ resulted in the novel finding that E1 was required 
for poly-Ub chain extension, suggesting it directly extends chains or may function as an  
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Figure 5.1 Proposed models of HIP2 Function.  Ubiquitination pathway components include the 
HIP2 E2 conjugating enzyme (blue), Ub (pink), an E3 ligating enzyme (yellow), a substrate 
(orange) to be ubiquitinated, and small green balls represent the reactive K48 on Ub or reactive K 
residue in the substrate.  (A) Model of HIP2~Ub and HIP2~Ub2 indicating blocked K48 residues 
that do not preferably react with another HIP2~Ub thiolester.  (B) Model of unanchored poly-Ub 
chain formation driven by UBA affinity for free Ub and poly-Ub chains.  Movement of the UBA 
domain would bring the Ub K48 lysine into reactive distance with the thiolester bound Ub.  (C) 
Model demonstrating how a preassembled poly-Ub chain can be loaded onto the E1 enzyme, 
transferred to HIP2 and then finally transferred to a substrate protein.  (D) The sequential addition 
model for HIP2 using an already mono-ubiquitinated substrate would function nearly identically 
to (B) only substrate-Ub would be bound to both the E3 and the UBA domain.  The E3 enzyme 
contacts the HIP2 catalytic core and the substrate only. 
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E2 dimerization scaffold (20).  In contrast, activity assays performed in this work on 
HIP2 and Ubc1 indicate that E1 enzyme removal after E2 thiolester charging did not 
affect poly-Ub chain extension.  This result shows the E1 enzyme does not directly assist 
poly-Ub chain extension.  The removal of the E1 enzyme also shows that it is not 
required as an E2 dimerization scaffold.  Since E3 enzymes were not studied in this work, 
we cannot discount the possibility of E3 assisted E2 dimerization, although there is 
currently no evidence to support E3 assisted HIP2 dimerization. 
 
5.4 The monomeric mechanism employed by HIP2 
Since HIP2 has been observed to be more active in unanchored poly-Ub chain 
activity than Ubc1, and was more thoroughly investigated in this work, only its proposed 
mechanism will be discussed in detail.  The observation that dimerization of HIP2 is very 
weak indicates these enzymes likely function in a monomeric fashion to build poly-Ub 
chains without E3 enzymes.  A monomeric HIP2 enzyme most likely functions by 
utilizing its ability to interact with at least two Ub molecules at once, one Ub covalently 
through a thiolester linkage at the active site, and a second Ub non-covalently using the 
UBA domain (17, 21).  These interactions may allow HIP2 to place two Ub molecules in 
close proximity to assist the formation of Ub2.  This possible mechanism is supported by 
SAXS data that indicates the HIP2 UBA domain is linked to the catalytic core by a 
flexible linker, just like Ubc1 (6).  This flexible linker may give the UBA domain the 
ability to be repositioned to place the acceptor Ub’s K48 residue within range for 
nucleophilic attack with the thiolester bound Ub donor (Fig 5.1B).  In this reaction, the 
resulting Ub2 would be unanchored and free in solution.  Therefore, this is the likely 
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mechanism utilized for the observed unanchored poly-Ub chains produced with only E1 
enzyme, HIP2 and Ub. 
The proposed monomeric HIP2 mechanism depicted in Figure 5.1B would be 
driven by the UBA affinity for acceptor Ub molecules.  The HIP2 UBA domain is known 
to bind Ub4 with a Kd of 155 µM while a single Ub moiety binds with a weaker Kd of 400 
µM (7).  These results indicate that the HIP2 UBA domain binds poly-Ub chains 
preferentially, an observation that has been reported previously on other isolated UBA 
domains (7).  The UBA domain’s preference for binding longer poly-Ub chains may 
explain previous studies on HIP2 that have shown that Ub2 acts as a better acceptor than a 
single Ub (4).  The UBA domain’s preference for free Ub2 chains over a single Ub 
indicates that the rate of unanchored poly-Ub chain formation should increase as these 
poly-Ub chains grow longer.  Activity assays have demonstrated that a HIP2-Ub complex 
can react with a HIP2~Ub thiolester to make a HIP2-Ub2 complex.  Initially, it was 
thought that this supported a dimeric mechanism for HIP2.  However, the association 
between HIP2-Ub/HIP2-Ub was determined to have a Kd of >1000 µM.  This binding is 
weaker than that for free Ub4 (155 µM) and free Ub (400 µM) indicating that HIP2-Ub is 
a less preferred acceptor.  Structural analysis of the HIP2-Ub complex may explain how 
HIP2-Ub can react with another HIP2~Ub thiolester.  SAXS experiments have shown 
HIP2-Ub to be on average a rather ‘elongated’ structure, while NMR experiments have 
found that there are significant contacts between HIP2 and Ub within HIP2-Ub.  The 
interactions between HIP2 and UbP in the HIP2-UbP complex show few large chemical 
shift changes and a high number of highly broadened residues on both HIP2 and UbP.  
This indicates that there may be intermediate exchange occurring between HIP2 and UbP 
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as a result of at least 1 tightly bound form and 1 loosely bound form of HIP2-UbP.  
Previous experimentation has shown E2~Ub structures to be highly mobile (22), which is 
consistent with both the observed average ‘elongated’ structure in SAXS and the 
proposed intermediate exchange between at least 2 Ub positions within HIP2-Ub in NMR 
experiments.  A mobile HIP2~Ub thiolester structure would result in an equilibrium 
between blocked and exposed Ub.  When Ub is exposed within HIP2~Ub, the Ub would 
be able to interact with another HIP2~Ub thiolester’s UBA domain accounting for its 
ability to act as an acceptor in activity assays.  However, the HIP2-Ub complex was not 
observed to be a preferred acceptor because the surface of Ub is transiently blocked when 
HIP2-Ub is in its more tightly associated form.  Since HIP2-Ub binds with lower affinity 
than free Ub, it is likely the HIP2-Ub2 product is an artifactual by-product of not having 
any available free Ub acceptor.  These results are consistent with the proposed UBA 
driven monomeric mechanism where longer chains bind more strongly to the UBA 
domain (Fig 5.1B). 
 
5.5 Preassembled poly-Ub chains may be used in vivo 
Previous experiments have shown that Ub and Ub2 can form thiolesters on the 
HIP2 enzyme with identical kinetics (4).  These results indicate that preassembled 
unanchored Ub2 can then be loaded onto the E1 enzyme and then transferred to HIP2 just 
as easily as a single Ub molecule.  Previous experiments have also shown that 
unanchored poly-Ub chains are found in vivo, and that these chains were able to be 
connected to substrates with kinetics indistinguishable from mono-ubiquitin using Ubc4 
(23).  The Ube2g2 E2 enzyme was also shown to be able to connect a synthesized poly-
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Ub chain directly onto a substrate (14).  These combined results show that loading E2 
enzymes with poly-Ub chains appears kinetically equivalent to using a single Ub moiety, 
and that poly-Ub chains can be directly transferred to substrates.  Therefore, preassembly 
of poly-Ub chains in solution by HIP2 could be followed by the loading of these chains 
onto HIP2 creating HIP2~Ubn thiolester intermediates.  The study of HIP2-Ub and HIP2-
Ub2 complexes has shown that the Ub K48 residues are occluded indicating these 
thiolester linked Ub and Ub2 moieties are likely to act predominantly as Ub donors in 
poly-Ub chain extension.  In this way, the UBA domain would act as an inhibitor of poly-
Ub chain extension on HIP2-Ubn.  HIP2-Ubn intermediates could then act as Ub donors 
and interact with both an E3 ligase and a substrate resulting in the transfer of the Ubn 
directly to a substrate in a single step (Fig 5.1C).  This mechanism describes how 
preassembled poly-Ub chains could be transferred onto substrates by the HIP2 enzyme. 
 
5.6 HIP2 poly-Ub chain preassembly in Alzheimer’s disease 
HIP2 has been linked to Alzheimer’s disease through involvement with the 
protein UBB+1.  UBB+1 is a frameshift mutant of Ub that contains a 19 residue C-terminal 
extension that cannot form a thiolester with ubiquitination enzymes (11).  Previous 
experiments indicate HIP2 can poly-ubiquitinate the UBB+1 protein on its K48 residue in 
vitro, and this UBB+1-Ubn resists disassembly by deubiquitinating enzymes and causes 
potent proteosome inhibition (11).  HIP2 activity has also been found to increase 
neurotoxicity and proteosome inhibition in vivo (12).  The UBA domain of HIP2 has 
recently been shown to interact with both UBB+1 and Ub in a similar manner, and in the 
same study, in vivo experiments showed that HIP2 UBA domain mutations reduced 
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proteosomal inhibition (17).  These results indicate that HIP2 poly-ubiquitination of 
UBB+1 is likely involved in the proteosomal inhibition experienced in Alzheimer’s 
disease.  UBB+1 is simply a normal Ub molecule with a 19-residue extension at the C-
terminus meaning it can be recognized as a Ub acceptor by the UBA domain of HIP2, but 
cannot form a thiolester with ubiquitination enzymes.  Therefore, HIP2 likely causes 
poly-ubiquitination of UBB+1 by mistakenly using this molecule as a normal Ub acceptor 
in unanchored poly-Ub chain assembly (Fig 5.1B).  By this mechanism, HIP2 would bind 
UBB+1 with the UBA domain and react it with a thiolester connected Ub to yield UBB+1-
Ub.  Proceeding reactions would use UBB+1-Ub as the acceptor eventually creating a 
UBB+1-Ubn product.  This molecule resists disassembly and accumulates to inhibit 
proteosomes.  UBB+1 poly-ubiquitination and related proteosomal inhibition has also 
been shown to increase aggregate formation and cell death in polyglutamine diseases 
such as Huntington’s disease (9, 24, 25).  The preassembly mechanism for poly-Ub 
chains by the HIP2 enzyme can therefore be utilized with UBB+1 to inhibit the 
ubiquitination proteolysis pathway resulting in severe pathological consequences. 
 
5.7 The sequential addition model for Ubc1 and HIP2 
Although HIP2 can preassemble poly-Ub chains in vitro, its major physiological 
role may be to utilize the sequential addition mechanism where poly-Ub chains are 
sequentially built on a substrate protein. This mechanism is supported by recent 
experimentation on the ubiquitination of Cyclin B by the large multisubunit anaphase 
promoting complex (APC – a RING E3) and the E2 enzymes Ubc4 and Ubc1 (8).  In this 
study, Ubc4 and Ubc1 appear to have different functions as Ubc4 was more active in 
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initial Ub attachment to substrates and Ubc1 was more active in extending chains on 
substrates that already have a single attached Ub (8).  HIP2 was also observed to extend 
chains on substrates in combination with UbcH10, although these results showed very 
low activity on the substrate Cyclin indicating this substrate may not be a preferred 
substrate of HIP2 (8).  Ubc1Δ (no UBA domain) was also investigated, and was found to 
yield substrate attached poly-Ub chains of shorter length (8).  The UBA domain of Ubc1 
is therefore required for full activity in substrate poly-Ub chain extension (8).  These 
results are consistent with a sequential addition model whereby Ubc4 mono ubiquitinates 
a substrate and Ubc1 adds Ub molecules to the growing chain.  It is reasonable to assume 
HIP2 may function similarly with a proper E3 enzyme and substrate.  The sequential 
addition mechanism may function in a similar manner to unanchored poly-Ub chain 
formation (Fig 5.1B), whereby the Ub acceptor of free Ub is replaced with a substrate 
bound Ub (substrate-Ub) (Fig 5.1D).  If the true biological function of Ubc1 and HIP2 is 
to extend poly-Ub chains on substrates, then the UBA domain may aid this activity by 
directly binding to the Ub attached to a substrate (Fig 5.1D).  The E2~Ub/E3/substrate-
Ub complex depicted in Figure 5.1D would provide affinity for substrate-Ub through 
both E3 binding and E2 UBA binding.  The UBA domain may therefore increase the 
reaction rate of this E2 enzyme by providing additional interactions for substrate-Ub 
extension by directly binding the growing chain.  This mechanism would suggest that the 
formation of poly-Ub chains prior to attachment to substrate observed for HIP2 and Ubc1 
is simply an artifactual activity caused by lack of E3 ligases and substrates, and therefore 
not the major biological function of these enzymes. 
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The sequential model for HIP2 and Ubc1 poly-Ub chain extension is also 
supported by analysis of required reaction times.  Significant unanchored poly-Ub chain 
activity requires reaction times on the order of hours without an E3 ligase and substrates 
(4, 5), while poly-ubiquitination of mono-ubiquitinated substrates had reaction times on 
the order of minutes for Ubc1, and 90 minutes for a non-specific substrate for HIP2 (8).  
These experiments indicate ubiquitination reactions occur more quickly in the presence 
of E3 enzymes that place E2~Ub thiolesters in close proximity to ubiquitinated 
substrates.  These faster reaction rates are more biologically significant than those for 
unanchored chain assembly. 
Ubiquitination of mono-ubiquitinated substrates was also demonstrated for the E2 
enzymes UbcH5 and Cdc34 whereby UbcH5 preferably mono-ubiquitinates substrates 
and Cdc34 efficiently performs poly-Ub chain extension on these mono-ubiquitinated 
substrate (26).  Sequential poly-Ub chain assembly has also been strongly supported for 
Cdc34 where substrates were seen to have Ub’s added one at a time through a 
millisecond timescale reaction system (27).  Although little is known of HIP2’s E3 
enzymes and substrates, support for the sequential addition model with its yeast homolog 
Ubc1 indicates that HIP2 may function in a similar manner.  The biological function of 
HIP2 may then be to extend chains on already mono-ubiquitinated substrate molecules 
(Fig 5.1D). 
 
5.8 Conclusions 
Structural investigation of HIP2-Ub and HIP2-Ub2 has characterized the 
intramolecular interactions observed within these intermediates.  HIP2-Ub and HIP2-Ub2 
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both have occluded Ub hydrophobic faces including the K48 residue indicating these 
species are preferred Ub donors and not Ub acceptors in poly-Ub chain extension (Fig 
5.1A).  These results in addition to thorough dimerization studies indicate HIP2 functions 
through a monomeric mechanism to build poly-Ub chains (Fig 5.1B).  The purpose of 
preassembling poly-Ub chains remains unknown, although previous kinetic assays 
indicate these preassembled chains could be loaded onto E2 enzymes and then transferred 
onto substrates (Fig 5.1C) (4, 14, 23).  This model would involve the use of the UBA 
domain to first aid in the construction of poly-Ub chains, followed by inhibiting chain 
extension during transfer to a substrate.  HIP2 may also utilize a sequential addition 
mechanism where a growing poly-Ub chain is bound to a substrate.  This mechanism is 
supported by the observation that Ubc1 (yeast homolog of HIP2) can preferentially 
extend chains on mono-ubiquitinated substrates (8).  HIP2 is suspected to behave in a 
similar fashion to extend poly-Ub chains on substrates, although there is currently little 
evidence for such activity.  This sequential addition model would utilize both the E3 
interaction with substrate, and the UBA interaction with a substrate attached poly-Ub 
chain (Fig 5.1D). 
The monomeric UBA driven mechanism of HIP2 can explain both the 
preassembly model and sequential addition model (Fig 5.1B, D).  The general mechanism 
of HIP2 function is identical between these two models, but the reaction rates may be 
faster with the sequential addition model due to additional interaction surfaces provided 
by the E3 enzyme and monoubiquitinated substrate.  Although both mechanisms are 
possible, the sequential addition model appears to be preferred due to the observation that 
poly-Ub chain activity of Ubc1 without E3 enzymes required hours, while poly-Ub chain 
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activity with E3 enzymes and substrates required only minutes (8).  The mechanisms 
depicted in Figure 5.1B and 5.1D would utilize the UBA domain’s interaction with Ub to 
position two Ub molecules in close proximity.   The affinity of UBA binding to Ub and 
Ub4 has a Kd of 400 and 155 µM respectively (7).  The cellular concentration of Ub is 
around 10 µM (28, 29) and the cellular concentrations of E2 enzymes are likely in the 
low µM (<10 µM) to nM range.  With these cellular concentrations and UBA/Ub Kd 
values, it is expected that unanchored poly-Ub chain activity would not proceed with 
significant reaction rates in the absence of an E3 enzyme and substrate.  The addition of 
the E3 enzyme is likely required to greatly increase the effective concentrations of HIP2 
and ubiquitinated substrate to increase the reaction rate.  Additionally, the mere binding 
of E3 enzymes to the E2 enzyme also has been shown to increase catalytic activity of the 
E2 enzyme (30, 31).  The sequential addition model is preferred over the preassembly 
model since there are currently no known mechanisms in vivo that would increase the 
kinetic rate of unanchored poly-Ub chain formation observed in HIP2.  However, the 
mechanism of unanchored chain formation appears to function in vivo with UBB+1, 
which can be involved in proteosome inhibition in Alzheimer’s and Huntington’s disease 
(9, 12). 
 
5.9 Future Work 
In this work, low-resolution structural details were acquired for HIP2 and HIP2-
Ub using SAXS.  Chemical shift perturbation studies were also performed to determine 
protein interaction surfaces within HIP2-Ub and HIP2-Ub2 complexes.  However, a high-
resolution structural model of ‘compact’ HIP2-Ub and HIP2-Ub2 was not completed due 
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to ambiguous constraints for computer-aided protein docking.  Additional NMR 
experiments may be required to provide sufficient protein-protein interaction data to 
properly dock these structures.  These experiments could include hydrogen-deuterium 
exchange and cross-saturation experiments both of which can provide residue specific 
information of a protein-protein interface.  This additional data may allow for a high 
quality structural model of HIP2-Ub or HIP2-Ub2.  These structures could then be used to 
investigate the preferred orientation of Ub and Ub2 in HIP2-Ub and HIP2-Ub2.  The 
position of thiolester attached Ub and Ub2 would determine the available surfaces of 
these proteins that could interact within larger protein complexes including E3 enzymes 
and substrates. 
Currently HIP2 has only been well studied for its unanchored chain formation 
activity and very little is known of its biological function with E3 enzymes and 
substrates.  The best identified E3 and substrate for HIP2 may be the E3 enzyme NARF 
(Nemo-like Kinase (NLK) – associated RING finger) and the transcription factors TCF 
(T Cell Factor) and LEF (Lymphoid Enhancer Factor).  NARF and TCF/LEF were 
identified by in vivo coimmunoprecipitation experiments and ubiquitination assays.  A 
recent study developed an approach that allows for in depth kinetic assays on 
ubiquitination in the millisecond to second timescale (27).  If this approach was utilized 
on HIP2 with a known E3 (NARF) and substrate (TCF/LEF), then the formation of poly-
Ub chains can be quantitated as they form.  This experiment would provide strong results 
to show whether HIP2 utilizes a sequential addition model to build poly-Ub chains on the 
substrate, or whether poly-Ub chains are preassembled by HIP2 and then connected to a 
substrate. 
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The monomeric mechanisms for HIP2 proposed in this work suggest that 
UBA/Ub binding allows HIP2 the ability to place two Ub molecules in close proximity to 
aid poly-Ub chain formation.  It may be possible to capture these two Ub molecules in 
close proximity using X-ray crystallography.  The HIP2 protein has been previously 
crystallized both alone and in complex with free Ub (17, 32).  These previous 
crystallizations should provide details to aid in future crystallizations of HIP2.  To 
determine how HIP2 can position two Ub molecules for poly-Ub chain assembly, it 
should be possible to crystallize the HIP2-Ub disulphide in complex with free Ub.  This 
crystal structure would be expected to have a significantly altered UBA position to allow 
a Ub-Ub linkage.  If the UBA positions the non-covalently bound Ub in close proximity 
to the thiolester, then it would be expected that this structure should be fairly compact 
making it a good candidate for protein crystallization.  This structure would be the first 
E2 structure to mechanistically detail how K48-linked poly-Ub chains can be formed.  
This structure would be immensely valuable to determining the structural and enzymatic 
details for how HIP2 performs K48-linked poly-Ub chain formation. 
X-ray crystallography could also be utilized to support the proposed sequential 
addition model depicted in Figure 5.1D.  Upon identification of an E3 enzyme and 
substrate for HIP2, these proteins could be mixed with a HIP2-Ub thiolester mimic to 
possibly create a tightly interacting complex.  The use of a mono-ubiquitinated substrate 
may increase the affinity of this complex by allowing UBA/Ub-Substrate interactions.  
Structural details of such a complex would greatly aid in determining HIP2’s possible 
biological role of extending poly-Ub chains on substrates through a sequential addition 
model. 
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